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1 Introduction 
As unicellular organisms, bacteria are constantly threatened by their rapidly changing 
environment. To thrive under such ever-changing conditions and compete with other 
microorganisms for resources, they are forced to sense and quickly adapt to different niches. 
On that account, bacteria have developed complex regulatory networks and elaborated 
survival strategies. Especially, pathogenic bacteria need a plethora of adaptive responses 
when they switch from an outside habitat to their host. Inside their host, bacteria encounter a 
resource rich environment, stable temperature, but they are also confronted with host 
responses that induce nutrient/iron depletion and the host's immune system, as well as the 
competing microbiota. Therefore, bacteria are forced to efficiently coordinate the expression 
of virulence, virulence-relevant fitness factors and colonization factors and need to decide 
about the right time and location of expression. Decision making and fine adjustment of these 
factors are regulated on every level of gene expression, in large overlapping regulatory 
networks [Marceau, 2005; Erhardt & Dersch, 2015; Chen et al., 2016]. 
 
1.1 The genus Yersinia 
Yersinia are Gram-negative Enterobacteriaceae. They are rod-shaped, facultative anaerobe 
bacteria. As psychrophilic bacteria, they are able to grow at a temperature minimum between 
1-4 °C. Nonetheless, the optimal growth temperature for Yersinia is between 20-30 °C [Perry 
et al., 2007]. 
Yersiniae are described as a highly diverse group of 18 individual species, of which three are 
virulent and pathogenic to humans and other mammals [McNally et al., 2016]. The three 
pathogenic yersiniae, namely Yersinia enterocolitica, Yersinia pseudotuberculosis and 
Yersinia pestis are closely related. As demonstrated by multilocus sequence typing, 
Y. pseudotuberculosis and Y. pestis share more than 90% DNA homology [Achtman et al., 
1999]. Evolutionary, Y. enterocolitica and Y. pseudotuberculosis branched from their last 
common ancestor 50 million years ago, while Y. pestis and Y. pseudotuberculosis diverged, on 
an evolutionary scale just recently, 1,500 - 20,000 years ago and share an approximate DNA 
identity of 98% [Achtman et al., 1999; Prentice & Rahalison, 2007]. Although pathogenic 
yersiniae are genetically highly homologous, they exhibit extreme differences in virulence 
and pathogenicity, e.g. route of transmission and infection and the caused disease. While 
Y. enterocolitica and Y. pseudotuberculosis are enteropathogenic species and often cause mild 
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self-limiting gastroenteritis, Y. pestis is the causative agent of plague, a systemic disease with 
one of the highest mortality rates [Savin et al., 2014; Wren, 2003]. 
 
Both enteropathogenic species, Y. pseudotuberculosis and Y. enterocolitica, are globally 
widespread in the environment. They can be found in soil, water, in animals and on the 
surface of plants. Y. enterocolitica can be found in wildlife and domestic animals, especially 
pigs are important reservoirs for human infection [Kapperud, 1991; Bockemühl & Roggentin, 
2004; Fredriksson-Ahomaa et al., 2006]. Although they are both able to infect a variety of 
animals, Y. enterocolitica is a widespread human pathogen, while Y. pseudotuberculosis only 
sporadically infects humans. Enteropathogenic Yersinia are transmitted by ingestion of 
contaminated food or water via the fecal-oral route. Thereby, they cause gastrointestinal 
diseases, called Yersiniosis. Yersiniosis describes a wide range of diseases, like enteritis, 
mesenteric lymphadenitis and colitis. Especially, in young children, old or immune-
suppressed patients, enteropathogenic yersiniae can cause complications like reactive arthritis, 
erythema nodosum and bacteremia [Bottone, 1997; Galindo et al., 2011; Naktin & Beavis, 
1999]. 
 
Y. pestis displays a complex sheltered life cycle. During the course of its evolution it gained 
the trait to survive and replicate inside the flea gut and also the ability to be transmitted by 
flea bites, but at the same time lost the ability for colonization of the intestine. This new route 
of transmission enabled it to bypass the gut infection phase, which the enteropathogenic 
Yersinia species share. In combination with the accumulation of new virulence factors and a 
complete or a partial loss of genes, Y. pestis exhibits a higher virulence and causes harsher 
diseases, but displays a reduced genomic flexibility and metabolic streamlining [McNally et 
al., 2016]. It is normally endemic in rodents and cycles, transmitted by flea bites, between its 
rodent reservoir and its arthropod vector. The vector-borne transmission leads to bubonic and 
septicemic plague and can cause a secondary, pneumonic plague. Pneumonic plague leads to a 
rapid, airborne transmission between humans via droplets which cause a primary pneumonic 
plague. A primary pneumonic plaque after airborne infection displays a very low incubation 
time of only 2-3 days and if untreated a 100% mortality rate [Perry & Fetherston, 1999; 
Prentice & Rahalison, 2007]. 
All pathogenic Yersinia species have a tropism for lymphatic tissues and carry a virulence 
plasmid termed pYV in Y. enterocolitica, pIB in Y. pseudotuberculosis and pCD in Y. pestis. 
This plasmid encodes a type III secretion system (T3SS), anti-inflammatory effector 
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molecules to overcome the host immune defense and the adhesin YadA. Y. pestis acquired 
additional plasmids that support survival in their arthropod vector, capsule formation (pFra) 
and dissemination from the bite site (pPCP1) [Du et al., 2002; Rajana et al., 2010; Chouikha 
& Hinnebusch, 2012]. 
 
1.2 Route of infection 
The infection process of Y. pseudotuberculosis can be divided into two phases, the initial and 
the ongoing infection phase. Y. pseudotuberculosis enters the body by ingestion of 
contaminated food or water (initial infection phase). This phase is characterized by the 
invasion and colonization of the host and the expression of appropriative virulence factors. 
After transmigration through the intestinal barrier, Yersinia is threatened by the host innate 
immune system and expresses virulence factors required for the evasion of immune cells and 
the dissemination into deeper organs (ongoing infection phase) (Fig. 1.1). 
1.2.1 Initial infection phase 
The initial infection phase is characterized by the expression of early virulence factors and the 
passage from the outer environment through the gastrointestinal tract [Heroven et al., 2007]. 
During the initial infection phase, no host response can be measured [Handley et al., 2004]. 
The route through the gastrointestinal tract already requires a fast adaptation to stresses, like 
changing pH, changing oxygen levels, proteolytic enzymes and nutrient competition with 
other bacteria [Foster, 1999; Wallace et al., 2016; Spiro & Guest, 1990; Fang et al., 2016]. 
When the pathogen reaches the terminal section of the small intestine, the ileum, it utilizes the 
adhesion and invasion factor InvA to adhere to and finally penetrate the intestinal layer by 
exploiting microfold cells (M cells) (Fig. 1.1). These immunosurveillance cells cover the 
Peyer's patches - the lymphatic tissue of the intestines. Unlike enterocytes, they lack apical 
microvilli, have a reduced glycocalyx and are proficient for phagocytosis and transcytosis 
[Mabbot et al., 2013; Grützkau et al., 1990; Clark et al., 1998]. Invasion and colonization are 
further boosted by the expression of O-antigen coupled LPS and other adhesins [Uliczka et 
al., 2011; Skurnik & Toivanen, 1993]. 
Expression of invasin is maximally activated at temperatures below 30 °C in stationary phase. 
It has been suggested that expression of invasin under environmental conditions already 
prepares enteropathogenic yersiniae to effectively and immediately cross the intestinal barrier 
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[Pepe & Miller, 1993; Revell & Miller, 2000]. Invasin structurally and sequentially belongs to 
the intimin family and mediates interaction with M cells by β1-integrine binding. 
Interaction of integrin and invasin leads to a close binding to the target cell and in turn 
triggers an active uptake by the zipper mechanism. The invasin-integrin interaction induces a 
host cell signaling cascade that leads to rearrangements of the actin cytoskeleton and 
formation of filo- and lamellipodia that engulf the adhering bacterium [Dersch & Isberg, 
2000; Oelschlaeger, 2001; Grassl et al., 2003]. 
 
1.2.2 Ongoing infection phase 
The ongoing infection phase starts, after a successful invasion of the lamina propria and the 
Peyer's patches. Inside the Peyer's patches, Yersinia proliferates and forms necrotic 
microabscesses [Autenrieth & Firsching, 1996]. The ongoing infection phase is characterized 
by an immense influx of activated phagocytes into the site of infection, cytokine production 
and tissue necrosis [Autenrieth et al., 1993; Dube et al., 2003 Handley et al., 2004; Balada-
Llasat & Mecsas, 2006]. After the invasion of the Peyer's patches, Yersinia starts to 
disseminate into deeper tissues and organs, like mesenteric lymph nodes, liver, spleen and 
kidneys, where the pathogen resides mostly extracellularly in microcolonies. The ongoing 
infection phase requires a reprogramming of the bacterial cell to survive and proliferate inside 
lymphatic tissues (Fig. 1.1) [Bengechea et al., 2004; Cornelis, 2006; Heesemann et al., 2006]. 
To successfully establish an infection inside lymphatic tissues, the pathogen expresses various 
factors encoded on its virulence plasmid pYV. This includes the adhesin YadA and the 
Yersinia outer proteins (Yops), which are directly injected into the cytosol of target cells by a 
T3SS [Atkinson & Williams, 2016]. 
YadA is a multifaceted adhesion protein present in Y. pseudotuberculosis and 
Y. enterocolitica that forms a fimbrial matrix on the bacterial cell envelope [Hoiczyk et al., 
2000]. It is encoded on the virulence plasmid pYV and is transcribed at 37 °C from a σ70-
dependent promoter by the thermoregulated virulence master regulator LcrF. After the 
invasion, YadA is the predominant adhesion protein in infected tissues [Skurnik & Wolf-
Watz, 1989; El Tahir & Skurnik, 2001; Hoiczyk et al., 2000]. The adhesin YadA mediates 
binding to ECM (extracellular matrix) proteins, serum complement resistance and 
autoagglutination. Therefore, it is essential to establish and maintain the infection 
[Mühlenkamp et al., 2015; Wren, 2003; El Tahir & Skurnik, 2001]. In Y. pestis, the yadA 
gene is inactivated due to a frame shift mutation. The inactivation of the yadA gene in 
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Y. pestis is thought to be due to the new transmission route. Considering its ability to 
efficiently bind to the ECM (in particular collagen), YadA would hinder the efficient 
spreading from the entry site into deeper tissues and increase susceptibility to neutrophil 
extracellular traps (NETs) [Casutt-Meyer et al., 2010; El Tahir & Skurnik, 2001]. The length 
of YadA and the Ysc-T3SS are well-matched, allowing efficient delivery of anti-phagocytic 
effector molecules by the injectisome into host cells [Mota et al. 2005]. 
 
 
Figure 1.1: Infection route of enteropathogenic Yersinia species. The pathogens are ingested with contaminated food and 
subsequently pass the stomach and enter the small intestines. Here the bacteria pass the intestinal barrier by adhering and 
transmigrating through M cells. After reaching the underlying Peyers patches, they start to express virulence plasmid-
encoded virulence factors like the adhesin YadA, the injectisome and anti-phagocytic effector proteins to resist the innate 
immune system. Starting from the Peyer's patches, the bacteria spread to the mesenteric lymph nodes and into systemic 
organs such as kidneys, liver and spleen. This picture is adapted from Heroven & Dersch, 20141 
 
1.2.2.1 The Ysc-Yop virulon 
All pathogenic Yersinia species encode a complex molecular machinery for efficient host cell 
'toxin' delivery. This Ysc-T3SS (Yop secretion) is encoded on the 70 kb virulence plasmid 
(pYV). It exhibits a syringe-like structure, called injectisome. Since the loss of the Ysc-T3SS 
correlates with an avirulent phenotype, its function is absolutely crucial for virulence and 
pathogenicity [Cornelis, 2010]. Together with the adhesin YadA, the injectisome enables 
adherent bacteria to inject effector molecules specifically into the target cell. The injectisome 
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creates a continuous channel between the bacterial and eukaryotic cytosol while bridging 
three membranes - the bacterial inner and outer membrane and the host cell membrane. 
Translocated effector molecules have a large repertoire of biochemical activities and modulate 
the function of crucial regulatory pathways in the eukaryotic cell. Subsequently, this allows 
the pathogen to evade the host innate immune response [Cornelis & Wolf-Watz, 1997]. 
 
Homologs of the injectisome can be found in other Gram-negative pathogens, like Shigella 
flexerni, Salmonella spp. and the plant pathogen Xanthomonas spp. [Cornelis, 2006]. The 
injectisome shares structural homologies with the flagellar T3SS, pointing to a common 
evolutionary origin [Abby & Rocha, 2012]. Similar to the flagellum, the injectisome consist 
of a cylindrical basal body, which anchors the complex in the IM (inner membrane) and OM 
(outer membrane) and harbors an export apparatus. The extracellular part forms a capped 
needle-like structure (Fig. 1.1). 
The injectisome is a self-assembling multiprotein complex that consists of multiple copies of 
29 individual structural proteins (Ysc proteins). The basal body is assembled into two double 
rings and an inner rod that forms a channel for protein export [Marlovits et al., 2004]. The O-
ring anchors the T3SS inside the OM and the peptidoglycan layer and is formed by a 15mer of 
secretin (YscC). Thereby, YscC forms two distinct rings inside the OM and a neck-like 
structure embedded into the periplasmatic peptidoglycan layer, which connects to the MS-
ring. The MS-ring (membrane and supramembrane) is located in the IM and consists of a 
membrane-anchored layer of YscD and YscJ 24mers [Schraidt & Marlovits, 2011]. The 
assembled cytosolic C-ring consists of a YscQ 22mer and accessory proteins (YscKLO). It 
functions as a sorting platform involved in cargo handling. Central for its function is the 
ATPase activity of the YscN protein. YscN is an AAA
+
-type ATPase, which catalyzes 
substrate unfolding and chaperone removal of T3SS substrates [Akeda & Galán, 2005; Notti 
& Stebbins, 2016]. Recently, the non-flagellar C-ring was demonstrated to be highly dynamic, 
which explains the struggle to crystallize a fully assembled C-ring. The C-ring is composed of 
a YscQ 22mer cycling between a cytosolic and docked pool. This cycle is regulated by 
ATPase activity and secretion status [Diepold et al., 2015]. The inner basal body is formed by 
YscRSTUV proteins, which assemble the export apparatus. The rod (YscI) and the 
extracellular needle (YscF) form a continuous channel build from homomultimers spanning 
the cytosol and the extracellular milieu. The needle tip is capped by a 5mer of scaffold protein 
LcrV [Broz et al., 2007]. The oligomerization of the LcrV needle cap is considered as a final 
checkpoint in injectisome assembly. Secretion of structural components is stopped and the 
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secretion machinery remains in a standby mode until needed. Upon cell contact, the 
injectisome is activated to secrete the hydrophobic translocator proteins (YopBD). During this 
process, the hydrophilic translocator LcrV functions as an assembly platform for YopB and 
YopD to induce pore formation in the eukaryotic cell membrane (Fig. 1.2) [Cornelis, 2002; 
Diepold & Armitage, 2015]. 
 
Figure 1.2: Overview of the injectisome and its components. Left and middle panel show a 3D reconstruction 
of the needle complex from cryo-electron microscopic data in a side (left) and cut (middle) view. The left panel 
shows an overview of the injectisome and its structural components. The injectisome consists of the C-ring 
(yellow), the export apparatus (red), the MS-ring in dark blue, the O-ring and needle components (light blue) and 
the needle tip and the translocon (green). This figure is adapted from Diepold & Wagner, 2014
2
. 
 
Macrophages can internalize Yersinia cells within one minute. Considering this, a fast 
response is needed to save the bacterium. By rapid injection of Yop effector molecules, 
phagocytosis can be blocked. The arsenal of antiphagocytic effector molecules comprises six 
different Yops (YopEHJMT and YpkA). A set of the Yop effectors (YpkA, YopE, YopH, 
YopT) inhibit phagocytosis by disrupting the cytoskeleton (YpkA, YopEHT), suppress the 
production of proinflammatory cytokines and chemokines (YopEHM) and also induce 
apoptosis (YopM). All Yops possess enzymatic activities that mimic and hijack cellular 
signaling pathways (Fig. 1.3) [Cornelis, 2002; Navarro et al., 2005]. 
 
                                                 
2
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Yersinia protein kinase A or YpkA (YopO in Y. enterocolitica) displays serine/threonine 
kinase and guanine nucleotide dissociation-like inhibitor (GDI) activities that disrupt the actin 
cytoskeleton. With these enzymatic activities, YpkA targets the Rho GTPase activation status 
of RhoA and Rac1. The Ser/Thr kinase activity inhibits the activity of Rho activators, like 
WASP, WIP or cofilin by phosphorylation. The GDI domain directly binds to RhoA or Rac1 
and interferes with the nucleotide exchange of GDP to GTP, which in turn also blocks 
reactivation [Barz et al., 2000; Juris et al., 2000; Navaro et al., 2007]. 
YopE is a GTPase-activating protein (GAP). It is involved in the inactivation of Rho 
GTPases, like RhoA, RhoG, Rac1, Rac2 and Cdc42, by increasing GTP hydrolysis. Similar to 
YpkA this leads to cytoskeleton disruption and as a consequence to inhibition of 
phagocytosis. Interestingly, the GAP activity also inhibits maturation of caspase-1, caspase-1-
mediated macrophage responses and IL-18 maturation [Schotte et al., 2004]. 
The cysteine protease YopT is an inhibitor of Rho-GTPases. It post-translationally cleaves 
modified (cysteine prenylated) Rho-GTPases (RhoA, Rac1, Cdc42). This leads to Rho-
GTPase release from the cellular membrane. As a consequence, the actin cytoskeleton is 
disrupted, which induces rounding of the host cell, inhibits the formation of the actin-rich 
phagocytotic cup and reduces chemotaxis. Intriguingly, YopT also interferes with the NFκB 
signaling pathway [Shao et al., 2001; Aepfelbacher et al., 2003; Schmidt, 2010]. 
YopH is a protein tyrosine phosphatase that specifically targets and dephosphorylates focal 
adhesion proteins, like focal adhesion kinase (Fak), paxillin or p130
Cas
. By this mechanism 
YopH disrupts focal contacts and stress fiber, preventing phagocytosis by macrophages and 
neutrophils. Additionally, YopH suppresses the oxidative burst in macrophages and reduces 
Ca
++
 signaling in neutrophils. Furthermore, it induces T-cell apoptosis, suppress B- and T-cell 
activation and inhibits chemokine production in macrophages. In combination with all these 
immune-modulatory effects, YopH is the most potent effector molecule and especially needed 
for evasion of the early innate immune response [Aepfelbacher et al., 2007; Black et al., 
2000; Fahlgren et al., 2009]. 
YopJ (YopP in Y. enterocolitica) is a multifunction protein. It possesses acyl transferase, 
cysteine protease and deubiquitinase activity. These functions especially interfere with the 
MAPK and NFκB pathways. Moreover, it induces cell death in macrophages [Mills et al., 
1997; Orth, 2002]. 
YopM is a leucine-rich repeat protein and the only effector that is secreted into the 
extracellular milieu. It can enter host cells either by a T3SS-mediated injection or a direct 
penetration of the cell membrane. Intracellular YopM targets RSK and PRK isoforms and 
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caspase-1 to inhibit cytokine production and induce apoptosis [Rüter et al., 2010; Höfling et 
al., 2015]. [Chung et al., 2016] A recent study demonstrated, YopM recruits the PRK1/2 
kinases to phosphorylate and thereby inactivate pyrin. This mechanism prevents the YopE- 
and YopT-triggered activation of the pyrin inflammasome and promotes virulence [Schoberle 
et al., 2016]. 
 
 
Figure 1.3: Overview of Yersinia effector proteins and their targets. Pathogenic yersiniae inject anti-phagocytotic effector 
proteins into the cytosol of host cells modulating multiple eukaryotic signaling pathways. YpkA, YopH, YopT and YopE 
disrupt the cytoskeleton. YpkA inhibits the nucleotide exchange of Rho GTPases, needed for actin polymerization, thereby 
inhibiting reactivation. Similarly, YopT interferes with the membrane localization of Rho GTPases. YopE deactivates Rho 
GTPases by increasing the GTP hydrolyzes rate. YopH disturbs focal adhesions by a phosphorylation and inactivation of 
central focal adhesions complex components. All these cytoskeleton-interfering effector proteins cooperate in the prevention 
phagocytosis. The remaining effector proteins block cytokine production and/or facilitate apoptosis. YopJ blocks cytokine 
production by interfering with the NFκB and MAPK pathways. YopM targets RSK1/PRK2 kinases and caspase I to inhibit 
cytokine production and induce apoptosis. This figure is derived from Navarro et al., 2005
3
. 
 
The export of effector proteins and assembly of the injectisome is strictly ordered and tightly 
regulated. After assembly of a functional injectisome, a target switch of the export apparatus 
from structural components to translocator and effector proteins occurs. Translocator and 
effector proteins are bound by Syc (specific Yop chaperone) proteins (e.g. SycEHTN and 
LcrH/SycD), which are needed for solubilization and export of their cognate binding partner. 
                                                 
3
 Reprinted from Current opinion in microbiology, 8/1, Navarro L, Alto N, Dixon JE, Functions of the Yersinia effector 
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These chaperones are subdivided, based on their fold, into class I chaperones (SycEHO) and 
class II chaperones (SycD/LcrH). Until now, four class I chaperone/effector pairs have been 
found - SycE/YopE, SycH/YopH, SycO/YpkA (YopO) and SycT/YopT. Additionally, the 
class II chaperone LcrH (SycD) binds the two translocator proteins YopD and YopB. 
Moreover, the chaperone SycH also binds regulator LcrQ. The gatekeeper protein YopN is 
only functional when bound by SycN and YscB [Akeda & Galán, 2005; Page & Parsot, 2002; 
Stebbins & Gallan, 2001]. 
The role of the Ysc-Yop-T3SS as a microsyringe that directly delivers effector molecules into 
target cells, is controversially discussed at the moment. As demonstrated by Akopyan et al., 
effector molecules are secreted into the supernatant prior to cell contact and localize to the 
bacterial cell envelope [Akopyan et al., 2011]. Deletions in the N-terminal domain of YopH 
also revealed the presence of two separate domains for secretion and translocation. Deletion 
of the secretion domain prohibited effector secretion, although when cells were coated with 
these secretion-defective YopH proteins, translocation into target cells still took place 
[Akopyan et al., 2011]. Vice versa, deletion of the translocation domain still allowed secretion 
into the supernatant, although these effector proteins were translocation-incompetent. 
Considering this, a two-step model was proposed, in which secretion and translocation are 
uncoupled. Effectors and translocators coat the bacterial cell prior to cell contact and function 
together in a binary AB-toxin-like delivery mechanism [Akopyan et al., 2011; Edgren et al., 
2012; Pilar & Coombes, 2011]. 
 
1.3 Regulation of Type III secretion 
In vitro, virulence genes of the ysc-yop and yadA regulon are strongly induced at 37 °C during 
the late exponential growth phase. When cultures are shifted from 25 °C to 37 °C expression 
of T3SS genes is activated and injectisomes assembly starts. Upon calcium depletion, 
transcription of T3SS-associated genes is massively induced, enormous amounts of Yops are 
secreted into the supernatant and a growth arrest occurs. This phenotype is also known as the 
low calcium response (LCR) [Sample et al., 1989; Straley et al., 1993]. In vivo, transcription 
of T3SS-associated genes encoded on the pYV plasmid is triggered at 37 °C by cell contact, 
which causes secretion of effector proteins [Hakansson et al.; 1996, Pettersson et al., 1996]. 
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1.3.1 The virulence master regulator LcrF 
Expression of all Ysc-Yop T3SS genes depends on the presence of the transcriptional master 
regulator LcrF. LcrF is a DNA binding protein that belongs to the family of AraC-type 
transcriptional regulators. The DNA-binding activity is conferred by two conserved helix-
turn-helix motifs [Gallegos et al., 1997]. The N-terminal domain of AraC-like proteins 
contributes to the dimerization and binding of cofactors [Schleif, 2010]. Although LcrF forms 
dimers in solution, no cofactor binding has been described. LcrF activates pYV-encoded 
T3SS genes by binding to a TTTTaGYcTgTat DNA motif in the vicinity of the respective 
promoter regions [Wattiau & Cornelis, 1994]. Recently, it was demonstrated that LcrF and its 
homolog ExsA from Pseudomonas aeruginosa recognize the consensus sequence 
AaAAAnwnMygrCynnnmYTGyaAk (M: A or C; W: A or T; Y: C or T; R: A or G; K: G or 
T) [Brutinel et al., 2008; King et al., 2013]. 
LcrF is encoded on the bicistronic yscW-lcrF operon and expressed from the σ70-dependent 
PyscW promoter. The yscW gene (virG in Y. enterocolitica) encodes the lipoprotein YscW that 
functions as a pilotin for YscC [Burghout et al., 2004; Schwiesow et al., 2015; Yother et al., 
1986]. 
 
Expression of lcrF is repressed at moderate temperature (25 °C), activated at 37 °C and even 
further triggered under low calcium conditions (secretion condition). This strict 
thermoregulation ensures expression of the T3SS regulon only inside the warm-blooded host. 
Thermoregulation is controlled on multiple layers of gene expression. One player is the 
Yersinia modulator A (YmoA). YmoA is a small, nucleoid-associated protein, homologous to 
the E. coli Hha protein. It is known to influence DNA supercoiling and gene expression. 
Binding to DNA occurs via heterocomplex formation of YmoA with the nucleoid structuring 
protein H-NS [Balsalobre et al., 1996; Madrid et al., 2006; Nieto et al., 2002]. The H-NS-
YmoA heterocomplex represses T3SS expression at moderate temperatures (15-30 °C). By 
binding to a sequence downstream of the PyscW transcriptional start site (TSS) [Böhme et al., 
2012; Schwiesow et al., 2015]. At 37 °C, repression of lcrF is diminished as YmoA is 
degraded in a ClpXP- and Lon protease-dependent manner (Fig. 1.4) [Jackson et al., 2004]. 
Thermoregulation of lcrF is also controlled on the post-transcriptional level, independent of 
the YmoA-mediated transcriptional thermocontrol. Deletion of ymoA does not fully derepress 
lcrF transcription at moderate temperature and thermosensitivity of the T3SS regulon is 
maintained, even when lcrF is constantly transcribed [Böhme et al., 2012; Hoe et al., 1992; 
Hoe & Goguen, 1993]. The intergenic region between the yscW and the lcrF gene folds into 
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two hairpin structures - hairpin 1 and hairpin 2. Hairpin 2 contains the ribosomal binding site 
(RBS), as well as a thermolabile four uridine ('four U') motif. At moderate temperatures, the 
'four U' motif incompletely base-pairs with the AGGA motif of the RBS and prohibits 
translation by blocking access of the 30S ribosome to the RBS. With increasing temperatures, 
the interaction of the 'four U' motif with the RBS is gradually disturbed and finally permits 
lcrF translation at 37 °C (Fig. 1.4) [Böhme et al., 2012; Hoe & Goguen, 1993; Waldminghaus 
et al., 2007; Kortmann & Narberhaus, 2012]. 
Other 'four U' motifs are located in the 5'-UTR of heat shock and virulence genes like in the 
Salmonella enterica agsA gene or in the Vibrio cholera toxT gene, where they function as an 
RNA thermometer [Weber et al., 2014; Kortmann & Narberhaus, 2012]. 
 
 
Figure 1.4: Expression of lcrF is thermoregulated on the transcriptional and post-transcriptional level. The 
transcriptional thermoregulation is mediated by YmoA. At 25 °C, it interacts with promoter PyscW and blocks transcription, 
while at 37 °C YmoA is degraded by the Lon and ClpXP proteases, which results in a derepression of transcription of yscW-
lcrF (upper left panel). The post-transcriptional thermoregulation is mediated by a thermolabile element ('four U' motif) in 
the 5'-UTR of the lcrF mRNA. At 25 °C, the 'four U' motif (blue) base pairs with the RBS (red) and blocks ribosomal access. 
At 37 °C, the thermometer melts open and allows the translational initiation (upper right panel). 
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1.3.2 Yop-dependent regulation of the injectisome 
The expression of yop genes and other T3SS-associated genes is regulated in a negative 
feedback loop, independent of other regulatory processes. This negative feedback loop 
functions on the post-transcriptional level with the involvement of at least four proteins: the 
minor translocator YopD, its cognate chaperone LcrH, LcrQ which possesses a YopH-
homolog domain and the YopH chaperone SycH. The interplay of these proteins prevents an 
uncontrolled overproduction of Yops and other T3SS-associated proteins under non-secretion 
conditions (high calcium concentration or in absence of cell contact) [Cambronne & 
Schneewind, 2004; Kopaskie et al., 2013]. 
 
YopD is a multifaceted protein with a molecular weight of 33 kDa. Although homologs in 
many injectisome encoding bacteria can be found, its full structure has not yet been resolved. 
Important structural features are its N-terminal coiled-coil domain, a hydrophobic and an 
amphipathic α-helix. Two additional regions are crucial for binding of its chaperone LcrH - 
the N-terminal hydrophobic domain and the amphipathic domain on the C-terminus [Costa et 
al., 2013; Francis et al., 2000; Olsson et al., 2004]. YopD has different functions, depending 
on its localization. Extracellular YopD acts as a minor translocator. Together with the major 
translocator YopB, it confers pore formation in the cell membrane of eukaryotic cells. In this 
process, it assists in the pore assembly and modifies pore size. A yopD mutant is defective in 
pore formation, while mutated YopD, missing its transmembrane (TM) domain, produces 
smaller pores in macrophages [Kwuan et al., 2013; Montagner et al., 2011; Neyt & Cornelis, 
1999]. Intracellular YopD, together with its cognate chaperone LcrH, possesses RNA-binding 
capabilities and functions as a post-transcriptional repressor of yop genes. Therefore, it plays 
an important role in the LCR of yersiniae [Olsson et al., 2004; Francis et al., 2001; Anderson 
et al., 2002]. Upon calcium depletion, YopD is secreted into the supernatant, massively 
triggering Yop synthesis and inducing growth restriction. Additionally, a yopD mutant 
displays a thermosensitive phenotype, as yop expression is deregulated and massively 
activated at 37 °C. Indicating that the interaction of YopD with its cognate chaperone LcrH 
(SycD in Y. enterocolitica) is strictly required for its regulatory function. Deletion of lcrH 
destabilizes YopD [Francis et al., 2001]. The YopD/LcrH-dependent feedback regulation of 
yop genes requires AU-rich sequences in the leader transcript of target mRNAs, similar to the 
LcrQ-dependent regulation [Chen & Anderson, 2011; Anderson et al., 2002; Cambronne et 
al., 2002]. However, an exchange of these AU-rich elements does not change binding 
capabilities of YopD, indicating that further factors are necessary for binding and regulation 
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[Chen & Anderson, 2011]. Also, binding of YopD to its target transcripts results in a 
destabilization and translational repression [Anderson et al., 2002]. Kopaskie and colleagues 
could demonstrate that YopD associates with the 30S ribosomal subunit and this interaction 
prevents assembly of the 70S ribosome. Fully assembled ribosomes are resistant to YopD 
binding [Kopaskie et al., 2013]. 
 
LcrH acts as a chaperone of both translocator proteins YopD and YopB, classifying it as a 
T3SS class II chaperone. Like other T3SS chaperones, it has a low molecular weight, an 
acidic pI and a C-terminal hydrophobic helix. It displays an all α-helical fold, composed of 
three tetratricopeptide repeats (TPR). These TPR motifs can form elongated structures 
conferred by their helix-turn-helix conformation. Class II chaperones generally form 
homodimers. Moreover, the C-terminus has a quite loose fold, supporting the idea of a 'fly-
casting' binding mechanism. In this model, the unfolded terminus binds at first loosely to its 
cognate partner, in turn increasing the binding strength. At the moment it is still 
controversially discussed whether LcrH dimers are loaded with one or more translocator 
proteins (Fig. 1.4) [Page & Parsot, 2002; Singh et al., 2013]. 
 
 
Figure 1.5: Crystal structure of the SycD-YopD complex. Representation of Y. enterocolitica chaperone dimer SycD 
(LcrH) with a bound peptide of translocator YopD. SycD possesses an all α-helical fold comprised of three tandem 
tetratricopeptide repeats. The extended YopD peptide binds the concave face of the TPR domain. The SycD chains are 
colored in red and blue. The YopD peptide is colored in purple. The picture is derived from Singh et al., 20134 
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Another LCR-associated regulator playing a major role in the negative feedback loop is 
LcrQ. LcrQ is a 12 kDa protein with homologies to the N-terminus of YopH [Rimpiläinen et 
al., 1992]. In Y. enterocolitica two lcrQ homologs, namely yscM1 and yscM2, are encoded on 
the virulence plasmid. As demonstrated in Y. enterocolitica, the YscM1/2-dependent post-
transcriptional yop genes repression targets the 5'-UTR of target genes, similar to YopD/LcrH 
[Cambronne et al., 2002]. The YopH chaperone, SycH, can bind to LcrQ, due to homologies 
to the N-terminus of YopH. LcrQ-dependent repression is released upon secretion of LcrQ or 
binding by the YopH chaperone SycH [Pettersson et al., 1996; Wulff-Strobel et al., 2002]. 
Cambronne and colleagues demonstrated that a short AUAAA sequence in the 5'-UTR of yop 
genes is involved in the LcrQ-dependent repression [Cambronne & Schneewind, 2002; 
Cambronne et al., 2004]. 
 
1.3.3 The Carbon storage system 
The carbon storage regulator (Csr) system is a well-studied global regulatory system found in 
many Gram-negative bacteria. The Csr system is involved in regulation of various virulence 
factors, quorum sensing, carbon metabolism, peptide uptake and biofilm formation. In 
Y. pseudotuberculosis, it consists of the RNA-binding protein (RBP) CsrA and two 
regulatory, non-coding RNAs, CsrB and CsrC [Heroven et al., 2012; Vakulskas et al., 2015]. 
CsrA is a small 9 kDa protein that functions as a dimer. The monomer folds into five 
consecutive, antiparallel β-strands (β1-5) and a C-terminal winged α-helix. Upon 
dimerization, a sandwich of intertwined β-strand is formed. The β1 and β5 strand confer 
RNA-binding activity by a single-stranded RNA binding motif (KH motif). Because of this 
architecture, the RNA-binding domains lie on opposing sides of the dimer, which enables 
binding of two neighboring RNA binding sites on the same RNA molecule (Fig. 1.6) 
[Gutiérrez et al., 2005; Mercante et al., 2006; Rife et al., 2005]. 
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Figure 1.6: Structure of the CsrA-RNA complex. Representation of a dimer of the CsrA-homolog RsmE (green/gray) in 
complex with two RNA stem-loops structures (yellow). The CsrA dimer contains two RNA-binding domains allowing 
cooperative binding of two different RNA sites. The picture is adapted from Schubert et al., 20075. 
 
The GGA sequence motif is the most conserved binding elements for CsrA [Dubey et al., 
2005]. Since GGA motifs are part of the RBS and found in many 5'-UTRs of bacterial 
mRNAs, further binding motifs are needed to facilitate specificity in target RNA-binding. 
Binding motifs are especially recognized when exposed on a single stranded hairpin structure. 
Further comparative studies lead to the classification of high affinity, primary (A(N)GGA) 
and low affinity, secondary binding sites (AGAGA, YGGGA, CTGGA) [Baker et al., 2002; 
Wang et al., 2005; Yankhin et al., 2011]. Furthermore, neighboring binding sites need a 
proper spacing of 10-63 nt for efficient binding. A smaller spacing is unlikely because of 
intramolecular, sterical hindrance by the dimer [Kulkarni et al., 2014]. 
Most direct targets of the CsrA protein are repressed by its presence. Repression depends on 
binding to multiple sites in the 5'-UTR or the first codons of target transcripts, while one 
binding site needs to overlap the SD. By this mechanism, CsrA competes with the 30S 
ribosomal subunit for binding of the SD which in turn inhibits translation initiation. As a 
secondary effect, this often leads to fast RNA decay, since ribosome binding protects RNAs 
from degradation by RNases (Fig. 1.7) [Deneke et al., 2013; Romeo et al., 2012]. Until now 
CsrA-dependent activation of gene expression was only demonstrated for the flagellar master 
regulator flhDC. Here, CsrA binding confers protection from RNase E-mediated cleavage and 
subsequent degradation [Yakhnin et al., 2013]. 
A tight regulation of the Csr system is needed due to the global effect on the bacterial fitness. 
The activity of CsrA is finely adjusted by the action of the two non-coding RNAs CsrB and 
CsrC. These non-coding RNAs are highly structured and harbor multiple binding motifs 
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exposed on hairpin loops, allowing binding of multiple CsrA molecules. Thereby, they 
function as 'molecular sponges' that fine-tune the pool of active CsrA proteins [Babitzke & 
Romeo, 2007; Liu et al., 1997]. The amount of CsrB/C is indirectly regulated by CsrA, as 
binding to the Csr-type RNAs stabilizes both non-coding RNAs [Böhme, PhD thesis; 
Heroven et al., 2012]. Furthermore, both RNAs are counter-regulated in Yersinia, as 
upregulation of one RNA downregulates its counterpart [Fortune et al., 2005; Heroven et al., 
2012]. By this means, they exhibit a compensatory regulation (Fig. 1.7) [Heroven et al., 
2008]. In E. coli, RNA turnover of CsrB/C is controlled by the regulator protein CsrD. CsrD 
triggers RNase E-dependent degradation of CsrB/C, increasing CsrA availability [Suzuki et 
al., 2006; Romeo et al., 2012]. In Gram-positive bacteria, like Bacillus subtilis, a CsrB/C-
type-independent regulation evolved, as homologs of these ncRNAs are completely missing. 
Instead, CsrA-mediated repression of motility is adjusted by direct protein-protein interactions 
with the alternative flagellar chaperone FliW, which is not present in Enterobacteriaceae. 
During assembly of the flagellar T3SS when high amounts of unbound cytosolic FliW are 
present, FliW directly binds CsrA and inhibits binding of target RNAs [Mukherjee et al., 
2011; Mukherjee et al 2016]. 
Besides the sequestration mechanism, the pool of CsrA is precisely regulated in an 
autoregulatory feedforward loop. In E. coli, csrA is transcribed from five promoters that are 
either σ70- or σ
S
-dependent. Autoregulation of CsrA is very complex. Transcription from the 
σS-dependent P3 promoter is indirectly activated by the presence of CsrA. The 5'-UTR of the 
csrA transcript harbors four CsrA binding sites and is directly targeted by the CsrA protein, 
leading to a translational repression. As translational inhibition can be rapidly induced, this 
leads to an efficient shut-down of CsrA production when a critical level is reached [Yakhnin 
et al., 2011; Vakulskas et al., 2015]. 
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Figure 1.7: Mechanism of action of the Csr system. The Csr system consists of the RNA-binding protein CsrA and the 
non-coding RNAs CsrB/C. CsrB/C are counter-regulated and are stabilized by binding of CsrA. Both non-coding RNAs 
harbor multiple CsrA-binding motifs and function as a 'molecular sponge' for CsrA, reducing the overall CsrA activity. 
Dimeric CsrA binds to the 'GGA' core motifs of target mRNAs in the vicinity of and overlapping with the ribosomal binding 
site, thereby denying translational initiation and/or destabilizing the transcript. As CsrA has a high binding affinity to CsrB/C, 
high amounts of CsrB/C sequester CsrA from target mRNAs, allowing ribosomal access and mRNA translation. 
 
1.3.4 The RNA degradosome 
The RNA degradosome is a central player in the control of protein synthesis and many other 
regulatory processes. It ensures the control of RNA homeostasis and facilitates a rapid 
adaptation to environmental changes. A lot of these adaptations are conferred by the RNA 
degradosome, a multiprotein complex that controls RNA processing, dynamics and stability. 
The RNA degradosome is best studied in E. coli. It consists of the endoribonuclease RNaseE, 
the polynucleotide phosphorylase PNPase, the glycolytic enolase Eno and the RNA helicase 
RhlB (Fig 1.8) [Bandyra et al., 2013]. 
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Figure 1.8: Schematic representation of the RNA degradosome complex. RNase E (purple) multimerizes and associates 
with the cytoplasmic membrane. The N-terminal half of RNase E (purple sphere) folds into a globular structure and contains 
the endoribonucleolytic catalytic core. The C-terminal half of RNase E confers membrane association and functions as an 
assembly platform for RNA helicase RhlB (green), enolase (yellow) and exoribonuclease PNPase (blue). Target RNAs are 
initially cleaved by RNase E and digested into nucleotides by PNPase, while secondary structures are unwinded by RhlB. 
The picture is adapted from Bandyra et al., 20136 
 
The endonuclease RNase E, encoded by the rne gene, is a large homotetrameric complex. Its 
N-terminus harbors the well conserved endoribonucleolytic site and an arginine-rich RNA-
binding domain. The N-terminus can be divided into smaller subdomains, briefly S1-, RNase 
H- and DNase I-like domains. The RNase H subdomain has structural functions and misses 
catalytic activity. The S1 subdomain recognizes and binds the 5'-end of monophosphorylated 
RNAs. The DNase I-like subdomain confers enzymatic activity. The endonuclease active site 
is located in a shallow groove and confers binding with low sequence specificity. However, 
the AU sequence specificity most probably reflects the fitting of single-stranded RNA into the 
groove. In summary, RNase E can cleave far from the 5'-end but has a preference for 5'-
monophosphorylated RNAs [Callaghan et al., 2005; Katarzyna et al., 2013; Mackie, 1998].  
The C-terminus is less well conserved and contains helices for membrane localization, RNA-
binding sites and the assembly site for other components of the degradosome [McDowall & 
Cohen, 1996; Khemici et al., 2008]. The C-terminal half of RNase E also seems to interact 
with other non-degradosome components, like Hfq, the ribosomal polyA-binding protein S1 
and RNase E inhibitor proteins [Feng et al., 2001; Morita et al., 2005]. The importance of 
RNase E as an assembly platform for other degradosome players becomes especially evident 
in the degradation mechanism. RNase E functions as the decay initiator by undertaking the 
initial cleavage of substrate RNAs. Following this, RNA helicases RhlB unfolds the RNA and 
                                                 
6
 Bandyra et al., 2013 is licensed under the Creative Commons Attribution (CC BY 3.0) license. 
https://creativecommons.org/licenses/by/3.0/ 
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PNPase digests the remaining fragments into nucleotides (Fig. 1.8) [Carpousis, 2007; Hui et 
al., 2014]. 
 
PNPase is a homotrimeric exoribonuclease that catalyzes the phosphorolytic 3'- to 5'-end 
degradation of RNAs. However, PNPase can also reverse this reaction and function as a 
template-independent polynucleotide polymerase [Andrade et al., 2009; Mohanty & Kushner, 
2000]. Each protomer contains two ribonucleolytic PH domains and two RNA-binding S1 
domains. The PH domains are arranged in a small channel allowing entrance only to unfolded 
single-stranded RNAs [Shi et al., 2008; Symmons et al., 2000]. PNPase requires the 
interaction with RNA helicase RhlB for this process. This interaction can be direct and 
independent of the scaffold protein RNase E [Gunn-Guang et al., 2002; Lin & Lin-Shao; 
2005]. Surprisingly, besides its role in RNA degradation, in vitro, PNPase together with the 
RNA chaperone Hfq was shown to protect certain sRNAs [Bandyra et al., 2016]. 
Interestingly, PNPase and the Csr system control their expression mutually. In E. coli, PNPase 
is involved in the CsrD-dependent degradation of CsrB/C and CsrA is involved in the 
autoregulation of pnp [Vakulskas et al., 2016; Leng et al., 2016; Suzuki et al., 2006]. 
Autoregulation of pnp is complex and involves CsrA binding and multiple nucleolytic 
cleavages. The leader transcript of pnp folds into multiple hairpin loops and contains two 
CsrA binding sites. The first one overlaps with the RBS and the second one is inaccessibly 
sequestered in a double-stranded stem-loop structure. Initially, the endoribonuclease 
RNase III cleaves the CsrA binding site-containing, double-stranded stem-loop structure. 
PNPase exonucleolytically degrades the 5'-fragment and liberates the CsrA binding site. Now, 
CsrA can access both binding sites and induces translational repression of pnp [Park et al., 
2015; Condon, 2015; Robert-Le Meur et al., 1994]. 
In Yersinia, both major degradosomal RNases, RNase E and PNPase, are post-transcriptional 
regulators of the Ysc-Yop T3SS. A dominant negative RNase E mutant is unable to secrete 
effector molecules, although intracellular effector levels are unchanged [Yang et al., 2008]. 
Similarly, PNPase is also crucial for the secretion of effector proteins. Surprisingly, only the 
RNA-binding domain, but not the catalytic activity of PNPase is needed for this process 
[Rosenzweig et al., 2005; Rosenzweig et al., 2007]. 
 
RhlB is a DEAD-box RNA helicase playing a crucial role in RNA degradation. Proteins of 
the DEAD-box family share a structurally conserved ATPase domain containing a Walker II 
motif, which harbors the D-E-A-D amino sequence. This DEAD-box domain hydrolyzes ATP 
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to power the unwinding of structured RNAs. A RecA-like tandem-repeat structurally 
resembles the catalytic core. These domains support ATP and RNA binding and catalysis 
[Caruthers & McKay, 2002; Cordin et al., 2006; Lindner et al., 1989]. The C-terminal RecA-
like domain also confers RNase E and PNPase interaction. The interaction with RNase E is 
boosted by the helicase activity of RhlB, which has a 5'-to 3'-directionality. In contrast, 
PNPase acts from the 3'- to 5'-end. Because of this, RhlB can rescue PNPase proteins that are 
stalled in hairpin structures. [Chandran et al., 2007; Liou et al., 2002; Tseng et al., 2015]. 
 
Enolase is a glycolytic protein that is only loosely connected to the degradosome. It is 
associated with the glycolysis cycle and reversibly catalyzes the dehydration of 2-
phosphoglycerate to phosphoenolpyruvate. Although enolase does not bind RNA, up to 10% 
of enolase proteins are in complex with the RNA degradosome. Its role in the degradosome is 
still unclear, but it seems to link the energetic state of the cell to mRNA degradation 
[Carpousis, 2007; Chandran & Luisi, 2006; Py et al., 1996; Morita et al., 2004]. 
 
The so far identified factors involved in the regulation of late virulence are summarized in 
Fig. 1.9. 
 
 
Figure 1.9: Working model of late virulence regulation in Y. pseudotuberculosis. The figure summarizes known relations 
between the components of the late virulence regulatory network. Expression of the late virulence master regulator lcrF is 
mainly controlled by the RNA-binding proteins CsrA and YopD/LcrH and degradosomal proteins (PNPase and RNase E). 
Positive effects (arrow-headed line) and negative (bar-headed line) effects are indicated. 
  Introduction 
22 
1.4 Aim of the study 
This study is focused on the molecular mechanism of the RNA-binding proteins YopD and 
CsrA in the regulation of late virulence genes in Y. pseudotuberculosis. Enteropathogenic 
Yersinia species need to coordinate the expression of their Ysc-Yop T3SS for survival and 
evasion from the innate immune response. The main hub for signal integration into the late 
virulence regulon is the transcriptional activator LcrF. Preliminary data revealed that lcrF 
expression is regulated by the action of two RNA-binding proteins [Steinmann, PhD thesis; 
Opitz, PhD thesis]. YopD, a bifunctional regulator with RNA-binding capabilities which also 
represses lcrF expression in a negative feedback loop under non-secretion conditions. CsrA, a 
central global-acting RNA-binding protein, which is involved in repression and activation of 
lcrF expression. Recent findings revealed that csrA expression is activated by YopD via an 
unknown mechanism. Through this mechanism, lcrF is regulated in a negative feedforward 
loop. As CsrA is also a central mediator in the regulation of many other stress adaptation and 
virulence systems, this connects the status of the Ysc-Yop T3SS to other regulatory modules. 
To analyze the underlying molecular mechanism of this negative feedforward loop, RNA-
binding regions of YopD and CsrA and the underlying regulatory networks should be 
identified and characterized. Moreover, to get a deeper understanding of CsrA's role in 
Yersinia virulence, new direct CsrA targets should be identified. 
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2 Material and Methods 
2.1 Materials 
2.1.1 Chemicals and buffers 
All chemicals used in this study were purchased from Merck, NEB, Fisher Scientific, Roth, 
Pierce, Qiagen, Sigma-Aldrich, T. H. Geyer, PerkinElmer, Invitrogen, Fermentas, Difco, BD 
Bioscience or Applichem, if not stated otherwise. The content of all buffers and solutions 
used in this study is described in the chapter of the corresponding method. 
 
2.1.2 Enzymes, Kits and Antibodies 
All enzymes, kits and antibodies with their manufacturers, which were used in this study, are 
listed in Table 2.1, 2.2 and 2.3, respectively. 
 
Table 2.1 Enzymes 
Enzyme Manufacturer 
Benzonase Merck 
Mango Tag™ DNA Polymerase Bioline 
Phusion® High-Fidelity DNA Polymerase New England Biolabs (NEB) 
Restriction enzymes NEB 
Taq Polymerase NEB 
T4 DNA Ligase NEB 
T4 RNA Ligase I NEB 
 
Table 2.2: Kits 
Kit Manufacturer 
Chemiluminescent Nucleic Acid Detection Module Thermo Fisher Scientific 
DIG luminescent detection Roche 
Mango Mix™ Bioline 
QIAquick™ PCR Purification Quiagen 
QIAquick™ Plasmid Midiprep Quiagen 
QIAquick™ PCR Miniprep Quiagen 
SensiFast™ SYBR® No-ROX Bioline 
SV Total RNA Isolation Promega 
TranscriptAid™ High Yield Fermentas 
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Table 2.3: Antibodies 
Antibody (dilution) Manufacturer 
Primary antibody  
Anti-CsrA (1:5.000) Davids Biotechnology 
Anti-H-NS (1:150.000) Davids Biotechnology 
Anti-LcrH (1:1.000) Davids Biotechnology 
Anti-YopD (1:2.500 - 1:10.000) Davids Biotechnology 
Secondary antibody  
Anti-rabbit Immunoglobulin HRP conjugate Cell Signaling 
 
2.1.3 Organisms 
2.1.3.1 Escherichia coli strains 
All strains used in this study are listed in table 2.4. 
 
Table 2.4: Escherichia coli strains 
Strain Description Reference 
DH10β F
-
 mcrA Δ(mrr-hsdRMS-mcrBC) Φ80dlacZΔM15 
ΔlacX74 endA1 recA1 deoR Δ(ara,leu)7697 araD139 
galU galK nupG rpsL λ- 
Casadaban & Cohen, 1980 
BL21(DE3) F- gal met r-m- lon hsdS λLysplacUV5-T7 gene1placI
q
 
lacI 
Studier & Moffatt, 1986 
S17-1λpir recA, thi, pro, hsdR
-
M
+
 (RP4-2 Tc::Mu-Km::Tn7), λpir Simon et al., 1983 
 
2.1.3.2 Yersinia pseudotuberculosis strains 
All strains used in during this study are listed in table 2.5. 
 
Table 2.5: Yersinia pseudotuberculosis strains 
Strain Description Reference 
YPIII pIB1, wild-type Bölin et al., 1982 
YP53 YPIII, pIB1, ∆csrA, Kan
R
 Heroven et al., 2008 
YP63 YPIII, pIB1, ∆clpP, Kan
R
 A.-K. Heroven 
YP67 YPIII, pIB1, ∆lon, Amp
R
 A.-K. Heroven 
YP79 YP69 (∆csrB), pIB, ∆csrC Heroven et al., 2012 
YP83 YPIII, pIB1, lcrF(GUU-30/-28AAA) R. Steinmann 
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YP84 YPIII, pIB1, lcrF(UU-28/-27CC) R. Steinmann 
YP91 YPIII, pIB1, ∆yopD R. Steinmann 
YP92 YPIII, pIB1, ∆lcrH R. Steinmann 
YP145 YP53, pIB1, ∆csrA ∆yopD, Kan
R
 R. Steinmann 
YP183 YP92 (∆lcrH), pIB1, ∆yopD This study 
YP326 YPIII (∆hslV) This study 
YP327 YPIII (∆ftsH) This study 
 
2.1.4 Plasmids 
All plasmids used in this study are listed in table 2.6. All constructed plasmids were 
sequenced by the in-house facility (GMAK). All gene coordinates are indicated relative to 
their translational start site. 
 
Table 2.6: Plasmids 
Plasmid Description Reference 
pACYC184 Expression vector, ori p15a, Tet
R
, Cm
R
 Chang & Cohen, 1978 
pAKH3 Mutagenesis vector, ori R6K, sacB, Amp
R
 Heroven et al., 2012 
pAKH56  pACYC184, PcsrA-csrA
+
 (-518/+183), Cm
R
 A. K. Heroven 
pAKH172 pET28a, csrA
+
, Kan
R
 A. K. Heroven 
pBAD33 Expression vector, ParaC, araO2, araC, ori p15a, Cm
R
, Guzman et al., 1995 
pDM4 Mutagenesis vector, ori R6K, sacB, Cm
R
 Milton et al., 1996 
pET28a Expression vector, ori 3286, Kan
R
 Novagen 
pFU50 dsRed2, Plac, ori 29807, Kan
R
 F. Uliczka 
pHSG576 Expression vector, ori pSC101, Cm
R
 Takeshita et al. 1987 
pJH4 pKB63, csrA'-'lacZ (-298/+17), Amp
R
 This study 
pJH5 pKB63, csrA'-'lacZ (-249/+17), Amp
R
 This study 
pJH6 pKB63, csrA'-'lacZ (-121/+17), Amp
R
 This study 
pJH10 pKB63, csrA'-'lacZ (-83/+17), Amp
R
 This study 
pJH12 pET28a, yopD
+
, lcrH
+
, Kan
R
 This study 
pJH25 pBAD33, araC(-22/0)::csrA
+
(+1/+186), Cm
R
 This study 
pJH27 pKB63, Ptet:csrA'-'lacZ (-70/+17), Amp
R
 This study 
pJH30 pAKH3, ∆hslV, Amp
R
 This study 
pJH33 pAKH3, ∆ftsH, Amp
R
 This study 
pJH35 pHSG576, PcsrA::csrA:3xFLAG
+ 
(-298/+183), Cm
R
 This study 
pJH36 pKB63, PyopD'-'lacZ(-3314/+20), Amp
R
 This study 
pJH38 pKB63, PyopD'-'lacZ(-1224/+20), Amp
R
 This study 
pJH48 pKB63, csrA'-'lacZ (-298/+17, ∆-89/-51), Amp
R
 This study 
pJH49 pKB63, csrA'-'lacZ (-298/+17, ∆-89/-33), Amp
R
 This study 
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pKB60 pHSG576, csrA (-518/+186), Cm
R
 K. Böhme 
pKB63 csrA'-'lacZ (-1071/+17), ori SC101, Amp
R
 K. Böhme 
pRS1 pFU50, ori 29807, Cm
R
 R. Steinmann 
pRS2 pRS1, yopD
+
, Cm
R
 R. Steinmann 
pRS3 pRS1, lcrH
+
, Cm
R
 R. Steinmann 
pRS5 pRS1, lcrH-yopBD
+
, Cm
R
 R. Steinmann 
pRS15 pRS1, ori p15A, Cm
R
 R. Steinmann 
pRS16 pRS2, ori p15A, yopD
+
, Cm
R
 R. Steinmann 
pRS17 pRS3, ori p15A, lcrH
+
, Cm
R
 R. Steinmann 
pRS34 pDM4, ∆yopD, Cm
R
 R. Steinmann 
pRS42 pDM4; yscW-lcrF(GUU-30/-27AAA)*, Cm
R
 R. Steinmann 
pRS43 pDM4; yscW-lcrF(UU-28/-27CC)*, Cm
R
 R. Steinmann 
pRS45 pDM4; yscW-lcrF(∆hairpin 1 -44/-25)*, Cm
R
 R. Steinmann 
pRS46 pDM4; yscW-lcrF(∆hairpin 2 -111/-57)*, Cm
R
 R. Steinmann 
*... relative to translational start site of lcrF 
2.1.5 Oligonucleotides 
The oligonucleotides used for cloning and mutagenesis were purchased from Metabion and 
are listed in table 2.7. The corresponding restriction sites are underlined. 
 
Table 2.7: Oligonucleotides 
Oligonucleotide Sequence (5'-- 3') Restriction 
site 
II275 GGGGCCCTGCAGCGAGTCAGAATAAGCATTCTTTG PstI 
III645 GGGCGCACTAGTTCAGACAACACCAAAAGCG SpeI 
III647 GGGCGCCTCGAGTCATCATGGGTTATCAACGCAC XhoI 
IV436 GGGGCCGAATTCGCCAGCGGCATTAG EcoRI 
IV437 GGGGCCGAATTCGTAATCATCTATTAAATCAACACGC EcoRI 
IV438 GGGGCCGAATTCGGACTCGACCAAGCTACTTAC EcoRI 
IV706 GGGCGCCATATGACAATAAATATCAAGACAGAC NdeI 
IV707 GGGGCCGAATTCTGGCTTACGTTTTCACGGTG EcoRI 
IV708 GGGCGCACTAGTGTGATGCAACGTCTGCTAGATG SpeI 
V511 GGGCGCGTCGACCTGCTTCAAAATCAGTAAGTC SalI 
V873 GCGGGAGCTCGTTCAGCGGTAACCATCAAAC SacI 
V876 CCGCGAGCTCCTTTATCATCCAGTTGGCCTTC SacI 
VI009 GCGGGAGCTCGCGATAAATATGTAATTCAGGCAC SacI 
VI012 CCGCGAGCTCGCAACACAGCGTTCAATATG SacI 
VI069 AATTATGCAGTGCGTTAATTACGTCACGGCGTACACTTACAATTG  
VI070 CAATTGTAAGTGTACGCCGTGACGTAATTAACGCACTGCATAATT  
VI071 GATGCCAACAGCTAGTTGATGTCACTCAAGGGATTAACCTC  
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VI072 GAGGTTAATCCCTTGAGTGACATCAACTAGCTGTTGGCATC  
VI073 GCGGGGATCCGCCAGCGGCATTAG BamHI 
VI074 GCGGGTCGACCGCTGCTTCAAAATCAC SalI 
VI182 GGCGAATTCATGAGTGCGTTGATAACCC EcoRI 
VI184 GCCCTGCAGGTCTTGATATTTATTGTCATGGTTATTC PstI 
VI185 GGCGAATTCGATCGTGCTTATCCAACGAG EcoRI 
VI419 GGTCTCTCTGTTTCCCCGCCTCATATAAAATGTAAGTAGC  
VI420 GCTACTTACATTTTATATGAGGCGGGGAAACAGAGAGACC  
VI421 GAAAAATTAAAAGAGTCGGGTCATATAAAATGTAAGTAGC  
VI422 GCTACTTACATTTTATATGACCCGACTCTTTTAATTTTTC  
 
2.1.6 Media and Antibiotics 
All media used were prepared with ddH2O and sterilized by autoclaving, if not indicated 
otherwise. The Media used are listed in table 2.8. For solid media 15 g/L of agar (Difco, 
USA) were added to liquid media. For selective media, antibiotics were added to a final 
concentration as listed in table 2.9. Antibiotics were prepared as stock solutions in the 
indicated solvents and filter sterilized afterward. 
 
Table 2.8: Media 
Media Composition 
BHI 
(Brain-Heart Infusion) 
37 g/L BHI (BD Biosciences, USA) 
DYT 
(Double Yeast Tryptone, complex medium) 
[Miller, 1992] 
10 g/L yeast extract, 5 g/l NaCl, 16 g/L tryptone 
LB broth 
(Lysogeny Broth Medium) 
[Sambrook et al., 1989] 
5 g/L yeast extract, 5 g/L NaCl, 10 g/L tryptone 
 
Table 2.9: Antibiotics 
Antibiotic Composition Final concentration 
Carbenicillin (Cb) 100 mg/mL in H2O (Roth, Germany) 100 µg/mL 
Chloramphenicol (Cm) 30 mg/mL in 70% EtOH (Roth, Germany) 30 µg/mL 
Kanamycin (Kan) 50 mg/mL in H2O (Merck, Germany) 50 µg/mL 
Rifampicin 20-30 mg/mL in methanol (Merck, Germany) 1 mg/mL 
Spectinomycin  50 mg//mL in H2O (Roth, Germany) 50 µg/mL 
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2.2 Methods 
2.2.1 General microbial methods 
2.2.1.1 Cultivation of bacterial cells 
Escherichia coli and Yersinia pseudotuberculosis cells were cultivated in liquid or solid 
media at 25 °C or 37 °C under aerobic conditions. Liquid cultures were grown in a Multitron 
Standard incubation shaker (Infors HT, Switzerland) at 200 rpm in reaction tubes or 
Erlenmeyer flasks. Bacteria on solid media were cultivated in a Heraeus B 6200 
microbiological incubator (Thermo Scientific, USA). 
 
2.2.1.2 Storage of bacterial strains 
For short periods bacterial strains were stored on LB agar plates at 4 °C. For mid or long term 
storage glycerol stocks were prepared from LB overnight cultures and stored in screw-top 
tubes at -80 °C. For glycerol stocks, 1.25 mL of bacterial cultures were mixed with 0.75 mL 
80% (v/v) glycerol. 
 
2.2.1.3 Determination of bacterial cell density 
Bacterial cell density was determined photometrically by measuring the optical density at a 
wavelength of 600 nm (OD600) with the Ultrospec 3100 pro spectrophotometer (Amersham 
Biosciences, USA).  
 
2.2.1.4 Chemically competent E. coli strains 
Chemically competent E. coli strains, used for heat shock transformation, were prepared by 
the rubidium chloride method. Therefore, 100 mL LB medium supplemented with 20 mM 
MgSO4 was inoculated 1:100 with a 37 °C E. coli overnight culture. Cells were cultivated to 
exponential phase for 3-5 h at 37 °C and harvested by centrifugation for 5 min at 3743 x g and 
4 °C in a 3-18K centrifuge (Sigma, UK). Pellets were washed in 40 mL of ice-cold, sterile 
TFB1 buffer and incubated for 10 min on ice. Afterward, cells were pelleted again at 
3743 x g, 4 °C and 5 min. The pellet was resuspended in 4 mL ice-cold, sterile TFB2 buffer 
and incubated on ice for 15-60 min. Finally, chemically competent cells were directly used in 
100 µL aliquots or stored at -20 °C for up to 6 months. 
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TFB1 buffer: 30 mM potassium acetate, 10 mM CaCl2, 50 mM MnCl2, 100 mM RbCl, 15% (v/v) glycerol, 
pH 5.8 
TFB2 buffer: 10 mM MOPS, 75 mM CaCl2, 10 mM RbCl, 15% (v/v) glycerol, pH 6.5 
 
2.2.1.5 Electrocompetent Y. pseudotuberculosis strains 
For transformation by electroporation, electrocompetent Y. pseudotuberculosis strains were 
needed. A 25 °C LB overnight culture was used for a 1:50 inoculation of 20 mL BHI medium. 
The culture was grown to exponential phase for 3 h at 25 °C to an OD600 of 0.5 to 0.8 and 
harvested by centrifugation for 5 min at 3743 x g and 4 °C in a 3-18K centrifuge (Sigma, 
UK). The pellet was resuspended in 2 mL ice-cold transformation buffer and transferred to a 
new 2 mL microtube. Cells were harvested in a pre-cooled 5417R microcentrifuge 
(Eppendorf, Germany) at 6797 x g, 4 °C for 3 min. After two additional washing steps with 
2 mL Transformation buffer, the pellet was resuspended in 200 µL Transformation buffer. 
Finally, 40 µL aliquots were directly used for electroporation. 
 
Transformation buffer: 272 mM sucrose, 15% (v/v) glycerol, sterile filtrated 
 
2.2.1.6 Transformation by heat shock of E. coli 
For routine transformation of E. coli cells with plasmid DNA or ligation products, DNA was 
introduced by heat shock into chemically competent E. coli strains, like BL21(DE3) or 
DH10β [Pope & Kent, 1996]. For that, a 100 µL aliquot of chemically competent cells was 
thawed on ice and 100 ng of plasmid DNA or 10 µL of ligation product was added and 
incubated on ice for 5 min. Afterward, a one-minute heat-shock at 42 °C was applied. Cells 
were immediately cold-shocked on ice for 2 minutes. Additionally, 1 mL of ice-cold BHI 
medium was added and bacteria were incubated at 37 °C and 1,000 rpm for at least 30 min for 
phenotypic expression of the resistance marker. Subsequently, bacteria were pelleted for 
3 min at room temperature and 8,000 rpm in a microcentrifuge. The supernatant was 
discarded and the pellet was resuspended in 100 µL LB medium and plated on the appropriate 
LB agar selection plate with the corresponding antibiotic. Bacteria were grown overnight at 
37 °C in an incubator. 
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2.2.1.7 Transformation of Y. pseudotuberculosis by electroporation 
Plasmid DNA is introduced into Y. pseudotuberculosis via electroporation. To do so, a high 
power electrical pulse was applied to electrocompetent cells to increase the permeability of 
the cell membrane. 
An aliquot of electrocompetent cells was thawed on ice and 100 ng of plasmid DNA were 
added. The bacteria-DNA mixture was pipetted into pre-chilled electro cuvettes. The electro 
cuvette was put into a Gene Pulser™ electroporator and the bacteria-DNA mixture was 
exposed to a high voltage electrical pulse with the following parameters: 
 
Voltage 2500 V 
Resistance 200 Ω 
Capacity 25 µF 
Time constant 5 ms 
 
The electroporated cells were directly mixed with 1 mL pre-chilled BHI medium and 
incubated for a minimum of 2 h at 25 °C and 1,000 rpm for phenotypic expression of the 
resistance marker. The cells were pelleted in a microcentrifuge for 3 min at 8,000 rpm at room 
temperature. The supernatant was decanted, bacteria were resuspended in 100 µL LB liquid 
medium and plated on LB agar plates containing appropriate antibiotics for phenotypic 
selection. Finally, bacteria were grown at 25 °C for two days or as long as required. 
 
2.2.1.8 Mutagenesis of Y. pseudotuberculosis 
Mutagenesis of Y. pseudotuberculosis was performed by chromosomal integration of a suicide 
plasmid by homologous recombination. The suicide plasmid was transferred via conjugation-
competent E. coli S17-λpir into target Yersinia cells. Therefore, overnight cultures of the 
target Y. pseudotuberculosis strain and E. coli S17-λpir harboring the suicide plasmid with an 
R6K ori were grown at 25 °C or 37 °C, respectively. To remove traces of antibiotics, 300 µL 
of E. coli cells were centrifuged for 3 min, 2780 x g and room temperature and washed twice 
in LB medium. Subsequently, the E. coli cell pellet was resuspended in 900 µL of 
Y. pseudotuberculosis overnight culture, centrifuged and resuspended in 100 µL LB medium. 
A sterile filter membrane (0.22 µm pore size) was placed on an LB agar plate and the 
bacterial suspension was spread on the filter membrane and incubated for 6 to 12 h at 25 °C. 
Subsequently, the filter membrane was placed in a sterile 50 mL reaction tube and bacteria 
were washed off the membrane by mixing in 1 mL sterile 1 x PBS. Then, the cell suspension 
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was pelleted by centrifugation, washed in 1 x PBS and plated on Yersinia selective solid 
media plates, supplemented with appropriate antibiotics. Bacteria were then incubated for 2 
days at 25 °C. Only those Y. pseudotuberculosis cells that stably integrated the mutagenesis 
plasmid into their genome were able to grow. Following this, bacteria were transferred to LB 
solid plates supplemented with 10% (w/v) sucrose. The suicide vector harbors the sacB 
marker gene, encoding levansucrase. In Gram-negative bacteria, the presence of sucrose 
expression of sacB leads to the accumulation of toxic levans in the periplasm [Reyrat et al., 
1998]. Therefore, only bacteria that lost the sacB-harboring vector backbone are selected. 
Finally, fast growing colonies were analyzed by colony PCR for deletion of the target locus. 
Y. pseudotuberculosis strain YP183 was constructed from YP92 with the mutagenesis vector 
pRS34. Strain YP326 and YP327 were both constructed from YPIII with the suicide plasmids 
pJH30 and pJH33, respectively (see chapter 2.2.2.6.4). 
 
2.2.2 Molecular biological methods 
2.2.2.1 Determination of nucleic acid concentration and purity 
Nucleic acid concentration and purity were determined by absorbance measurement utilizing 
a NanoDrop™ ND-1000 UV spectrometer (Thermo Scientific, USA). The nucleic acid 
concentration was measured by their absorbance at λ = 260 nm. An absorption of A260 = 1.0 
corresponds to an RNA concentration of 40 µg/µL. The ratio of A260 and A280 was used to 
assess the nucleic acid purity. A ratio of ~1.8 or ~2.0 is defined as pure DNA or RNA, 
respectively. The ratio of A260 to A230 was used as a secondary parameter for evaluation of 
nucleic acid purity. Values between 2.0 and 2.2 could be considered as pure DNA/RNA. 
Lower values indicate contaminants that absorb at A230, such as phenol. 
 
2.2.2.2 Polymerase chain reaction (PCR) 
Polymerase chain reaction is a powerful tool to specifically amplify linear DNA fragments for 
cloning and gene analysis [Saiki et al., 1988]. By using specific flanking oligonucleotides 
(primer) a thermostable DNA-dependent DNA polymerase amplifies double stranded DNA 
regions in changing thermocycles. Thereby, the PCR proceeds in cycles of three repeating 
steps: double-stranded DNA (dsDNA) is denatured at 95 °C, primer specifically anneal to the 
single-stranded DNA template at 50-62°C and complementary single stranded DNA is 
synthesized at 72 °C. The annealing temperature depends on primer length and its GC content 
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and was calculated by ApE plasmid editor software (M. Wayne Davis). The elongation time 
depends on the fragment length to be synthesized and on the synthesis rate of the used DNA 
polymerase. 
When high fidelity in DNA synthesis was needed, e.g. for amplification of cloning inserts, the 
Phusion® High-Fidelity DNA polymerase (Thermo Scientific, USA) was used. This 
polymerase harbors a 3'-5' exonuclease proofreading activity, resulting in low error rates. The 
MangoMix™ (Bioline, Germany) containing the MangoTaq™ DNA polymerase (Bioline, 
Germany) was taken for control colony PCR to check for positive clones. Phusion polymerase 
PCR reactions were carried out in a volume of 50 µL, whereas colony PCRs were prepared in 
aliquots of 15 µL according to the manufacturer's instructions). For colony PCR, a single 
colony was picked with a sterile pipette tip and mixed directly into the PCR reaction mixture 
(E. coli). To screen for Yersinia mutants, a single colony was mixed into 10 µL of sterile 
ddH2O and boiled for 10 min at 95°C. 1 µL of lysed bacterial cells was added to the PCR mix. 
All PCRs were amplified in the T3,000 Thermocycler (Peqlab, Germany) or the Mastercycler 
EP S gradient cycler (Eppendorf, Germany). 
 
2.2.2.3 Isolation of plasmid DNA 
Depending on the plasmid copy number 5-10 mL LB overnight culture was used for plasmid 
preparation. For rapid and low-scale extraction of plasmid DNA the QIAprep® Miniprep kit 
(QIAGEN, Germany) was utilized according to the manufacturer's instructions).  
 
2.2.2.4 Gel extraction and purification of DNA 
DNA Purification and extraction from agarose gels for further application was performed with 
the QIAquick® PCR purification kit or QIAquick® Gel extraction kit (QIAGEN, Germany) 
according to the manufacturer's recommendations. Therefore, DNA fragments of interest were 
separated by agarose gel electrophoresis (AGE), stained with ethidium bromide, visualized 
and isolated under UV light (λ = 315 nm). Small DNA fragments less than 100 nucleotides 
were purified using the NucleoSpin® Gel and PCR Clean-up kit (Macherey-Nagel, 
Germany). The DNA was routinely eluted in 50 µL ddH2O. 
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2.2.2.5 Agarose gel electrophoresis for separation of DNA fragments 
Separation of DNA molecules was carried out by agarose gel electrophoresis (AGE). When 
power is applied, the negatively charged DNA molecules transmigrate through an agarose gel 
matrix towards the anode. During this process, DNA molecules are separated depending on 
their size and conformation. In this work 0.8% (w/v) agarose gels in 1 x TAE buffer were 
used for gel extraction after plasmid digestion and to check PCR fragments for integrity and 
correct size. For DNA fragments smaller than 100 nucleotides 2.5% (w/v) agarose gels were 
used. Separation was done in a gel electrophoresis chamber (Peqlab, Germany) in 1 x TAE 
buffer for 45 min at 120 V. To determine the fragment size, 3 µL of GeneRuler DNA Ladder 
Mix (Thermo scientific, USA) was used. Before applying, the samples were diluted in 6 x 
DNA Gel Loading Dye (Thermo Scientific, USA). To visualize DNA fragments, agarose gels 
were stained in an ethidium bromide bath (1 µg/mL in ddH2O) for 15 min and documented 
with a GelDoc™ XR+ (Bio-Rad, USA) at a wavelength of 302 nm. 
 
TAE buffer:  40 mM TRIS acetate (pH 8.0); 1 mM EDTA (pH 8.0) 
 
2.2.2.6 Cloning techniques 
2.2.2.6.1 Restriction digest 
Targeted cleavage of DNA molecules to determine the size or insertion of a specific DNA 
fragment into a specific vector site was carried out by restriction digestion. In this study type 
II restriction endonucleases (NEB, USA) that recognize and cleave specific palindromic 4-8 
nucleotide long sequences were used. These nucleases produce blunt or sticky ends (5'-single 
stranded sequence). For simultaneous digestion with two restriction enzymes the suitable 
reaction buffer was chosen according to the manufacturer's instructions). The reaction was 
incubated for 2 h at 37 °C and subsequently separated by AGE or purified by PCR 
purification. 
 
Restriction digest reaction (50 µL) 
DNA (0.1-2.0 µg) x µL 
Reaction buffer (10x) 5 µL 
Reaction enzyme 1 (1U/µL) 1 µL 
Reaction enzyme 2 (1U/µL) 1 µL 
ddH2O x µL 
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2.2.2.6.2 Dephosphorylation of plasmid DNA 
After restriction digestion, 5'-phosphates were removed by dephosphorylation using the 
Antarctic Phosphatase (NEB, USA), to prevent recirculation of linearized plasmid DNA. 
After isolation of a cleaved cloning vector by gel extraction, appropriate amounts of 10 x 
Antarctic Phosphatase Reaction buffer and 1 µL Antarctic Phosphatase were added and 
incubated for 30 min at 37 °C. The reaction was heat inactivated at 70 °C for 5 min and used 
for ligation. 
 
2.2.2.6.3 Ligation 
Insertion of DNA fragments into a linear, dephosphorylated cloning vector was done by 
ligation with T4 DNA ligase (Promega, USA). T4 DNA ligase catalyzes ligation of DNA 
strands by forming a phosphodiester bond. To increase the ligation rate, ligation reactions 
were carried out in two reactions with a 1:1 and 1:6 vector-to-insert ratio (v/v). Additionally, 
to examine the religation rate of the cloning vector ddH2O instead of insert DNA was used. 
The reaction was incubated for 2 h at room temperature or overnight at 18 °C. Afterward, the 
ligation reaction was transformed by heat shock into chemically competent E. coli DH10β and 
plated onto LB agar plates supplemented with the corresponding antibiotics. Clones carrying 
the respective antibiotics resistance marker were picked and checked by colony PCR. 
Therefore, insert- and plasmid-specific primer were used to check for proper insertion and 
orientation of the insert fragment. Finally, plasmid DNA was prepared from positive clones 
and sequenced by the HZI in-house sequencing facility. 
 
Ligation reaction (10 µL) 
Ligase buffer (10x) 1 µL 
Vector DNA 1 µL or 3.5 µL 
Insert DNA 6 µL or 3.5 µL 
ATP (10 mM) 1 µL 
T4 DNA Ligase 1 µL 
 
2.2.2.6.4 Construction of plasmids 
The csrA-lacZ reporter fusion plasmids pJH4, pJH5, pJH6, pJH10 and pJH27 were all 
constructed by amplification of csrA upstream fragments from chromosomal DNA of the Y. 
pseudotuberculosis strain YPIII. The resulting fragment and vector pKB63 were digested with 
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EcoRI and PstI and ligated. The following primer combinations were used to amplify the 
inserts: IV436/II275 (pJH4), IV437/II275 (pJH5), IV438/II275 (pJH6), IV707/II275 (pJH10) 
and V835/II275 (pJH27). The forward primer for the construction of pJH27 encodes the 
tetracycline promoter (Ptet) at its 5'-end. 
The lacZ reporter plasmids pJH36 and pJH39 were created by amplification of a yopD 
upstream fragment with primer pair VI185/VI184 and VI182/VI184, respectively. The inserts 
and pKB63 were digested with EcoRI and PstI and ligated. 
The YopD/LcrH overexpression plasmid pJH12 was constructed by amplification of the 
yopD gene with primer pair IV706 and III644 and the lcrH gene with primer pair IV708 and 
III647 from DNA of the virulence plasmid of YPIII. The yopD fragment was cut with 
NdeI/SpeI and the lcrH gene fragment was digested with SpeI/XhoI. Both fragments were 
ligated into the NdeI/XhoI sites of plasmid pET28a. 
The complementation plasmid pJH25 was constructed by amplifying the csrA gene with 
primer pairs V821 and V511. To create a CsrA-independent, inducible csrA complementation 
vector, the csrA gene was fused to the 5'-UTR of the araC gene of E. coli K12. The araC 
upstream region was introduced by forward primer V821 containing the corresponding 
sequence at its 5' end. The resulting fragment was digested with XbaI and SalI and ligated into 
the XbaI/SalI site of pBAD33. 
Mutagenesis plasmids pJH30 and pJH33 were used for a markerless deletion of the hslV and 
ftsH gene by homologous recombination. To create a markerless deletion, an insert containing 
the upstream and downstream regions, without the target gene's coding sequence, was created 
by three step PCR. First, two 500 nt fragments of the up- or downstream region of the target 
gene were amplified by PCR from chromosomal DNA of YPIII. Thereby, the reverse primer 
of the upstream fragment and the forward primer of the downstream fragment contained a 
20 nt long homologous sequence to the down- or upstream fragment. Next, both fragments 
were used as DNA templates for the final amplification of the full-length insert using the 
forward primer of the upstream fragment and the reverse primer of the downstream fragment. 
The full-length fragment was digested with SacI and ligated into the SacI site of pAKH3. The 
upstream fragment of pJH30 was amplified with primers V873/VI069 and the downstream 
fragment using primer pair VI070/V876. The full-length product was amplified with primer 
pair V873/V876. The up- and downstream fragments for construction of pJH33 were 
amplified with primer pairs VI009/VI072 and VI073/VI012, respectively. The final full-
length fragment was amplified by PCR using primers VI009/VI012. 
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The csrA-3xFLAG expression vector pJH35 was constructed by ligating the PCR product of 
primer combination VI073/VI074 amplified from chromosomal DNA of strain YPIII into the 
BamHI/SalI site of pKB60. To create a C-terminally 3xFLAG tagged CsrA variant, the 
3xFLAG epitope was introduced by reverse primer VI074. 
The csrA-lacZ reporter plasmids pJH48 and pJH49, harboring deletions in the csrA upstream 
region were all constructed using plasmid pKB63 as a backbone. Deletions were introduced 
by three step PCR from genomic DNA of strain YPIII as described for pJH30 and pJH33. To 
do so, the up- and downstream regions of the deletion site were amplified by PCR. Both 
fragments contained overlapping homologous regions at their 3' or 5' end. These homologous 
regions allowed the amplification of a third full-length fragment containing a markerless 
deletion in the 5'-UTR of the csrA gene. To create plasmid pJH48, the upstream fragment 
was amplified by PCR with primer IV436 and VI419 and the downstream fragment was 
amplified utilizing primer VI420 and II275 using chromosomal DNA of Y. 
pseudotuberculosis strain YPIII as a template. To create the final full-length fragment, the up- 
and downstream fragment functioned as a template for a third PCR with the primer 
combination IV436/II275. The digested inserts were ligated into the EcoRI/PstI site of 
pKB63. The same procedure was used for the construction of pJH49. The PCR products of 
primer combination IV436/IV421 (upstream fragment) and of VI422/II275 (downstream 
fragment) were used as a template for the final full-length fragment (IV436/II275). 
 
2.2.2.7 Isolation of total RNA from Y. pseudotuberculosis 
The SV total RNA isolation kit (Promega, USA) was applied for quick isolation of total RNA 
from Y. pseudotuberculosis. To do so, bacterial cultures were grown under the desired 
conditions. Two mL of the culture was transferred to a 2 mL reaction tube and harvested by 
centrifugation (18,000 x g, 5 min, 4 °C). After removal of the supernatant, total RNA was 
extracted according to the manufacturer's instruction. Finally, RNA concentration was 
photometrically measured using the NanoDrop™ ND-1000 UV spectrometer (Thermo 
Scientific, USA). Samples were stored at -20 °C. 
 
2.2.2.8 Phenol-chloroform extraction of RNAs 
Removal of contaminating proteins and lipids is crucial for downstream applications (e.g. 
biotinylation or RNA electromobility shift assay) of in vitro transcribed or biotinylated RNAs. 
For extraction of RNAs, samples were filled up to a volume of 150 µL with RNase-free 
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ddH2O, 400 µL CPI was added and mixed vigorously. Separation of phases was done by 
centrifugation for 5 min at full speed. The nucleic acid rich aqueous phase was transferred to a 
new test tube. Then, 405 µL of ice-cold absolute ethanol and 45 µL of 3 M sodium acetate 
(pH 4.5) were added and the samples were mixed thoroughly. To visualize precipitated 
nucleic acids, 2 µL glycogen (RNase and DNase free) was added. The RNA was precipitated 
at -20 °C for at least 2 h or overnight. After centrifugation 18,000 x g and 4 °C for 30 min the 
supernatant was carefully removed using a pipette and the pellet was washed with 500 µL 
70% ethanol. Again, samples were centrifuged 18,000 x g for 15 min at 4 °C, the supernatant 
was carefully removed and the pellet was air dried and resuspended in 20-50 µL of TE buffer. 
RNA concentration was determined with the NanoDrop™ ND-1000 UV spectrometer 
(Thermo Scientific, USA) and samples were stored at -20 °C. 
 
TE buffer: 10 mM Tris-HCl (pH 8.0), 1 mM EDTA 
 
2.2.2.9 Hot Phenol RNA extraction 
The isolation of high yield and high-quality RNA for critical downstream applications, like 
RNA-sequencing, was carried out by hot phenol extraction. For this purpose, bacterial pellets 
were resuspended in 250 µL RNA resuspension buffer and transferred into 2 mL safe-lock 
tubes. After addition of 250 µL RNA lysis buffer, samples were inverted five times and 
incubated for 90 s at 65 °C to ensure a rapid and complete cell lysis. The cell lysate was then 
supplied with 500 µL pre-heated aqua phenol (65°C), incubated for 3 min at 65 °C and snap 
frozen in liquid nitrogen for at least 30 s. Samples were centrifuged for 10 min at 18,000 x g 
at room temperature and the aqueous phase was transferred to a fresh 2 mL safe-lock tube. To 
prevent rupture of reaction tubes due to too rapid thawing during centrifugation, samples were 
pre-thawed for 1 min at room temperature before centrifugation. This process was repeated 
twice. The supernatant was mixed with 300 µL chloroform-isoamyl alcohol (24:1) in a 
1.5 mL tube, mixed vigorously for at least 30 s and centrifuged (3 min, 18,000 x g, room 
temperature). The aqueous phase was transferred to a new reaction tube and the step was 
repeated once more. Finally, the RNA in the aqueous phase was precipitated with 1/10 
volume 3 M NaOAc pH 4.5, 2.5 volumes of absolute ethanol and 2 µL of glycogen overnight 
at -20 °C. The precipitate was collected by centrifugation for 30 min at 18,000 x g and 4 °C. 
The ethanol was removed and the pellet was washed in 500 µL ice-cold 70% ethanol and 
centrifuged (15 min, 18,000 x g, 4 °C). Finally, ethanol was removed completely by pipetting, 
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the pellet was air-dried and resuspended in TE buffer. RNA concentration and quality were 
assessed with the NanoDrop™ ND-1000 UV spectrometer (Thermo Scientific, USA). 
 
RNA resuspension buffer:  0.3 M Sucrose in 0.01 M NaOAc (pH 4.5) 
RNA lysis buffer:   2% SDS in 0.01 M NaOAc (pH 4.5) 
 
2.2.2.10 Agarose gel electrophoresis of RNA 
Denaturing agarose gel electrophoresis was carried out to separate total RNA for control of 
RNA integrity and for the detection of specific RNAs by northern blot analysis. Thereby, the 
negatively charged RNA is separated depending on the molecular weight as it migrates 
through an agarose gel matrix in an electrical field. A 1.2% agarose gel in 1 x MOPS buffer 
was used for RNA separation. For this purpose, 5-60 µg total RNA was mixed with RNA 
loading buffer, heated for 10 min at 70 °C and incubated on ice for at least three minutes. The 
denatured RNA samples were loaded on a MOPS agarose gel and separated for 1 h at 120 V. 
The ethidium bromide in the loading buffer ensured the detection of 16 S and 23 S ribosomal 
RNAs as a loading control. Ribosomal RNAs were visualized with a GelDoc™ XR+ (Bio-
Rad, USA) at a wavelength of 302 nm. For identification of specific RNAs, the gel was 
further used for northern blotting. 
 
MOPS (20 x):   200 mM MOPS; 50 mM sodium acetate; 10 mM EDTA 
RNA loading buffer (5 x): 2.7% formaldehyde; 0.1 mg/mL ethidium bromide; 4 mM EDTA; 0.03% 
    bromphenol blue; 20% glycerol in 4 x MOPS 
 
2.2.2.11 Northern blot analysis 
Detection of specific RNAs, e.g. for gene expression analysis, was carried out by northern 
blotting. After RNA separation by agarose gel electrophoresis, the RNA was transferred to a 
0.45 µm Nytran® N nylon blotting membrane (GE Healthcare, Germany) with a vacuum 
blotter (vacuum blotter Model 785 and vacuum regulator; Bio-Rad, USA) at 5 bar for 1.5 h in 
10 x SSC buffer, according to the manufacturer's instructions). The transferred RNA was 
cross-linked to the membrane with UV light for 3 min in a Stratalinker UV crosslinker 
(Agilent Technologies, USA). 
Specific RNAs were then identified by hybridization with DIG-labeled DNA probes and 
detected by utilizing the DIG luminescent detection kit (Roche, Switzerland) according to the 
manufacturer's instructions. For this purpose, cross-linked blots were prehybridized in 
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hybridization buffer for 1 h at 42 °C in an OV2 mini-hybridization oven (Biometra, 
Germany). Hybridization of DIG-labeled probes and target RNAs occurred overnight at 42 °C 
in hybridization buffer. Before use, 5 µL of DNA probes were diluted in 100 µL ddH2O, 
denatured twice for 10 min at 95 °C and incubated on ice for 5 min after each heating step. 
All probes used in this study were amplified by PCR with a 10 x DIG DNA labeling Mix 
(Roche, Switzerland) instead of the standard dNTP mix. Their corresponding primer pairs are 
listed in table 2.10. 
 
Table 2.10: DNA probes used for mRNA detection 
probe primer pair 
csrA V004/V005 
lcrF I214/I303 
 
The next day, the membrane was washed twice in washing buffer I for 5 min and two times in 
washing buffer II for 15 min at 68 °C in a hybridization oven. The membrane was blocked in 
CDP* blocking buffer for 30 min. Incubation with anti-DIG AP-conjugates (Sigma, UK) 
diluted 1:6,000 in CDP* blocking buffer was carried out for 1 h. Blots were washed twice in 
CDP* washing buffer for 15 min and equilibrated for 5 min in CDP* detection buffer. The 
blot was developed with CDP* diluted 1:100 in detection buffer for 5 min. The 
chemiluminescent signal could be documented either by utilizing the ChemiDoc XR+ System 
for high abundant RNAs or otherwise using a CL-XPosure X-ray film (Thermo Scientific, 
USA). 
 
SSC (20 x):   0.3 M trisodium citrate; 3 M NaCl 
Washing buffer I (1 x):  2 x SSC; 2% SDS 
Washing buffer II (1 x):  0.1 x SSC; 0.1% SDS 
CDP* maleic acid buffer: 0.1 M maleic acid; 0.15 M NaCl; pH 7.5 
CDP* blocking buffer:  10% (w/v) blocking reagent in CDP* maleic acid buffer 
CDP* washing buffer:  0.1 M maleic acid; 0.15 M NaCl; 0.3% TWEEN-20; pH 7.5 
CDP* detection buffer:  0.1 M Tris-HCl; 0.1 M NaCl; pH 9.5 
 
2.2.2.12 RNA stability assay 
To determine the stability of mRNA transcripts, an RNA stability assay was performed. For 
this purpose, synthesis of new RNAs was stopped, by the addition of rifampicin that blocks 
the activity of the bacterial DNA-dependent RNA polymerase. As a result, the stability of 
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target RNAs can be monitored and analyzed by addressing differences in mRNA levels over 
time using northern blot analysis. 
The corresponding Yersinia strains were grown in 100 mL Erlenmeyer flasks with 20-30 mL 
LB medium and if necessary with the corresponding antibiotics, for 2 h at 25 °C followed by 
a shift to 37 °C for 4 h. Transcription was stopped by addition of 1 mL rifampicin to a final 
concentration of 1 mg/mL (Serva, Germany). Generally, 1.8 mL of the culture was taken and 
added to 0.2 mL stop solution at appropriate time points. Samples were mixed well by 
inverting and snap frozen in liquid nitrogen. Total RNA was isolated, quantified and analyzed 
by northern blotting as described previously. 
To determine mRNA half-life, target transcripts and ribosomal RNAs were quantified using 
the ImageJ image processing software [Schneider et al., 2012]. The mRNA quantity at time 
point zero of each strain was taken as a reference. The ratio of mRNA to 16 S and 23 S 
ribosomal RNAs of each sample was calculated relative to the reference. The half-life of the 
respective transcript was calculated as described below. The decaying constant λ was 
calculated as the absolute value of the exponential regression coefficient. 
 
  
 
 
  
     
 
 
 
t(1/2) - transcript half-life  
λ - decaying constant 
 
Stop solution: 10% (v/v) aqua phenol in absolute ethanol 
 
2.2.2.13 Quantitative real-time PCR 
Fast and sensitive analysis of transcript levels was done by quantitative real-time reverse 
transcription PCR. For this purpose, the RNA was reverse transcribed to complementary 
DNA (cDNA) by a reverse transcriptase. The resulting cDNA was used as a template for PCR 
amplification. The accumulation of dsDNA can be quantified by measuring the emission of 
the incorporated fluorescent dye SYBR Green I. The resulting SYBR Green-dsDNA complex 
can by quantified by excitation at λ = 497 nm and measuring the emission of green light at λ = 
520 nm [Bustin et al., 2005]. 
Total RNA was isolated using the SV total RNA isolation kit (Promega, USA). Residual 
DNA was removed by TURBO™ DNase (Thermo Scientific, USA) treatment according to 
the manufacturer's instructions). Samples were diluted to a concentration of 10 ng/µL and the 
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respective RNAs were analyzed with corresponding primer pairs as listed in table 2.11 The 
sopB gene was used as a reference. Quantitative real-time PCR was performed utilizing the 
SensiFAST™ SYBR® No-ROX kit (Bioline, Germany). Therefore, a master mix was 
prepared with a final volume of 12.5 µL per reaction. For each primer pair a non-template 
control, replacing the RNA template with RNase-free ddH2O was used. For each RNA sample 
a no reverse transcription control, containing RNase-free ddH2O instead of reverse 
transcriptase was used.  
 
Example of a one reaction master mix: 
2 x SensiFAST SYBR No-ROX Mix 6.25 µL 
Forward primer (10 µM) 0.5 µL 
µL Reverse primer (10 µM) 0.5 µL 
Reverse transcriptase  0.125 µL 
RiboSafe RNase inhibitor  0.25 µL 
RNase-free ddH2O 2.375 µL 
 
A volume of 10 µL master mix reaction was pipetted into 0.1 mL strip tubes and 2.5 µL of 
RNA sample (10 ng/µL) were added. All reactions were kept in a pre-cooled steel block. 
Reverse transcription and the following qPCR reaction were done in a Rotor-Gene Q 
lightcycler with a 3-step cycling program. 
 
1. Reverse transcription 
 1 x 45 °C for 20 min 
2. PCR initial activation step 
 1 x 95 °C for 5 min 
3. 3-step cycling (40 cycles) 
 Denaturation  95 °C for 10 s 
 Annealing  60 °C for 20 s 
 Elongation  72 °C for 10 s 
 Final Elongation 72 °C for 10 min 
 
A melt profile analysis with a temperature ramp from 58 °C to 99 °C was done to check 
product specificity. Relative expression was calculated using the Rotor Gene Q Series 
Software by determination of the crossing point (CP) after setting a threshold of 0.015. The 
CP is defined as "the point at which fluorescence rises appreciably above the background 
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fluorescence" [Pfaffl, 2001]. Assuming a primer efficiency of 2, relative expression was 
calculated according to the Pfaffl's formula. 
      
            
               
 
                            
 
Table 2.11: Oligonucleotides used in qRT-PCR 
Oligonucleotide Sequence (5' -> 3') Function 
III393 CCGACGTAAAGCCGCGATAC sopB (fw) 
III394 CCTCGTTCATAAGCACTCGTC sopB (rev) 
IV529 CGCGACTCAGCAAGAAGAG rne (fw) 
IV530 GCCGATGTCTGGGCGCAG rne (rev) 
IV931 CGCCCAGACGCGCTTCGGCC pnp (rev) 
IV946 GTTGGGCGCGGTCGTCTTCGG pnp (fw) 
VI165 GGCCGTTTAATCGATTACGCGAAAC rhlB (fw) 
VI166 GCCAATTCACGTACCCGATACGAG rhlB (rev) 
VI167 CCGCCGTGTATTAGCCAAATTACC rhlE (fw) 
VI168 CGCTTTGGGCGATCTGCTCTG rhlE (rev) 
VI173 GCCTGAACACGGCTGTTGGTG eno (fw) 
VI174 GGCTTTGTTACCTTCGCCAGC eno (rev) 
 
2.2.2.14 In vitro transcription of RNAs 
To obtain defined RNAs for RNA electromobility shift analyses (RNA-EMSA), RNAs were 
transcribed in vitro according to the TranscriptAid T7 High Yield Transcription Kit (Thermo 
Scientific, USA) user handbook. Double-stranded DNA templates were amplified from 
chromosomal DNA of strain YPIII by PCR with specific primer pairs for the desired region. 
PCR templates for 5'-lcrF mutants were amplified from plasmid DNA pRS42 (open mutation: 
GUU-30/-27AAA), pRS43 (closed mutation: UU-28/-27CC), pRS45 (∆hairpin 1) or pRS46 
(∆hairpin 2). For this purpose, the respective forward primer encoded the T7 promoter to 
allow transcription by the T7 DNA-dependent RNA polymerase. All primers used to generate 
the T7 promoter containing DNA template are listed in table 2.12. Obtained PCR fragments 
were purified using the NucleoSpin® Gel and PCR Clean-up kit (Macherey-Nagel, 
Germany). This kit allowed purification of very small DNA fragments (down to 50 bp). In 
vitro transcription was carried out at 37 °C for 2 h or overnight in a 20 µL reaction mix with 
6 µL template DNA according to the manufacturer's recommendation. Subsequently, the 
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DNA template was digested with 2 µL DNaseI for 15 min at 37 °C. DNaseI was then 
inactivated by addition of 2 µL of 0.5 M EDTA at 65 °C for 10 min. Finally, RNA was 
purified by phenol-chloroform extraction. 
 
Table 2.12: Oligonucleotides used for in vitro transcription 
Oligonucleotide Sequence (5' -> 3') Function 
V830 GGGCGCGTAATACGACTCACTATAGCTTACATTTTATATGAATGTAATGGC csrA(-105)_fw 
V066 GGGCGCGTAATACGACTCACTATAGGAATGTAATGGCTTACGTTTTC csrA(-91)_fw 
V832 GGGCGCGTAATACGACTCACTATAGCACGGTGTATGATGGATAATG csrA(-70)_fw 
VI386 GCGCGTAATACGACTCACTATAGGGCGGGGAAACAGAGAG csrA(-50)_fw 
V708 GGGCGCGTAATACGACTCACTATAGAACAGAGAGACCCGACTC csrA(-42)_fw 
V631 GTTTCCCCGCCATTATCC csrA(-39)_rev 
III731 GAATAAGCATTCTTTGCTCC csrA(+10)_rev 
I514 GGGCGCGTAATACGACTCACTATAGGCACTCTATTATTATCCAGAC hns(-55)_fw 
V700 GGGCGCGTAATACGACTCACTATAGCAACAATACCGTGAAATGC hns(+175)_fw 
I515 GCAGTTCATTTGGATCAATAC hns(+226)_rev 
VI525 GGCTAATACGACTCACTATAGTACCTGAAGGGGAATGGGAG glgC(-125)_fw 
VI526 AGTCTGTACTTTCAAACCTC glgC(+25)_rev 
V730 GGGCGCGTAATACGACTCACTATAGGGGAATGGGTTGTTATTTTAC yscW(-107)_fw 
III733 CGACTCACGCCAGTCCC yscW(+8)_rev 
V731 GGGCGCGTAATACGACTCACTATAGGGTGATTTATTATATTGGTTTTGGTTG lcrF(-123)_fw 
V732 CTCTAGTGATGCCATAAATGTTATAC lcrF(+15)_rev 
I404 TTTGAA TTCGCCATCTTGTGAATGCTCAAC lcrF(+75)_rev 
V733 GGGCGCGTAATACGACTCACTATAGGCTAAAATAGCAACCACAGGC yscA(-101)_fw 
V734 CCATTGAATCTTCACAATCTAATCCCG yscA(-1)_rev 
* T7 primer underlined 
 
2.2.2.15 3'-Biotinylation of RNAs 
The RNA fragments for RNA electromobility shift assays (RNA-EMSAs) were labeled at 
their 3'-ends with biotin. To do so, biotin-labeled cytosine (pCp-Biotin) was ligated to the 3'-
end of in vitro transcribed RNAs. For a biotinylation reaction, 1 µg of purified transcript was 
denatured at 70 °C for 10 minutes and immediately put on ice. Before usage, all reagents were 
thawed on ice, besides PEG-8,000 which was pre-warmed at 37 °C until the volume was 
fluid, and DMSO, which was thawed at room temperature. 
Biotin labeling of 1 µg linearized RNA was performed in a volume of 20 µL in 1 x T4 RNA 
ligase buffer, 1 mM ATP, 10% (w/v) DMSO, 1 µM pCp-Biotin (Jena Bioscience, Germany), 
15% (w/v) PEG-8,000 and 1 µL T4 ssRNA ligase 1 (20 units; NEB, USA). The reaction was 
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carried out at 18 °C for 2 h or overnight. Afterward, the labeled RNA was purified by phenol-
chloroform extraction and RNA concentration was measured using the NanoDrop™ ND-1000 
UV spectrometer (Thermo Scientific, USA). Northern blotting of 20 fmol RNA and 
subsequent detection with the Chemiluminescent Nucleic Acid Detection Module (Thermo 
Scientific, USA) was carried out to analyze the labeling efficiency and RNA integrity. 
 
2.2.2.16 Detection of Biotin-labeled RNAs 
For detection of biotinylated nucleic acids, the Chemiluminescent Nucleic Acid Detection 
Module (Thermo Scientific) and supplied buffers were used. All incubation steps were carried 
out in 50 mL Falcon tubes on a tube roller. Since only small volumes of buffer were used, it 
was crucial to remove all remaining buffer volumes by pipetting. Before usage, an aliquot of 
5 mL 1 x blocking buffer and 4 x wash buffer was pre-warmed in a water bath (37-50 °C) 
until precipitates were resolubilized. UV-cross-linked membranes were blocked for 15 min in 
5 mL blocking solution. Afterward stabilized Streptavidin-HRP conjugates were added in a 
dilution of 1:300. The membrane was washed four times for 5 min in 5 mL of 1 x wash buffer 
and equilibrated in 5 mL substrate equilibration buffer. Finally, the membranes were wrapped 
in a foil and developed by incubation for 5 min in 1 mL Chemiluminescent Substrate Working 
Solution (500 µL Luminol/Enhancer Solution and 500 µL Stable Peroxide Solution). Detected 
RNAs were documented utilizing the ChemiDoc™ XRS+ (Bio-Rad, USA) imaging system. 
 
2.2.2.17 RNA electromobility shift assay (RNA-EMSA) 
Electromobility shift assays are a valuable tool to study RNA binding capabilities of a protein 
to a specific target RNA. For this purpose, increasing amounts of the protein were incubated 
with biotin-labeled target RNAs. Migration of RNA-protein complexes through a gel matrix is 
retarded for high molecular complexes in comparison to free RNAs. Leading to the 
appearance of a shifted RNA. To evaluate RNA binding capabilities of a protein, the protein 
was purified as described in section 2.2.3.5 and dialyzed against 1 x band shift buffer. Visible 
protein precipitates were removed by centrifugation (18,000 x g, 4 °C, 5 min) and protein 
concentration was evaluated by a Bradford assay (Thermo Fisher Scientific). If not mentioned 
otherwise, all reaction steps were performed on ice. Prior to the binding reaction, RNAs were 
diluted in 1 x band shift buffer, incubated for 10 min at 70 °C for RNA linearization and 
immediately cooled on ice. For a 10 µL binding reaction, 20 fmol of each control and target 
RNA and 0-10,000 fmol of protein were incubated for 20 min on ice. This corresponded to 
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2 nM of each RNA and 0-1,000 nM protein. In the next step, the samples were 
electrophoretically separated in a native 5-8% TBE polyacrylamide gel (1,5 mm spacer, 10 
wells) and successively transferred by semi-dry blotting to a positively charged nylon 
membrane (Roche, Switzerland). For this, the gel is placed on top of the membrane and 
sandwiched between a pair of Whatman paper. The transfer took place in 1 x TBE for 30 min 
at 20 V with a Trans-Blot® SD Semi-Dry Transfer Cell (Biorad, Germany). RNAs were 
cross-linked to the membrane in a Stratalinker® UV-Crosslinker (Stratagene, USA) with 
120,000 µJ or for 3 min. Finally, biotinylated RNAs were detected as described in section 
2.2.2.16. 
 
Table 2.13: 7% TBE-polyacrylamide gel 
Component Volume 
10 x TBE 1 mL 
40% (w/v) Polyacrylamide 1.75 mL 
10% APS 100 µL 
TEMED 10 µL 
ddH2O (RNase-free) 7.25 mL 
Protocol for a 1.5 mm spacer plate 
 
1 x bandshift buffer (YopD/LcrH): 20 mM Na2HPO4/NaH2PO4 (pH 8.0), 100 mM KCl, 5% (w/v) glycerol, 
2 mM DTT 
1 x bandshift buffer (CsrA): 20 mM HEPES (pH 7.6), 100 mM KCl, 5% (w/v) glycerol, 2 mM DTT 
 
2.2.2.18 CsrA-RIP-Seq 
Identification of potential RNA binding partners of CsrA was performed by RNA-binding 
protein immune precipitation followed by high-throughput sequencing (RIP-Seq). The 
Y. pseudotuberculosis wild-type strain YPIII was transformed with plasmid pJH35 encoding a 
3xFLAG-tagged CsrA protein variant or the empty vector control pHSG576. The strains were 
cultivated in 500 mL LBBD supplemented with chloramphenicol for 2 h at 25 °C, followed by 
a 4 h temperature shift to 37 °C. Cells were harvested by centrifugation in an SLA-3000 rotor 
(10 min, 6.000 rpm, 4 °C). Pellets were stored at -40 °C until use. 
The cell pellet was thawed on ice and resuspended in 6 mL ice-cold PBS and lysed by four 
passages through a French Press cell at 18.000 psi. The lysate was cleared by centrifugation 
(30 min, 18.000 x g, 4 °C). The resulting supernatant was normalized corresponding to their 
cultures OD600 by the addition of ice-cold PBS to ensure an equal concentration of cellular 
 Material and Methods 
46 
contents. 1.5 mL of normalized cleared supernatants were used for the IP experiment 
(immune precipitation). 
100 µL of Anti-FLAG® Magnetic Beads (Sigma, UK) were washed three times in 1 mL PBS 
before usage. 1.5 mL of normalized cleared supernatant were added and incubated for 1 h on 
a tube roller at 4 °C. The supernatant was removed and the beads were washed five times with 
ice-cold PBS. Finally, beads were used for RNA extraction by the hot phenol method. To 
evaluate the quality of the IP experiment, 0.5 OD equivalents of the supernatant, flow 
through, wash fraction and beads (elution fraction) were collected. Samples were prepared 
and separated by SDS-PAGE and subsequently stained with Coomassie. According to the hot 
phenol protocol, beads were resuspended in 250 µL resuspension and lysis buffer. Residual 
DNA traces were removed by TURBO™ DNase (Thermo Scientific, USA) treatment 
according to the manufacturer's instructions). To ensure high quality of RNA samples for 
RNA-Seq, RNA integrity was analyzed by the Agilent BioAnalyzer 2100 electrophoresis 
system. Library preparation of RNA samples was performed with the ScriptSeq RNA-Seq 
Library Preparation Kit (Illumina, USA). High-throughput sequencing was performed using 
the Genome Analyzer IIx (Illumina, USA). Analysis of RNA integrity and RNA-sequencing 
experiment were performed by the in-house gene analytic facility (GMAK). Quality control, 
sequencing adapter clipping and quality trimming of the output sequence were performed 
utilizing the fastqc [Andrews, 2010] and fastq-mcf tools [Aronesty, 2011]. The sequencing 
output quality was analyzed using FastQC (Babraham Bioinformatics). All sequenced 
libraries were mapped to the YPIII chromosome (NC_010465) and the pIB virulence plasmid 
(NC_006153) with Bowtie2 (ver. 2.1.0) using the default parameters. The resulting BAM files 
were filtered for unique mapped reads with SAM tools, which were used for downstream 
analysis [Li et al., 2009]. 
 
2.2.2.19 Measurement of promoter activity using β-galactosidase reporter fusions 
Measurements of transcriptional or post-transcriptional gene expression using gene fusions to 
lacZ were performed by β-galactosidase activity assay. To do so, the promoter region of the 
respective target gene including the 5'-UTR and the first codons is fused to the lacZ reporter 
gene (translational fusion). When the corresponding promoter or upstream region is activated, 
the lacZ gene coding for the β-galactosidase enzyme is expressed and its activity can be 
measured. This assay is based on the enzymatic activity of β-galactosidase, which cleaves 
galactose to glucose and lactose. The artificial, colorless substrate ortho-nitrophenyl-β-D-
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galactopyranoside (ONPG) is also recognized and cleaved to galactose and the yellow colored 
ortho-nitrophenyl, whose absorption can be photometrically measured at λ = 415 nm. 
For this assay, 5 mL bacterial cultures were grown under desired conditions and the optical 
density was measured at λ = 600 nm (OD600). Typically, over day cultures were grown for 2 h 
at 25 °C and shifted to 37 °C for 4 h. The OD600 of these cultures was adjusted to a final 
OD600 of 0.1 to 0.9. Typically, 1 mL of a 1:10, or for strains with a growth defect a 1:5 
dilution, was measured. 200 µL of the diluted culture was lysed for 10 min by addition of 
50 µL 20% SDS and 100 µL chloroform. Afterward, 1.8 mL Z-buffer was added. The 
reaction was started by addition of 400 µL ONPG and the time was measured until the 
solution turned yellow. The reaction was stopped by addition of 1 mL 1 M NaCO3. 200 µL of 
the reaction were finally photometrically measured with a Sunrise™ microplate reader 
(Tecan, Switzerland) at λ = 415 nm, corresponding to the β-galactosidase activity and at 
λ = 655 nm corresponding to the bacterial background. The β-galactosidase activity could be 
calculated by the following formula. 
 
          
              
             
 
t - time [min] 
V - volume [mL] 
OD - optical density measured at indicated wavelength 
 
5 x Z-buffer: 300 mM Na2HPO4; 100 mM NaH2PO4; 50 mM KCl; 5 mM MgSO4 
 
2.2.3 Protein biochemical methods 
2.2.3.1 Measurement of protein concentration (Bradford assay) 
Quantification of protein concentration was carried out by Bradford Assay (Bradford, 1976). 
The principle is based on the formation of a protein-dye complex. In this work, Coomassie 
Brilliant Blue G250 was used, which specifically binds to unpolar and cationic side chains 
and thereby stabilizes the blue anionic form of the Coomassie dye. Since the absorption 
maximum of the blue Coomassie form is at λ = 595 nm, measurement of absorption at this 
wavelength was used for protein quantification. For this purpose, 5 µL of protein solution and 
250 µL of Bradford reagent were incubated for 5 min at room temperature in a 96-well 
microplate. Samples were photometrically measured in a Sunrise™ microplate absorbance 
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reader (Tecan, Switzerland). After determining the extinction of a BSA equilibration curve 
(25-1000 ng/µL), the protein concentration was calculated. 
 
2.2.3.2 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Separation of proteins based on their size was carried out by denaturing SDS polyacrylamide 
gel electrophoresis (SDS-PAGE) [Laemmli, 1970]. Unfolded and negatively charged proteins 
are separated, powered by an applied electrical field, as they migrated through a discontinuous 
polyacrylamide gel matrix. Since proteins were unfolded, denatured and negatively charged 
by boiling in a denaturing buffer containing SDS, they are separated solely by their molecular 
weight, independent of their net charge and conformation. 
During this work, SDS-PAGE was carried out as vertical electrophoresis in Mini-
PROTEAN® tetra cells system (Bio-Rad, USA). For proteins larger than 15 kDa, Laemmli 
polyacrylamide gels with a 5% stacking gel and depending on molecular weight of the target 
protein, a 12% or 15% resolving gel were used. 
 
Table 2.14: SDS glycine polyacrylamide gel 
Component Resolving gel 
(5%) 
Separating gel 
(12%) 
Separating gel 
(15%) 
Upper buffer 2.5 mL - - 
Lower buffer - 2.5 mL 2.5 mL 
30% (w/v) Polyacrylamide 1.1 mL 4.0 mL 5 mL 
ddH2O 6.5 mL 3.5 mL 2.5 mL 
APS (10% w/v) 50 µL 50 µL 50 µL 
TEMED 10 µL 10 µL 10 µL 
 
Upper buffer (4 x):  1.5 M Tris-HCl pH 8.8; 4% SDS 
Lower buffer (4 x):  0.5 M Tris-HCl pH 6.8; 4% SDS 
SDS running buffer (10 x): 33 mM Tris-HCl pH 8.3; 192 mM glycine; 0.1% SDS 
 
For proteins smaller than 15 kDa, such as CsrA, SDS tricine polyacrylamide gels with a 15% 
separating gel were used [Schägger, 2006]. 
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Table 2.15: SDS tricine polyacrylamide gel 
Component Resolving gel 
(5%) 
Separating gel 
(15%) 
3 x gel buffer 3.1 mL 5.0 mL 
30% (w/v) Polyacrylamide 1.1 mL 7.5 mL 
ddH2O 7.6 mL 1.5 mL 
Glycerol - 1.5 mL 
APS (10% w/v) 150 µL 150 µL 
TEMED 15 µL 15 µL 
 
Gel buffer (3 x): 3 M Tris-HCl, pH 8.45; 0,3% SDS 
Anode buffer (10 x): 1 M Tris; 225 mM HCl 
Cathode buffer (10 x): 1 M Tris; 1 M tricine; 1% SDS 
SDS sample buffer (3 x): 240 mM Tris-HCl pH 6.8; 8% SDS; 40% Glycerol; 12% DTT; 0.02% bromphenol 
   blue 
 
2.2.3.3 Coomassie staining of proteins after SDS-PAGE 
Visualization of proteins after separation by SDS-PAGE was carried out by staining with 
Coomassie Brilliant Blue. For this purpose, gels were incubated in Coomassie stain on a 
shaker until the gels are completely stained in blue. Afterward, the staining solution was 
removed and gels were washed several times in water until protein bands were visible and the 
background was sufficiently destained. The staining solution could be reused several times. 
The staining and washing process was accelerated by heating of the gel in staining solution or 
ddH2O in a microwave oven. 
 
Coomassie stain: 0.05% (w/v) Coomassie Brilliant Blue G250; 20% (v/v) isopropanol; 10% (v/v) acetic acid 
 
2.2.3.4 Western blot and immune detection 
Identification of specific proteins was carried out by western blotting following immune 
detection. (Towbin et al., 1979). After separation of protein samples by SDS-PAGE, proteins 
were electrophoretically transferred and thereby immobilized on a hydrophobic Immobilon®-
P PVDF membrane (Sigma, UK). For this purpose, the PVDF membrane was activated in 
100% methanol and presoaked, together with two pieces of Whatman paper 17 Chr (Neolab, 
Germany) and the polyacrylamide gel. The gel was topped by the membrane and sandwiched 
between the Whatman paper and foam pads. The transfer was performed in the Mini Trans-
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Blot® cell system (Bio-Rad, USA). To do so, the sandwich was placed in the Mini Trans-
Blot® cell, the gel facing the cathode and the membrane facing the anode. The tank was filled 
with transblot buffer and the transfer took place for 1 h at 100 V. Following transfer, the 
membrane was blocked in TBST-M for at least 15 min at room temperature or overnight at 
4 °C on a shaker. Afterward the primary antibody was added (concentration listed in table 
2.3) and the membrane was incubated for 1 h at room temperature or overnight at 4 °C. 
Routinely, incubation with antibody solution was done in 15 mL solution on a shaker or in 
5 mL solution in a 50 mL Falcon tube on a roller. After removal of the antibody solution, the 
blot was rinsed twice with a small volume of 1 x TBST and washed three times for 10 min in 
TBST. The membrane was incubated for at least 1 h with a secondary antibody in TBST-M. 
Depending on the primary antibody used, goat anti-mouse horseradish peroxidase (HRP) 
conjugates or goat anti-rabbit HRP conjugates were used at a 1:8,000 dilution. After removal 
of the antibody solution, the blot was rinsed and washed as stated above and target proteins 
were detected by chemiluminescence utilizing the Western Lightening ECL II kit (Perkin 
Elmer, USA) and documented using the ChemiDoc XR+ System (Bio-Rad, USA). 
 
Transblot buffer (1 x): 25 mM Tris; 192 mM glycine; 20% methanol (v/v) 
TBST (10 x):  20 mM Tris-HCl, pH 7.5; 150 mM NaCl; 0.05% (v/v) TWEEN-20 
TBST-M (1 x):  5% (w/v) in 1 x TBST 
 
2.2.3.5 Expression and purification of recombinant proteins 
For the study of protein-RNA interactions in RNA electromobility shift assays (RNA-EMSA), 
CsrA was expressed with a C-terminal His6 epitope from pAKH172. His6-YopD and LcrH 
were expressed from pJH12. For this purpose, pAKH172 or pJH12 were transformed into 
chemically competent E. coli BL21(DE3) by heat shock. For protein expression, cells were 
grown to an OD600 of ~0.5 in 500 mL DYT supplemented with kanamycin. Subsequently, 
protein expression was induced by addition of 1 mM IPTG for 5 h at 18 °C. Cells were 
harvested by centrifugation for 10 min at 6,000 rpm and 4 °C in an SLA-3000 rotor. The cell 
pellet was stored at -20 °C. 
The cell pellet was resuspended in 10 mL CsrA lysis buffer supplemented with 20 mM 
imidazole and cOmplete™ EDTA-free protease inhibitor cocktail (Roche, Switzerland). Cells 
were lysed by four passages through a French Press cell disruptor (G. Heinemann, Germany) 
at 18,000 psi. To remove cell debris, lysates were cleared by centrifugation (30 min at 
18,000 x g and 4 °C) and sterile filtered with a 0.2 µm syringe sterile filter. CsrA-His6 was 
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then purified by Ni-NTA affinity chromatography utilizing a 1 mL HisTrap FF Crude column 
in a ÄKTApurifier (GE Healthcare, Germany) according to the manufacturer's instructions). 
Prior usage all buffers were sterile filtered, degassed and pre-cooled to 4 °C. 
Bound protein was eluted from the column by applying an imidazole gradient from 0 to 
500 mM over 20 column volumes in 1 mL fractions. Fractions were tested for protein content 
photometrically by their absorption at 260 nm. Since protein detection at 260 nm is based on 
the absorption of aromatic amino acid side chains and CsrA does not contain any tryptophan, 
absorption of peptide bonds was determined at 230 nm. Fractions with a peak at 230 nm 
(protein containing) were analyzed for purity and protein content by SDS-PAGE and 
Coomassie stain. The fraction with the highest protein content was dialyzed overnight at 4 °C 
in 1000 x volumes of dialysis buffer. Dialyzed proteins were then stored at -20 °C [Maurer, et 
al. 2016]. 
His-YopD/LcrH complexes were purified by flow-through Ni-NTA affinity chromatography 
with a bed volume of 0.5 mL Protino Ni-NTA agarose (Macherey & Nagel, Germany). Prior 
to use, the column was washed with 10 mL ddH2O to remove traces of the ethanol containing 
storage solution and equilibrated with 10 mL YopD lysis buffer supplemented with 20 mM 
imidazole. Subsequently, 10 mL lysates were loaded on the column and run by gravity flow. 
Subsequently, the column was washed two times with 10 mL of YopD lysis buffer 
supplemented with 50 mM imidazole. Bound protein was eluted by adding six bed volumes of 
YopD lysis buffer supplemented with 250 mM imidazole. To analyze the quality of the 
purification efficiency, fractions of the supernatant, flow through, wash and elution fractions 
were analyzed by SDS-PAGE and Coomassie staining. The fraction with the highest purity 
and an equal ratio of YopD to LcrH were dialyzed overnight in YopD dialysis buffer and 
stored at 4 °C. The column could be reused after removing residual bound protein by eluting 
with 10 x column volumes of YopD lysis buffer with 250 mM Imidazole. The columns were 
then equilibrated in 20% ethanol and were stored at 4 °C. 
 
CsrA lysis buffer:  50 mM HEPES (pH 7.6), 150 mM NaCl 
CsrA dialysis buffer:  50 mM HEPES (pH 7.6), 150 mM KCl, 2 mM DTT, 5% glycerol 
YopD lysis buffer:  50 mM Na2HPO4/NaH2PO4, pH 8.0; 150 mM NaCl 
YopD dialysis buffer:  50 mM Na2HPO4/NaH2PO4, pH 8.0; 150 mM KCl; 2 mM DTT; 5% glycerol 
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2.2.3.6 Protein stability assay 
Analysis of protein stability was carried out by an in vivo protein degradation assay. 
Therefore, over day cultures of Y. pseudotuberculosis were grown under desired conditions. 
Subsequently, protein synthesis was stopped by antibiotics and samples were taken. To ensure 
a complete shutdown of protein synthesis spectinomycin and chloramphenicol (Roth, 
Germany) were added to a final concentration of 0.5 mg/mL, corresponding to time point 
zero. Typically, 2 mL of the culture were taken at appropriate time points and pelleted in a 
pre-cooled centrifuge. Additionally, bacterial cell density was measured to check growth 
arrest and stop of translation. The cell pellet was resuspended in 1 x SDS loading buffer to a 
concentration of 1 OD600 equivalents and boiled for 5 min at 95 °C. Protein samples were then 
stored at -20 °C until they were analyzed by western blotting. 
 
2.2.4 Bioinformatic methods 
2.2.4.1 CsrA target prediction with CSRA_TARGET_PREDICTER 
Prediction of potential CsrA target RNAs was done by a self-written Python script, based on 
an algorithm outlined by Kulkarni and colleagues [Kulkarni et al., 2014]. Upstream sequence 
of annotated coding genes, spanning the region from -150 to +60 relative to the annotated 
start codon were extracted with a self-written Python script. FASTA sequence files and 
annotation tables of coding genes were obtained from the PATRIC bacterial bioinformatics 
database [Wattam et al., 2013]. For this analysis, upstream sequences of monocistronic and 
polycistronic genes of E. coli K12 MG1655 (NC_000913) and Y. pseudotuberculosis YPIII 
(NC_10465) were extracted. These sequences were then analyzed by 
CSRA_TARGET_PREDICTER. The corresponding flowchart is depicted in figure 3.21A. 
Subsequently, from all input sequences non-overlapping primary and secondary sites were 
located and counted. Primary sites were defined as A(N)GGA motifs (AAGGA, ACGGA, 
AGGGA, ATGGA, AGGA), while secondary sites were defined as AGAGA, CTGGA, 
CGGGA and TGGGA. In a first step, sequences with a primary site in the vicinity to the 
Shine-Dalgarno (SD) sequence were chosen. The region in the vicinity to the SD was defined 
according to Kulkarni and colleagues as the region from -30 to +5 nt relative to the start 
codon. Then the total number of binding sites (primary or secondary sites) in the whole 
sequence were counted and only sequences with a total number of at least three primary or 
secondary sites were selected. Since CsrA binds secondary binding sites with a low affinity, 
additional binding sites need to be in close vicinity. For that reason, only secondary sites were 
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considered whose maximal distance to the next binding site (primary or secondary) was less 
or equal than 10 nt [Kulkarni et al., 2014]. From these sequences, only the ones were chosen, 
which contained at least three primary sites or two primary site and two or more secondary 
sites. Finally, the distance between consecutive motifs was determined and all remaining 
sequences with at least two neighboring sites with a distance of 10 to 60 nt were considered as 
putative direct CsrA targets. 
For the comparison of predicted CsrA targets in E. coli and Y. pseudotuberculosis, the protein 
sequence of all annotated ORFs were extracted and aligned using the protein-protein 
BLASTP command line tool (Protein-Protein BLAST 2.3.0+) with an e-value threshold 
(≤ 0.001) [Camacho et al., 2009]. For the analysis of differences in the CsrA binding motif 
distribution of assigned genes, the upstream region (-150 to +60 relative to the translational 
start site) of these genes was aligned utilizing the ClustalO command line tool (Clustal Omega 
1.2.1) with default settings [Sievers et al., 2011]. 
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3 Results 
After assembly of the injectisome, it remains in a stand-by mode until secretion is triggered 
by host cell contact. Under these conditions, T3SS gene expression needs to be shut-down to 
not overstrain the protein quality control system and the energetic homeostasis of the bacterial 
cell. To accomplish this, Yersinia developed a sophisticated feedback mechanism that 
represses T3SS genes until cell contact takes place and secretion is triggered. This state is 
monitored and controlled by the translocator and RNA-binding protein YopD, which acts as a 
general yop gene repressor. Additionally, the status of the Ysc-Yop T3SS is linked to the 
central Csr system. It could be shown that the RNA-binding protein CsrA, together with 
YopD, represses expression of the T3SS master regulator LcrF. First experiments also 
demonstrated that YopD activates csrA expression in the absence of host cell contact [Opitz, 
PhD thesis; Steinmann, PhD thesis]. The present study investigates the underlying mechanism 
of the two RNA-binding proteins CsrA and YopD controlling T3SS expression. 
 
3.1 YopD activates csrA expression 
The global acting RNA-binding protein CsrA is involved in the regulation of a plethora of 
cellular processes, such as motility or biofilm formation [Heroven et al., 2012]. CsrA is also 
linked to the regulation of the Ysc-Yop T3SS in Y. pseudotuberculosis and controlled by the 
translocator protein YopD [Steinmann, PhD thesis]. 
In a previous study, it could be demonstrated that a deletion of yopD reduces csrA mRNA 
levels [Steinmann, PhD thesis]. To further assess the principle of YopD-dependent csrA 
regulation and to identify the YopD-dependent regulatory region in the csrA locus, 
translational csrA'-'lacZ reporter fusions carrying continuous deletions of the 5'-end of 
varying lengths were tested for YopD dependency. So far, the promoter structure of the 
Y. pseudotuberculosis csrA gene locus is unknown. In E. coli, the csrA regulatory region is 
well described and contains five different promoters (see Fig. 3.1A) [Yakhnin et al., 2011]. 
Therefore, the csrA upstream region of Y. pseudotuberculosis and E. coli were compared 
using a Clustal Omega alignment analysis (Fig. S1). In E. coli, promoters P1/2 are located at 
the 3'-end of the alaS gene. The corresponding region (fragment F2) is poorly conserved 
(>50%) in Y. pseudotuberculosis. Promoter P3 of E. coli is located in the intergenic region of 
the alaS and the csrA gene. This region (fragment F3) is only lowly conserved (>50%). 
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Promoters P4/5 are located downstream of P3 and are well conserved (84%) in 
Y. pseudotuberculosis (fragment F4/5) (see Fig. 3.1). 
A manual analysis of RNA-Seq data verified the existence of two promoters with homology 
to the E. coli promoters P3 and P5 [Nuss et al., 2015]. The E. coli promoters P1/2/4 might be 
as well present in Y. pseudotuberculosis, but are only active under unidentified conditions. 
For this reason, the E. coli promoter nomenclature (P1-5) will be used in this study. 
To identify regions essential for csrA expression and to analyze the influence of YopD on the 
csrA upstream region, csrA'-'lacZ fusions were designed harboring different parts of the csrA 
upstream region, e.g. region -1071 to +17 nt (pKB63), region -298 to +17 nt (pJH4), 
region -249 to +17 nt (pJH5), region -121 to +17 nt (pJH5) and region -83 to +17 nt (pJH10) 
(Fig. 3.1A). 
 
 
Figure 3.1: Analysis of YopD-dependent regulation of essential promoter regions of csrA. (A) Schematic presentation of 
the alaS-csrA gene locus of Y. pseudotuberculosis showing the different promoters as described in E. coli (broken arrows, 
P1-P5). Promoters identified only in E. coli are depicted in gray. Promoters identified both in Y. pseudotuberculosis [Nuss, 
unpublished data] and E. coli [Yakhnin et al., 2011] are depicted in black. A schematic presentation of the translational csrA'-
'lacZ deletion constructs and upstream regions (fragment F1-5), encoding the different putative promoters, is depicted below. 
(B) The YopD-dependent expression of translational csrA'-'lacZ reporter fusions was monitored in the Y. pseudotuberculosis 
wild-type (YPIII) and the yopD mutant (YP91) strain. Strains were transformed with the empty vector (pV; pRS15) or 
complemented with its yopD+ derivate pRS16 (pyopD+) and different csrA'-'lacZ deletion constructs (pKB63 (blue), pJH4 
(red), pJH5 (green), pJH6 (purple) or pJH10 (orange)). The specific β-galactosidase activity [µmol/(min*mg)] was measured 
after the strains were grown in LB medium for 2 h at 25 °C following a shift to 37 °C for 4 h. The data represent the mean +/- 
the standard deviation of 3 biological and 3 technical replicates. The data were analyzed by a paired Student's t-test to 
compare differences in promoter activity in the wild-type with * - P < 0.05; ** - P < 0.005; *** - P < 0.001; ns - not 
significant). (C) To compare the overall YopD-dependency of the different csrA'-'lacZ deletion constructs, the specific β-
galactosidase activity of the respective csrA'-'lacZ fusion was normalized to the corresponding wild-type. The data were 
analyzed by an unpaired t-test. 
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The different csrA'-'lacZ fusion constructs were transformed into the Y. pseudotuberculosis 
wild-type (YPIII) and a yopD mutant (YP91) strain. The yopD mutant was additionally 
complemented with a yopD
+
 plasmid. The bacteria were grown in overnight cultures for 2 h at 
25 °C and shifted to 37 °C for 4 h to induce expression of the Ysc-Yop T3SS (T3SS-inducing 
conditions). Neither deletion of the most upstream region encompassing the alaS gene 
(fragment 1) nor the deletion of sequence -298 to -249 nt (fragment 2) affected the csrA'-'lacZ 
activity. This might indicate that in Y. pseudotuberculosis these segments do not include 
promoters P1 and P2 or these promoters are not expressed under the used conditions. 
Additionally, the deletion of the region -249 to -121 nt (fragment F3), containing promoter P3 
(pJH6) slightly but significantly reduced the β-galactosidase activity. The lowest expression 
was observed for fragment F5, containing only the well-conserved promoter P5 (Fig. 3.1B). 
This indicates that expression of csrA in Y. pseudotuberculosis is mainly controlled by the 
region containing promoters P3, P4 and P5. Thereby, Yersinia promoter P5 seems to be the 
most induced promoter under T3SS-inducing conditions. Deletion of yopD led to a decrease 
of 50% β-galactosidase activity, irrespective of the length of the different promoter regions. 
This effect could be compensated by the ectopic expression of yopD (Fig. 3.1C). This 
indicates that the YopD influence does not depend on segments of the csrA promoter region 
that are located upstream of position -83 nt relative to the translational start site (Fig. 3.1). 
 
3.2 YopD binds the csrA leader transcript close to promoter P4/5 
Previously, it has been shown that YopD together with its chaperone LcrH bind to RNA to 
suppress target gene expression [Chen & Anderson, 2011]. To test if the activation of csrA 
expression is a result of direct binding of YopD to the csrA 5'-UTR, the interaction of csrA 
mRNA and YopD was tested in an RNA electromobility shift assay (RNA-EMSA). As YopD 
is only stable when its cognate chaperone LcrH is present, N-terminally His-tagged YopD and 
LcrH were cloned in tandem. Both were overexpressed in E. coli and the His-YopD/LcrH 
complex was co-purified by Ni-NTA affinity chromatography (Fig 3.2B). A biotinylated 5'-
csrA RNA fragment, spanning the region from the -35 region of promoter P4 to the first three 
codons (-91 to +10 nt), was incubated with increasing amounts of purified YopD/LcrH 
complexes. A specific shift of the csrA RNA fragment was detected, but not of the control 
fragment, encompassing a part of the coding region of hns (+175/+226) (Fig. 3.2A+C). To 
specify the YopD interaction site in the 5'-UTR of csrA, YopD RNA-EMSAs were carried 
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out, whereby the csrA 5'-UTR fragment (-105/+10) was shortened from the 5'-end by 20 nt (-
70/+10 or -50/+10) (Fig. 3.3A). Upon adding YopD/LcrH complexes to the target RNA 
fragments, all fragments, but the shortest (-50/+10) formed a high molecular weight complex. 
The shortest fragment was not bound. This indicates the YopD binding region is close to 
position -50 relative to the translational start site (Fig. 3.2D-G). The affinity to the targets was 
strongly dependent on the integrity of the YopD/LcrH complex as seen when comparing Fig. 
3.2DE and Fig. 3.2FG. The affinity depended mostly on LcrH in the samples and resulted in 
differences in the protein concentration required for YopD binding in different protein 
fractions. Also, the ratio of YopD to LcrH was important because lower amounts of LcrH in 
the fraction led to an affinity decrease (data not shown), demonstrating that LcrH is needed 
for RNA-binding activity of YopD (see also chapter 3.4). 
 
 
Figure 3.2: YopD/LcrH interacts with the csrA 5'-UTR in the vicinity to promoters P4/P5. (A) Schematic presentation 
of the csrA gene locus of Y. pseudotuberculosis showing the transcriptional start sites (TSS; broken arrows), the -35 and -10 
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boxes (blue box), the Shine-Dalgarno sequence (SD; red box) and parts of the csrA gene (green arrow). The in vitro 
transcribed RNA fragments used in RNA-EMSA are depicted below. The region of the RNA fragments is indicated relative 
to the translational start site. (B) Coomassie blue-stained SDS-PAGE of Ni-NTA affinity chromatography purified 
His6-YopD/LcrH complexes. Supernatant (S); wash fraction (W); eluate fraction (E1-6). (C-G) Binding of YopD/LcrH 
complexes to the csrA leader transcript was analyzed by RNA-EMSAs. Parts of the csrA 5'-UTR and the hns control 
fragment were in vitro transcribed and biotin-labeled. 2 nM of the resulting csrA and the hns control fragment were incubated 
with increasing concentrations of purified YopD/LcrH complexes, separated onto a native 7% TBE-PAA gel and the biotin-
labeled RNAs were visualized after transfer to a nitrocellulose membrane. Higher molecular bands, as a result of 
YopD/LcrH-RNA binding, are indicated with asterisks. Different YopD/LcrH fractions are marked (YopD/LcrHa-c). 
 
3.3 YopD binds to the csrA 5'-UTR-independent of an AU-rich 
element 
Alignment analyses of YopD repressed genes led to the assumption that an AT-rich element 
can be found in the vicinity to the ribosomal binding site (RBS), which is involved in the 
YopD-dependent regulation [Chen & Anderson, 2011]. A similar element is present close to 
the RBS of csrA between position -24 to -14 upstream of the ATG (Fig. 3.3A). To investigate 
the role of this element in RNA binding of YopD and to further narrow down the binding 
region, 50 nt long, overlapping RNA fragments were tested in gel shift experiments. The 
fragment encompassing the region from position -105 to -60 and -42 to +10 were not bound 
by YopD/LcrH even at high concentrations and independent of the AT-rich element. Binding 
only occurred with the RNA fragment spanning from position -91 to -39 (Fig 3.3B). This 
demonstrates that the YopD binding region is located close to the transcriptional start site and 
the -10 regions of promoters P4 and P5. In contrast to YopD-repressed genes, the AT-rich 
region in the csrA leader transcript does not influence binding of YopD/LcrH. 
 
 
Figure 3.3: An AT-rich element in the csrA 5'-UTR is not required for YopD/LcrH binding. (A) Schematic presentation 
of the csrA gene locus of Y. pseudotuberculosis showing the transcriptional start sites (TSS; broken arrows), the -35 and -10 
boxes (blue box), the Shine-Dalgarno sequence (SD; red box), an AT-rich element (gray box) and parts of the csrA gene 
(green arrow). The in vitro transcribed RNA fragments used in RNA-EMSA are depicted below. The region of the RNA 
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fragments is indicated relative to the translational start site. (B) Binding of YopD/LcrH complexes to the csrA leader 
transcript was analyzed by RNA-EMSAs. Parts of the csrA 5'-UTR were in vitro transcribed and biotin-labeled. 2 nM of the 
resulting csrA fragment was incubated with increasing concentrations of purified YopD/LcrH complexes, separated onto a 
native 5% TBE-PAA gel and the biotin-labeled RNAs were visualized after transfer onto a nitrocellulose membrane. Higher 
molecular bands, as a result of YopD/LcrH-RNA binding, are indicated with asterisks. 
 
3.4 LcrH alone does not confer CsrA activation 
In the Gram-positive soil bacterium, B. subtilis, the function of csrA is dependent on the 
loading status of a flagellar T3SS chaperone and therefore on the secretion status of the 
flagellar T3SS. The flagellin protein Hag is intracellularly protected by its chaperones FliS 
and FliW. When the flagellar filament is assembled and Hag gets secreted, FliW remains in 
the cytosol. Free FliW binds to CsrA, thus preventing CsrA from the repression of hag 
translation [Mukherjee et al., 2011]. As well in Y. pseudotuberculosis, regulation of csrA is 
dependent on the secretion status of the cell. In a yopD mutant or when secretion is triggered 
by calcium depletion, csrA gene expression is repressed [Steinmann, PhD thesis]. In order to 
test whether YopD or LcrH alone are able to affect CsrA expression, synthesis of CsrA in the 
yopD, lcrH and yopD/lcrH double mutant and in mutants complemented with either a yopD
+
 
or a lcrH
+
 plasmid were analyzed by western blot analysis under T3SS-inducing conditions. 
Deletion of yopD as well as of lcrH strongly decreased CsrA protein amounts within the 
bacterial cell (Fig. 3.4A). Furthermore, in a yopD/lcrH background expression of lcrH or 
yopD alone could not restore CsrA to wild-type levels. This demonstrates that both proteins, 
YopD and LcrH, contribute to CsrA synthesis. Low CsrA levels in the lcrH mutant are most 
likely caused by the absence of LcrH which indirectly affects YopD protein levels. As shown 
in Fig 3.4A, the absence of LcrH results in low levels of YopD and supports previous studies 
showing that loss of lcrH inhibits YopD synthesis [Wattiau et al., 1994]. Furthermore, 
binding of LcrH alone to the csrA 5'-UTR RNA fragment is rather unspecific as no specific 
RNA-protein complex band is detectable even at very high LcrH concentrations (Fig. 3.4B). 
Interestingly, YopD also influences LcrH protein levels, as deletion of yopD strongly 
increases LcrH levels (Fig. 3.4A). 
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Figure 3.4: Role of the chaperone LcrH in the regulation of csrA expression. (A) The wild-type (YPIII) and the yopD 
(YP91) mutant, the lcrH mutant (YP92) and the yopD/lcrH mutant (YP183) strain were transformed with either the empty 
vector (pV; pRS1) or complemented with its derivate pRS2 (pyopD+) or pRS3 (plcrH+). Strains were grown in LB medium 
for 2 h at 25 °C with a subsequent shift to 37 °C for 4 h. The CsrA, YopD and LcrH protein content was analyzed by western 
blot analysis (WB). An equivalent of OD600 = 1 was prepared for SDS-PAGE and a subsequent western blot analysis with 
polyclonal α-CsrA, α-YopD and α-H-NS rabbit sera. The H-NS band served as a loading control. A lower molecular weight 
LcrH degradation product is marked (LcrH*). (B) Binding of YopD/LcrH complexes or LcrH alone to the csrA leader 
transcript was analyzed by RNA-EMSAs. Parts of the csrA 5'-UTR was in vitro transcribed and biotin-labeled. 2 nM of the 
resulting csrA was incubated with increasing concentrations of purified YopD/LcrH complexes, separated onto a native 5% 
TBE-PAA gel and the biotin-labeled RNAs were visualized after transfer to a nitrocellulose membrane. Higher molecular 
bands, as a result of protein-RNA binding, are indicated with asterisks. The region of the csrA RNA fragment is indicated 
relative to the translational start site. 
 
3.5 Deletion of the putative YopD binding region does not fully 
remove YopD-dependent regulation of csrA 
RNA binding studies revealed a putative YopD binding site in the csrA locus to a region close 
to the -10 regions and the transcriptional start sites of promoter P4 and P5. To test if deletion 
of the putative binding region eliminates the YopD dependency of csrA, two deletions were 
introduced within the translational csrA'-'lacZ reporter fusion plasmid (pJH4) encoding the 
entire csrA upstream region with all putative promoter sites. The first deletion spanned a 
region including the -35 and -10 region of promoters P4 and P5 (pJH48), while the second 
deletion additionally excluded the TSS of P4 and P5 (pJH49) (Fig. 3.5A). Deletion of 
promoters P4 and P5 reduced the csrA'-'lacZ activity in the wild-type strain YPIII under 
T3SS-inducing conditions by 70%. This confirms the previous observation that the putative 
promoters P1 and P2, as well as promoter P3, are barely expressed (see Fig. 3.1) whereas 
promoters P4+5 seem to be the main drivers of csrA transcription under this growth condition. 
An additional deletion of the P4/5 TSS region decreased the LacZ activity by 90% in 
comparison to the full-length reference reporter construct pJH4. This could indicate that a 
regulatory element is located in this region (Fig. 3.5B). Deletion of the putative YopD/LcrH 
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binding site did not completely abolish the YopD-dependent regulation in the pJH48 and the 
pJH49 csrA'-'lacZ reporter plasmids. However, a comparison of the relative β-galactosidase 
activity of the different csrA'-'lacZ reporter plasmids revealed that the deleted region in the 
mutated reporter plasmid pJH48 and pJH49 might be involved in YopD-dependent regulation. 
Expression of the mutated reporter plasmids pJH48 and pJH49 were less reduced in the yopD 
mutant (65% and 74%) than in the wild-type reporter construct pJH4 (45%) (Fig. 3.5C). 
According to these data, the deletion of the putative YopD binding site, as defined in RNA 
binding studies, does not completely abolish YopD-dependent regulation of csrA indicating 
an additional factor is involved in csrA regulation. 
 
 
Figure 3.5: Deletion of the putative YopD binding region does not fully abolish YopD-dependent csrA regulation. (A) 
Schematic presentation of the csrA gene locus of Y. pseudotuberculosis showing the transcriptional start sites (TSS; broken 
arrows), the -35 and -10 boxes (blue box), the Shine-Dalgarno sequence (SD; red box) and parts of the csrA gene (green 
arrow). A schematic presentation of the downstream sequence of the translational csrA'-'lacZ constructs containing the whole 
csrA regulatory upstream region (pJH4) or mutated reporter constructs (pJH48 and pJH49) with a deletion in the putative 
YopD binding region (∆BS1 and ∆BS2) is depicted below. (B) The YopD-dependent expression of translational csrA'-'lacZ 
reporter fusions was monitored in Y. pseudotuberculosis wild-type (YPIII) and the yopD mutant (YP91) strain. Strains were 
transformed with the empty vector (pV; pRS15) or complemented with its derivate pRS16 (pyopD+) and different csrA'-'lacZ 
reporter constructs (pJH4 (blue), pJH48 (red) or pJH49 (green)). The specific β-galactosidase activity [µmol/(min*mg)] was 
measured after the strains were grown in LB medium for 2 h at 25 °C following a shift to 37 °C for 4 h. The data represent 
the mean +/- the standard deviation of 3 biological and 3 technical replicates. The data were analyzed by a paired Student's t-
test to compare differences in promoter activity in the wild-type with * - P < 0.05; ** - P < 0.005; *** - P < 0.001; ns - not 
significant). (C) To compare the overall YopD-dependency of the different csrA'-'lacZ deletion constructs, the specific β-
galactosidase activity of the respective csrA'-'lacZ fusion was normalized to the corresponding wild-type. 
 
3.6 CsrA directly binds to its leader transcript 
Previous results indicated the presence of an additional regulator binding the region between 
promoters P4 and P5. Analysis of the well conserved upstream region of csrA revealed at least 
two high-affinity binding motifs for CsrA (ANGGA). One of these binding sites overlap with 
the ribosomal binding site, another one is located between the -10 regions of promoters P4 
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and P5. Two additional putative low-affinity binding sites (AGAGA, GGGGA) are located 
between these two high-affinity binding sites. These binding sites are also present in the E. 
coli csrA upstream region and are directly bound by CsrA [Kulkarni et al., 2014; Yakhnin et 
al., 2011]. This led to the question whether CsrA could be the missing regulator binding to the 
same upstream region as YopD/LcrH. To analyze binding of CsrA to its 5'-UTR, two 
transcripts were tested for CsrA binding in RNA gel shift assays. The first RNA transcript 
contained both primary binding sites and both putative secondary binding sites (-70/+10), 
while the second transcript was truncated from the 5'-end and missed the 5'-primary binding 
motif (-50/+10) (Fig. 3.6A). The respective transcripts were incubated with increasing 
amounts of C-terminally His-tagged CsrA protein. RNA-EMSAs with the longer transcript 
led to the formation of two high molecular weight RNA-CsrA complexes. At low CsrA 
concentrations, a small RNA-CsrA complex appeared, while at the highest protein 
concentration a larger high-molecular RNA-CsrA complex was formed, indicating that 
multiple CsrA molecules interacted with the RNA fragment (Fig. 3.6B). The shorter transcript 
(-50 to +10) was not bound by the CsrA protein (Fig. 3.6C). Interestingly, the absence of the 
upstream primary binding site eliminated the specific binding by CsrA demonstrating the 
importance of both ANGGA motifs for effective, high affine binding of CsrA to its transcript. 
Furthermore, both putative secondary binding sites do not seem to play role in CsrA-csrA 
binding. 
 
 
Figure 3.6: CsrA interacts with its leader transcript. (A) Schematic presentation of the csrA gene locus of Y. 
pseudotuberculosis showing the transcriptional start sites (TSS; broken arrows), the -35 and -10 boxes (blue box), the CsrA 
binding sites (light red box; ps - primary high affinity binding site; ss - secondary low affinity binding site), the Shine-
Dalgarno sequence (SD; red box) and parts of the csrA gene (green arrow). The in vitro transcribed RNA fragments used in 
RNA-EMSA are depicted below. The region of the RNA fragments is indicated relative to the translational start site. (B-C) 
Binding of CsrA to the csrA leader transcript was analyzed by RNA-EMSAs. Parts of the csrA 5'-UTR and the hns control 
fragment were in vitro transcribed and biotin-labeled. 2 nM of the resulting csrA and the hns control fragment were incubated 
with increasing concentrations of CsrA, separated onto a native 7% TBE-PAA gel and the biotin-labeled RNAs were 
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visualized after transfer to a nitrocellulose membrane. Higher molecular bands, as a result of CsrA-RNA binding, are 
indicated with asterisks. 
 
3.7 Complex autoregulation of csrA in Y. pseudotuberculosis 
Autoregulation of csrA expression in E. coli occurs by a complex autoregulatory mechanism, 
including indirect activation of its own transcription and a direct repression of translation 
[Yakhnin et al., 2011]. To further analyze the CsrA-dependent csrA regulation in 
Y. pseudotuberculosis, expression of a translational csrA'-'lacZ fusion in which the first 70 nt 
upstream of the start codon were fused under the control of the constitutive tet promoter 
(pJH27), was investigated in the absence of csrA and in the presence of an arabinose-
inducible csrA+ plasmid (pJH25) (Fig. 3.7AB). Deletion of csrA did not affect the reporter 
activity. However, high levels of CsrA strongly repressed csrA'-'lacZ activity (Fig. 3.7B). 
This strongly suggests, that similar to E. coli, binding of CsrA of Y. pseudotuberculosis to the 
region in proximity of promoters P4/5 led to translational repression of csrA. Expression of a 
csrA'-'lacZ construct, encoding the entire 5'-region of csrA (P1-5), was slightly but 
significantly down-regulated in the csrA mutant. This indicates a positive transcriptional 
autoregulation of the csrA locus. Complementation of the csrA mutant with a PBAD::csrA 
construct could not fully restore wild-type levels. This could be explained by the observed 
repressive effect of CsrA on its own translation. (Fig. 3.7C). To further investigate the effect 
of CsrA on its own transcription, expression of a translational csrA'-'lacZ fusion in which 
promoters P4 and P5 (pJH48) and thus the repressive CsrA binding site was deleted was 
analyzed. The absence of csrA resulted in a reduced csrA'-'lacZ expression. Complementation 
of csrA with the PBAD::csrA construct led to an induction of csrA'-'lacZ reporter gene activity 
above the wild-type level (Fig. 3.7D). As the binding motif needed for autorepression was 
deleted, high CsrA protein levels could not inhibit csrA expression as observed in the full-
length construct. In summary, this demonstrated csrA is autoregulated in a direct negative and 
a positive indirect manner ensuring a tightly controlled expression of csrA. Since no 
additional CsrA binding sites are located upstream of promoters P4 and P5 the positive 
autoregulation is most probably mediated indirectly on the transcriptional level as described 
for E. coli (Yakhnin et al., 2011). 
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Figure 3.7: Autoregulation of csrA. (A) Schematic presentation of the csrA gene locus of Y. pseudotuberculosis showing 
the transcriptional start sites (TSS; broken arrows), the -35 and -10 boxes (blue box), CsrA binding sites (light red box; ps - 
primary high affinity binding site; ss - secondary low affinity binding site), the Shine-Dalgarno sequence (SD; red box) and 
parts of the csrA gene (green arrow). A schematic presentation of the translational csrA'-'lacZ constructs containing the whole 
csrA regulatory upstream region (pJH4, blue), mutated reporter constructs (pJH48, red) with a deletion in the putative YopD 
binding region (∆BS1) or a translational csrA'-'lacZ reporter construct encoding the csrA upstream region under the control of 
a constitutive Ptet promoter (pJH27, green) is depicted below. (B-D) The CsrA-dependent expression of translational csrA'-
'lacZ reporter fusions was monitored in Y. pseudotuberculosis wild-type (YPIII) and the csrA mutant (YP53) strain. Strains 
were transformed with the empty vector (pV; pBAD33) or complemented with its derivate pJH25 (pcsrA+) and different 
csrA'-'lacZ reporter constructs (pJH27 (B), pJH4 (C) or pJH48 (D)). The specific β-galactosidase activity [µmol/(min*mg)] 
was measured after the strains were grown in LB medium supplemented with 0.5% arabinose for 2 h at 25 °C following a 
shift to 37 °C for 4 h. The data represent the mean +/- the standard deviation of 3 biological and 3 technical replicates. The 
data were analyzed by an unpaired Student's t-test with * - P < 0.05; ** - P < 0.005; *** - P < 0.001; ns - not significant). 
 
3.8 YopD and CsrA are both required for csrA control 
Previous data of this work demonstrated that regulation of csrA is the result of a complex 
interplay between YopD and CsrA. First, both proteins bind to similar regions in the 5'-UTR 
of csrA whereby YopD is required for activation and CsrA for a direct translational repression 
and an indirect transcriptional activation of csrA expression (Fig. 3.7). Second YopD is 
required for efficient CsrA synthesis (Fig. 3.4) thus also indirectly affecting csrA transcription 
and translation. 
As CsrA levels are decreased in absence of yopD, increasing CsrA levels might induce its 
own expression. To analyze whether CsrA is able to induce its own expression in the absence 
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of yopD, a translational csrA'-'lacZ reporter gene fusion encompassing either the whole 
regulatory region (pJH4), a deletion in the primary CsrA binding site and part of the YopD 
binding site (pJH48), or a third fusion with an even more extended deletion of the YopD 
binding site (pJH49), were introduced in the Y. pseudotuberculosis wild-type strain, in the 
yopD mutant and in the yopD mutant containing a plasmid with csrA under an inducible 
promoter (pJH25) (Fig. 3.8A). 
Deletion of yopD resulted in a strongly reduced csrA'-'lacZ activity of the wild-type construct 
(pJH4). Increasing CsrA levels in absence of YopD did not induce the csrA expression. The 
most presumable explanation is CsrA indirectly induces its transcription, but also binds to its 
repressive site in the P4/5 region of the 5'-UTR, thereby preventing csrA translation and 
compensating the transcriptional activation (Fig. 3.8B). Indeed, deletion of CsrA's binding 
site in pJH48 and pJH49 resulted in a 1.27 and 1.30 fold induction in the yopD mutant 
containing the csrA expressing plasmid compared to the yopD mutant with the empty vector 
control (Fig. 3.8C). However, as observed previously, csrA expression cannot be fully 
restored (Fig. 3.7D). 
As CsrA is involved in the translational YopD-dependent control of csrA expression, the 
influence of YopD and CsrA on csrA expression was analyzed. To do so, the expression of a 
translational csrA'-'lacZ fusion, containing the YopD and CsrA binding region, under the 
control of the constitutive tet promoter (pJH27, see chapter 3.7) was analyzed in presence of 
a yopD
+
 plasmid (pRS16) in the wild-type (YPIII), the yopD mutant (YP91), the csrA mutant 
(YP53) and the yopD/csrA double mutant (YP145) strain. 
As observed before, the deletion of yopD resulted in a strong reduction of csrA'-'lacZ activity. 
The deletion of csrA mildly increased the csrA'-'lacZ activity by removing the autorepression 
of csrA. Although expression of yopD could restore the csrA'-'lacZ activity to wild-type levels 
in the yopD mutant, expression of yopD did not affect csrA'-'lacZ activity in the csrA mutant. 
Interestingly, deletion of yopD and csrA partially restored csrA'-'lacZ activity compared to the 
wild-type, demonstrating that the control of csrA by YopD is dependent on CsrA. Notably, 
YopD can induce csrA expression independent of csrA, as an expression of YopD in the 
yopD/csrA double mutant completely restored csrA'-'lacZ reporter gene activity to wild-type 
levels (Fig. 3.8D). 
In conclusion, both proteins are required for full activation of csrA under T3SS-inducing 
conditions. CsrA is needed for the indirect transcriptional activation, while YopD-mediated 
activation is achieved by binding to the csrA 5'-UTR, which additionally weakens the 
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translational autorepression of csrA. However, too high CsrA level might prevent csrA 
translation by interfering with YopD. 
 
 
Figure 3.8: YopD and CsrA are both involved in regulation of csrA. (A) Schematic presentation of the csrA gene locus of 
Y. pseudotuberculosis showing the transcriptional start sites (TSS; broken arrows), the -35 and -10 boxes (blue box), CsrA 
binding sites (light red box; ps - primary high affinity binding site; ss - secondary low affinity binding site), the Shine-
Dalgarno sequence (SD; red box) and parts of the csrA gene (green arrow). A schematic presentation of the translational 
csrA'-'lacZ constructs containing the csrA regulatory upstream region (pJH4), reporter constructs (pJH48 and pJH49) with a 
deletion in the putative YopD binding region (∆BS1 and ∆BS2) or a translational csrA'-'lacZ reporter construct encoding the 
csrA upstream region under the control of a constitutive Ptet promoter (pJH27) is depicted below. (B-D) The CsrA- and 
YopD-dependent expression of translational csrA'-'lacZ reporter fusions were monitored in Y. pseudotuberculosis wild-type 
(YPIII), the yopD mutant (YP91), the csrA mutant (YP53) and the yopD/csrA (YP145) mutant strain. Strains were 
transformed with the empty vector (pVa; pBAD33 or pVb pRS15) or complemented with its derivate pJH25 or pRS16 (pcsrA
+
 
or pyopD+) and different csrA'-'lacZ reporter constructs (pJH4 (blue), pJH48 (red), pJH49 (purple) or pJH27 (green)). (B+D) 
The specific β-galactosidase activity [µmol/(min*mg)] was measured after the strains were grown in LB medium for 2 h at 
25 °C following a shift to 37 °C for 4 h. To induce expression of the pBAD33 plasmid and its derivate, strains were grown in 
LB medium supplemented with 0.5% arabinose. The data represent the mean +/- the standard deviation of at least 2 
biological and 2 technical replicates. (C) To compare the overall influence of CsrA on the YopD-dependency of the different 
csrA'-'lacZ deletion constructs, the specific β-galactosidase activity of the respective csrA'-'lacZ fusion was normalized to the 
corresponding wild-type. The data were analyzed by an unpaired Student's t-test with * - P < 0.05; ** - P < 0.005; *** - P < 
0.001; **** - P < 0.0001; ns - not significant). 
 
3.9 Transcript stability of csrA is not influenced by YopD 
As demonstrated previously, YopD binds to the leader region of the csrA mRNA. 
Additionally, deletion of yopD causes a reduction in csrA mRNA and protein level 
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(Steinmann, PhD thesis; Fig. 3.4A), indicating that YopD affects CsrA synthesis on the 
posttranscriptional level. Hence, an RNA stability assay was used to analyze the stability of 
csrA mRNA in the wild-type and the yopD deficient strains grown under T3SS-inducing 
conditions. However, the csrA transcript stability in the wild-type and the yopD mutant were 
comparable and an RNA half-life of approximately 2.7 min was observed in both strains 
(Fig. 3.9A+B). Interestingly, a second transcript became visible in the yopD mutant, 
indicating the induction of an additional promoter in absence of YopD. 
 
 
Figure 3.9: The stability of the csrA transcript is not affected by YopD. (A) RNA stability assay of the wild-type (YPIII) 
and the yopD mutant strain (YP91) to determine the stability of the csrA transcript. All strains were grown in LB medium for 
2 h at 25 °C following a shift to 37 °C for 4 h and transcription was stopped by addition of rifampicin to a final concentration 
of 1 mg/mL. Samples were taken before the addition of rifampicin (0) and then 2.5 min, 5 min, 7.5 min, 10 min and 15 min 
after the transcription stop. The total RNA was isolated, separated and the csrA transcript was detected by northern blot 
analysis using a csrA specific DIG-labeled DNA probe. The 16S and 23S ribosomal RNA was stained with ethidium bromide 
and served as a loading control. (B) The northern blot was documented and quantified using the ImageJ software. Data are 
presented as the relative csrA intensity (csrA intensity/rRNA intensity) over time on a half-logarithmic scale. 
 
3.10 YopD induces csrA only at 37 °C 
Translocator YopD is part of the thermo-induced ysc-yop regulon and thus mainly expressed 
at 37 °C. According to this, the question arose if csrA is thermo-regulated through the action 
of YopD. Thus, csrA transcript levels and also the CsrA and the YopD protein content were 
monitored at 25 °C and 37 °C in the wild-type and the yopD mutant by northern and western 
blot analysis. Interestingly, low YopD protein levels were already detectable at 25 °C which 
dramatically increased at 37 °C, reflecting the thermo-induction of the ysc-yop regulon. At 
both temperatures, no differences in csrA transcript level could be recognized in the wild-
type, although CsrA protein levels were increased at 37 °C. As described previously, csrA 
transcript and protein levels were decreased in the yopD mutant (Fig. 3.10). Although high 
YopD levels are present at 37 °C csrA transcript levels were not induced in the wild-type 
supporting the hypothesis that YopD induces csrA post-transcriptionally. Indeed this is 
reflected by an increase of CsrA protein levels at 37 °C in the wild-type compared to 25 °C. 
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Figure 3.10: YopD is already expressed at 25 °C, but activates csrA expression only at 37 °C. The wild-type (YPIII) and 
the ∆yopD (YP91) mutant strain were grown in LB medium for 6 h at 25 °C or for 2 h at 25 °C with a subsequent shift to 
37 °C for 4 h (37 °C). csrA transcript concentration was monitored by northern blot analysis (NB). The total RNA was 
isolated, separated and the csrA transcript was detected by northern blot analysis using a csrA specific DIG-labeled DNA 
probe. The 16S and 23S ribosomal RNA was stained with ethidium bromide and served as a loading control. The CsrA and 
YopD protein content were analyzed by western blot analysis (WB). An equivalent of OD600 = 1 was prepared for SDS-
PAGE and subsequent western blot analysis with polyclonal α-YopD and α-CsrA rabbit sera. An unspecific band served as a 
loading control (c). 
 
3.11 YopD/LcrH cannot activate csrA expression in E. coli 
YopD is an inducer of csrA expression in Y. pseudotuberculosis. The YopD-binding region in 
the csrA upstream region is highly conserved in E. coli and Y. pseudotuberculosis (Fig. S1). 
To test whether heterologous expression of YopD/LcrH could induce csrA activation in E. 
coli, E. coli DH10β, harboring an empty control vector (pRS1) or a lcrH/yopD vector (pRS5), 
were grown at 37 °C and protein samples were taken during different growth phases for 
western blot analysis (Fig. 3.11A). Plasmid pRS5 encodes the lcrH-yopBD operon fused 
under control of the constitutive Plac promoter. Apparently, YopD protein could only be 
detected in E. coli when expressed from the complementation vector. YopD expression 
peaked in late exponential phase and during the transition phase reflecting the yopD 
expression pattern in Y. pseudotuberculosis. Consistent with Yakhnin and colleagues, csrA 
expression increases over time and peaks in stationary phase in E. coli [Yakhnin et al., 2011]. 
Heterologously expressed YopD/LcrH complexes do not regulate csrA expression in E. coli, 
as the CsrA protein level is not changed in presence of YopD. This indicates that other 
Yersinia-specific factors are required for YopD/LcrH-mediated CsrA synthesis. 
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Figure 3.11: csrA expression in E. coli is not influenced by the heterologous expression of YopD and LcrH. (A+B) The 
E. coli DH10β wild-type was transformed with the empty vector (pV; pRS1) or complemented with its derivate pRS5 (plcrH-
yopBD+) and grown in LB medium at 37 °C. Samples were taken and the optical density (OD600) was determined to monitor 
the growth of both strains, additionally, an equivalent of OD600 = 1 was prepared for SDS-PAGE and subsequent western blot 
analysis. (A) Influence of lcrH and yopD on the growth of E. coli. Data is represented as the optical density (OD600) over 
time on a half-logarithmic scale. Sample time points are indicated by square dots. (B) Western blot analyses of protein 
samples taken along the growth curve. Samples were separated by SDS-PAGE following a western blot analysis with 
polyclonal α-CsrA, α-YopD and α-H-NS rabbit sera. The H-NS band served as a loading control. The OD600 of each sample 
is indicated. 
 
3.12 YopD expression is decoupled from the PlcrG promoter at 25 °C 
The yopD gene is encoded at the 3'-end of the polycistronic lcrGVH-yopBD operon. The 
transcriptional master activator LcrF activates transcription of this operon at 37 °C. 
Additionally, Li and colleagues suggested the presence of an unknown promoter located 
directly upstream of yopD, in the yopB gene [Li et al., 2014]. To analyze the impact of the 
two promoters on the temperature-dependent expression of yopD, the activity of a 
translational construct encompassing either the whole operon starting from PlcrG (-327 nt 
relative to the translational start site of lcrG; lcrGVH-yopBD'-'lacZ; pJH36) or from the 
second promoter located in the yopB gene, PyopD (-1224 nt relative to the translational start site 
of yopD; yopD'-'lacZ; pJH39). In both constructs, the promoter-less lacZ gene was fused to 
the first six codons of the yopD gene (Fig. 3.12A). The translational reporter gene fusion 
constructs were introduced into the wild-type strain YPIII and β-galactosidase activity was 
measured at 25 °C and 37 °C. Expression of both reporter gene constructs was strongly 
induced at 37 °C compared to 25 °C (Fig. 3.12B). Interestingly, the main promoter driving 
yopD expression under environmental temperatures (25 °C) seems to be PyopD (69% compared 
to 31% of PlcrG). At 37 °C, the percentage of both promoters controlling yopD is almost 50% 
(Fig. 3.12C). This mechanism uncouples expression of yopD from the expression of its 
chaperone LcrH and the major translocator YopB, especially at 25 °C probably resulting in an 
imbalance in the YopD to LcrH ratio. 
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Figure 3.12: YopD-dependent expression at 25 °C is mainly driven by an internal promoter. (A) Schematic presentation 
of the lcrGVH-yopBD operon of Y. pseudotuberculosis showing the different promoters (broken arrows, PlcrG + PyopD). A 
schematic presentation of the translational yopD'-'lacZ constructs, encoding the whole operon including the PlcrG and PyopD 
promoters (pJH36) or the yopB gene including the PyopD promoter (pJH38), is depicted below. (B) The temperature-dependent 
expression of translational yopD'-'lacZ reporter fusions was monitored in the Y. pseudotuberculosis wild-type (YPIII). The 
wild-type strain was transformed with the different yopD'-'lacZ constructs (pJH36 (blue) or pJH38 (green)). The specific β-
galactosidase activity [µmol/(min*mg)] was measured after the strains were grown in LB medium either for 6 h at 25 °C 
(25 °C) or 2 h at 25 °C following a shift to 37 °C for 4 h (37 °C). The data represent the mean +/- the standard deviation of 3 
biological and 3 technical replicates. The data were analyzed by an unpaired Student's t-test with * - P < 0.05; ** - P < 0.005; 
*** - P < 0.001; ns - not significant). (C) To calculate the relative activity of the 2 promoters, PlcrG and PyopD, to the whole 
promoter activity, the specific activity of the yopD'-'lacZ reporter construct (pJH38) was subtracted from the full-length 
lcrGVH-yopBD'-'lacZ reporter fusion (pJH36) and the percentage of PlcrG and PyopD was calculated. 
 
3.13 Protein stability of YopD is decreased at 25 °C 
Expression of yopD occurs mainly at 25 °C from its own promoter and is thus uncoupled from 
the expression of its chaperone LcrH. As YopD requires its chaperone LcrH for stabilization, 
this would result in less stable YopD protein. For this reason, YopD protein stability was 
analyzed at 25 °C or 37 °C. To do so, the wild-type strain YPIII was grown for 6 h at 25 °C 
(25 °C) or 2 h at 25 °C and shifted to 37 °C for 4 h (37 °C). Protein synthesis was stopped by 
the addition of translation inhibiting antibiotics (chloramphenicol/spectinomycin). As shown 
in Fig. 3.13A, YopD is degraded at 25 °C displaying a half-life of 78 min. In contrast, at 
37 °C, YopD is completely stable with a half-life of more than 3 h. 
To test whether the reduced stability of YopD at 25 °C is the result of reduced LcrH levels, 
YopD protein levels were analyzed in the wild-type strain containing either a lcrH expression 
plasmid (pRS17) or the empty vector control (pRS15) by western blot analysis. The analysis 
demonstrated that low YopD levels could be increased by heterologous expression of lcrH at 
25 °C and at 37 °C (Fig. 3.13B). This indicates, that the reduced stability of YopD is the 
result of low LcrH levels.  
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Temperature-dependent protein stability is often caused by regulated proteolysis by ATP-
dependent proteases or general proteolysis triggered by unfolded or misfolded proteins. To 
test whether one or more known proteases are involved in the degradation of YopD at 25 °C, 
YopD protein levels were analyzed at 25 °C in various ATP-dependent protease mutant 
strains. For this approach, the major players in regulated proteolysis Lon, ClpP, HslV and 
FtsH were chosen [Kirstein et al, 2009]. ClpP associated proteases are not involved in the 
destabilization, as deletion of the clpP gene did not influence YopD or LcrH level. The loss of 
lon, ftsH or hslV surprisingly even decreased YopD and LcrH amounts (Fig. 3.13C). This 
might indicate that an ATP-dependent protease targets an upstream regulator of the lcrVGH-
yopBD operon, as both proteins are affected in these mutants. Due to the down-regulation of 
YopD and LcrH in these protease mutants, stabilizing effects might be present but cannot be 
assessed. For this reason, a regulated proteolysis of YopD by these proteases cannot be 
excluded. 
 
 
Figure 3.13: Protein stability of YopD is decreased at 25 °C. (A) Protein stability assay of the wild-type (YPIII) to 
determine the stability of the YopD protein. All strains were grown in LB medium either for 6 h at 25 °C (25 °C) or for 2 h 
following a shift to 37 °C for 4 h (37 °C) and protein synthesis was stopped by addition of spectinomycin and 
chloramphenicol to a final concentration of 0.5 mg/mL. Samples were taken before (0) and then 15 min, 30 min, 60 min, 
120 min and 180 min after the translation stop. The YopD protein and H-NS content were analyzed by western blot analysis. 
An equivalent of OD600 = 1 was prepared for SDS-PAGE and subsequent western blot analysis with polyclonal α-YopD and 
α-H-NS rabbit sera. The H-NS band served as a loading control. The western blots were documented and quantified using the 
ImageJ software. Data are presented as the relative YopD intensity (YopD intensity/H-NS intensity) over time on a half-
logarithmic scale. (B) Expression of lcrH increases YopD protein levels. The Y. pseudotuberculosis YPIII wild-type was 
transformed with the empty vector (-; pRS15) or complemented with its derivate plcrH + (+; pRS17). All strains were grown 
in LB medium either for 6 h at 25 °C (25 °C) or for 2 h at 25 °C following a shift to 37 °C for 4 h (37 °C). Whole cell 
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extracts were prepared and taken for western blot analysis. An equivalent of OD600 = 1 was prepared for SDS-PAGE and 
subsequent western blot analysis with polyclonal α-YopD and α-H-NS rabbit sera. The H-NS band served as a loading 
control. (C) The influence of ATP-dependent proteases on YopD and LcrH levels was analyzed by western blot analysis. The 
wild-type (YPIII), the lon mutant (YP67), the clpP mutant (YP63), the ftsH mutant (YP327) and the hslV mutant (YP326) 
strain were grown in LB medium for 2 h at 25 °C with a subsequent shift to 37 °C for 4 h. Samples were taken and an 
equivalent of OD600 = 1 was prepared for SDS-PAGE and subsequent western blot analysis with polyclonal α-YopD and α-
LcrH rabbit sera. An unspecific protein band served as a loading control (c). 
 
3.14 YopD interacts with the untranslated leader transcript of the 
yscW-lcrF operon 
YopD is an important regulator of the ysc-yop regulon and is known to repress the expression 
of yop genes and the virulence master regulator lcrF [Steinmann, PhD thesis; Böhme et al., 
2012]. The lcrF gene is the last gene of the bicistronic yscW-lcrF operon. Previous 
experiments demonstrated, lcrF expression is controlled by the negative regulators YopD, 
LcrH and LcrQ by decreasing lcrF RNA stability [Steinmann, PhD thesis]. Furthermore, the 
expression of yopQ is post-transcriptionally regulated by YopD and LcrH in Y. enterocolitica. 
Together, both bind the leader transcript and thereby destabilizing the yopQ mRNA 
[Anderson et al., 2002]. Additionally, 'AUAAA' motifs are described as putative binding sites 
for YopD/LcrH [Anderson, 2011]. Such putative binding motifs are located in the 5'-UTR of 
yscW as well as the 5'-UTR of lcrF (Fig. 3.14A). Therefore, the capability of YopD/LcrH to 
bind the 5'-UTR of yscW and lcrF mRNA and thereby destabilizing the whole transcript, were 
investigate by RNA-EMSAs. To do so, two RNA fragments, encoding either 107 nt upstream 
of the translational start site including the first three codons of yscW (5'-yscW) or the entire 
intergenic region of yscW-lcrF and 15 nt of the lcrF CDS (5'-lcrF) were in vitro transcribed 
and investigated for binding of the YopD/LcrH complex by RNA-EMSA (Fig. 3.14A). The 
RNA-EMSA revealed that both 5'-UTRs were bound by YopD/LcrH, although the 5'-lcrF 
RNA fragment was bound with a slightly higher affinity (67 nM), compared to the 5'-yscW 
RNA fragment (135 nM). A second higher molecular weight complex was recognizable for 
both transcripts, although these appeared earlier when testing the 5'-lcrF transcript (Fig. 
3.14BC). This indicates that YopD/LcrH is able to specifically and directly interact with the 
5'-UTR of yscW and lcrF. 
The intergenic region of yscW-lcrF is involved in thermoregulation of lcrF expression and 
contains an RNA thermometer structure. The mRNA folds into a secondary structure, 
consisting of two hairpins structures required for efficient expression of lcrF. Hairpin 1 is 
involved in the stabilization of the overall architecture of the thermo-responsive element 
located in hairpin 2. Hairpin 2 contains a 'four U' RNA thermometer element which base-pairs 
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and sequesters the RBS at moderate temperature. Additionally, a putative YopD binding motif 
is located upstream of the 'four U' motif ('AUAAA'; Fig. 3.14D) [Böhme et al., 2012; 
Steinmann, PhD thesis; Chen & Anderson, 2011].  
To further analyze the interaction of YopD/LcrH with the 5'-UTR of lcrF, binding of 
YopD/LcrH complexes to fragments with a deletion of the hairpin 1 or a part of the hairpin 2 
sequences was investigated in RNA-EMSAs (Fig 3.14D). Both 5'-lcrF hairpin mutants were 
incubated with increasing concentrations of purified YopD/LcrH complexes and binding 
capabilities were compared to the wild-type 5'-lcrF transcript. Interestingly, binding of 
YopD/LcrH was not completely abolished by the deletion of hairpin 1 or hairpin 2 (Fig. 
3.14EF). Additionally, deletion of hairpin 1, removed the second high molecular shift, present 
in the wild-type and ∆hairpin 1 RNA fragment (Fig. 3.14E). Deletion of the 'AUAAA' motif-
containing hairpin 1 did not affect the YopD/LcrH binding pattern. Taken together, this 
suggests YopD binds to an alternative binding site in the yscW-lcrF mRNA apart from the 
described 'AUAAA' binding motif. 
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Figure 3.14: YopD/LcrH binds the 5'-UTR of yscW and lcrF. (A) Schematic presentation of the yscW-lcrF gene locus of 
Y. pseudotuberculosis showing the PyscW promoter (broken arrows) and the yscW and lcrF gene (block arrow). The in vitro 
transcribed RNA fragments used in RNA-EMSA are depicted below. Putative YopD binding sites are indicated (vertical 
arrow). The region of the RNA fragments is indicated relative to the translational start site of the corresponding gene. 
(BC+EF) Binding of YopD/LcrH complexes to the upstream region of yscW and lcrF was analyzed by RNA-EMSAs. Parts 
of the yscW, lcrF 5'-UTR and its hairpin mutants, and the hns control fragment were in vitro transcribed and biotin-labeled. 
2 nM of the resulting yscW, lcrF and the hns control fragment were incubated with increasing concentrations of purified 
YopD/LcrH complexes, separated onto a native 7% TBE-PAA gel and the biotin-labeled RNAs were visualized after transfer 
to a nitrocellulose membrane. Higher molecular bands, as a result of YopD/LcrH-RNA binding, are indicated with asterisks. 
(D-F) Hairpin 2 of the yscW-lcrF intergenic region is needed for efficient YopD/LcrH binding. (D) In silico prediction of the 
secondary structure of the yscW-lcrF intergenic region of wild-type and hairpin mutants with the lowest free energy (mFold 
[Zuker, 2003]). Deletions of hairpin 1 (green) and hairpin 2 (blue) are presented below. The position of a putative YopD 
binding site (AUAAA), the RNA thermometer ('Four U' motif) and the ribosomal binding site (RBS) are marked in red. 
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3.15 CsrA interacts with multiple regions of the yscW-lcrF transcript 
Previous studies demonstrated that the RNA binding protein CsrA controls the expression of 
lcrF. CsrA was shown to repress yscW-lcrF transcription indirectly but also to stimulate yscW 
and lcrF translation by a so far unknown mechanism [Opitz, PhD thesis; Pimenova, Master 
thesis]. Interestingly, the yscW-lcrF operon contains several putative CsrA binding sites 
(GGA or ANGGA motifs). The yscW leader transcript comprises five 'GGA' sequence motifs, 
whereby two are partially overlapping, high-affinity 'ANGGA' motifs. The 5'-UTR of lcrF 
only harbors one 'GGA' motif (Fig. 3.15A). The 5'-UTR of the yscW mRNA, as well as the 
lcrF 5'-UTR were in vitro transcribed, labeled with biotin and incubated with increasing 
amounts of purified CsrA protein. The RNA-EMSA demonstrated that the 5'-yscW was 
already bound at low CsrA protein concentrations (5 nM). A second high molecular shift 
appeared at CsrA concentrations between 40 and 60 nM (Fig. 3.15B). CsrA displayed a lower 
affinity to the intergenic 5'-lcrF fragment. Only a single high molecular weight complex 
appeared at a CsrA concentration of 40-60 nM (Fig. 3.15D). Notably, CsrA-bound transcripts 
possess at least one binding site in the vicinity to the 'GGA' core motif located in the RBS, 
thereby increasing binding affinity and specificity [Van Assche et al., 2015; Mercante et al., 
2009; Vakulskas et al., 2015]. In previous toe print assays it could be demonstrated that 
besides the high-affinity 'ANGGA' motif, an 'AGAGA' sequence could constitute as such a 
motif [Baker et al., 2005]. This motif could be discovered in the first codons of the lcrF gene 
at position +12 to +16 relative to the translational start site. To test the importance of this 
secondary binding site with respect to CsrA binding, the intergenic 5'-lcrF fragment was 
prolonged by 60 nt at the 3'-end and binding of this fragment was compared to the shorter 5'-
lcrF fragment, in which parts of the putative low-affinity binding site were missing (Fig. 
3.15C). CsrA displayed only a weak affinity to the shorter 5'-lcrF fragment, while the 
prolonged 5'-lcrF_long transcript was already bound at lower CsrA concentrations (Fig. 
3.15E). These results indicate that CsrA specifically interacts with multiple sites of the yscW-
lcrF mRNA. Especially, the yscW 5'-UTR was bound with a somewhat high affinity probably 
due to multiple high-affinity binding sites (Fig. 3.15B). The observation of a secondary, low 
affinity 'AGAGA' motif, 24 nt apart from the 'AGGA' motif in the RBS, was unexpected as 
low-affinity motifs were previously only identified in close vicinity (less than 10 nt) to a 
neighboring high-affinity CsrA binding site. 
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Figure 3.15: CsrA interacts with multiple sites of the yscW-lcrF transcripts. (A) Schematic presentation of the yscW-lcrF 
gene locus of Y. pseudotuberculosis showing the PyscW promoter (broken arrows) and the yscW and lcrF gene (block arrow). 
The in vitro transcribed RNA fragments used in RNA-EMSA are depicted below. Putative CsrA binding sites are indicated 
(vertical arrow). The region of the RNA fragments is indicated relative to the translational start site of the corresponding 
gene. (B+DE) Binding of CsrA to regions of yscW and lcrF was analyzed by RNA-EMSAs. Parts of the yscW 5'-UTR, lcrF 
5'-UTR and the hns control fragment were in vitro transcribed and biotin-labeled. 2 nM of the resulting yscW, lcrF and the 
hns control fragment were incubated with increasing concentrations of CsrA, separated onto a native 7% TBE-PAA gel and 
the biotin-labeled RNAs were visualized after transfer to a nitrocellulose membrane. Higher molecular bands, as a result of 
CsrA-RNA binding, are indicated with asterisks. In silico prediction of the secondary structure of the 5'-UTR of yscW and 
lcrF with the lowest free energy (mFold [Zuker, 2003]) are presented below. CsrA binding sites are indicated (light red 
boxes). (C-E) A secondary low-affinity binding motif is needed for efficient CsrA binding of the lcrF 5'-UTR. (C) Schematic 
presentation of the lcrF gene locus of Y. pseudotuberculosis showing the CsrA binding sites (light red box; ps - primary high-
affinity binding site; ss - secondary low-affinity binding site), the Shine-Dalgarno sequence (SD; red box) and parts of the 
lcrF gene (green arrow). 
 
3.16 The status of the lcrF RNA-thermometer influences binding of 
CsrA 
The CsrA binding site in the intergenic region between the yscW and lcrF gene directly 
overlaps with the RBS of lcrF. Interestingly, the RBS base pairs with a regulatory 'four U' 
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motif. Since the RBS is incorporated into the thermosensitive stem-loop structure at low 
temperature (25 °C), also the access of CsrA to its binding motif is blocked. To investigate 
whether a 'closed' or 'open' thermo loop influences CsrA binding, a wild-type 5'-lcrF RNA 
fragment (5'-lcrF; see Fig. 3.16) and fragments containing substitution mutations in the 'four 
U' motif were in vitro transcribed, biotinylated and were compared for CsrA binding in RNA-
EMSA. In the 'open' fragment, the 'UUUU' motif was changed to an 'AAAU' sequence that 
results in an opening of the thermo loop (5'-lcrF open). In the second fragment, the 'four U' 
motif was changed to 'UGGU' resulting in a perfect complementarity to the RBS and a closed 
thermo loop (5'-lcrF closed) [Steinmann, PhD thesis].  
When comparing the wild-type 5'-lcrF RNA fragment to the one with the open mutation, no 
difference in the CsrA RNA binding capabilities of CsrA could be observed. In contrast, CsrA 
binding to the 5'-lcrF transcript with the 'closed' mutation was strongly inhibited as no shift 
appeared (Fig. 3.16). This indicates that CsrA binds to the 'AGGA' motif of the RBS and 
influences its opening state and subsequent translation. 
 
 
Figure 3.16: CsrA interaction with the lcrF 5'-UTR depends on the opening state of the RNA thermometer. Binding of 
CsrA to the untranslated region of lcrF with a wild-type (YPIII) or mutated 'four U' motif (open - YP83; closed - YP84) was 
analyzed by RNA-EMSAs. The 'four U' motif was either mutated to destabilize (open; lcrF(GUU-30/-28AAA)) or to 
stabilize (closed; lcrF(UU-28/-27CC)) base pairing with the ribosomal binding site. Parts of the lcrF 5'-UTR was in vitro 
transcribed and biotin-labeled. 2 nM of the resulting lcrF was incubated with increasing concentrations of CsrA, separated 
onto a native 5% TBE-PAA gel and the biotin-labeled RNAs were visualized after transfer to a nitrocellulose membrane. 
Higher molecular bands, as a result of CsrA-RNA binding, are indicated with asterisks. Cropped in silico prediction of the 
secondary structure of the lcrF RNA thermometer of the wild-type and the open and closed 'four U' motif mutants with the 
lowest free energy (mFold [Zuker, 2003]) are presented next to the corresponding RNA-EMSA. The position of the CsrA 
binding site (light red) and the 'four U' motif (light blue) are indicated.  
 
3.17 CsrA and YopD influence the stability of the yscW-lcrF 
transcript 
Both YopD and CsrA are able to directly bind to the lcrF transcript. Previous results indicated 
that deletion of csrA only slightly affected lcrF mRNA stability although the overall transcript 
level was induced [Opitz, PhD thesis]. In contrast, the lcrF mRNA stability increased in a 
yopD-deficient mutant strain [Steinmann, PhD thesis]. Considering that YopD is also required 
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for efficient CsrA synthesis (Fig. 3.10), absence of YopD decreases the CsrA-dependent 
influence on lcrF transcript stability. To overcome the combinatory effects of YopD and CsrA 
on lcrF mRNA stability, the lcrF half-life was compared between the wild-type strain YPIII, 
the yopD mutant (YP91), the csrA mutant (YP53) and the yopD/csrA double mutant (YP145) 
using an RNA stability assay. The strains were grown under T3SS-inducing conditions for 2 h 
at 25 °C following a shift to 37 °C for 4 h. Transcription was stopped by adding rifampicin 
and lcrF transcript levels were assessed by northern blot analysis (Fig. 3.17A). The lcrF 
transcript level was generally very low in the wild-type, while in the yopD mutant and the 
csrA mutant high mRNA levels were detectable at time point zero. In the wild-type, a low 
RNA half-life of approximately 3 min could be detected. In the absence of yopD, the lcrF 
transcript is strongly stabilized. In contrast, the lcrF transcript was considerably destabilized 
in the csrA deficient mutant in comparison to the wild-type. The absence of both RNA 
binding proteins (yopD/csrA) led to an intermediate lcrF stability. Quantification of the 
transcript further showed that the lcrF transcript was more stable in the double mutant than in 
the wild-type, but less stable than in the yopD deficient mutant (Fig. 3.17B). These results 
demonstrate, that the transcript stability of lcrF is influenced by both RNA-binding proteins. 
The presence of YopD destabilizes, while CsrA stabilizes the lcrF transcript. 
 
 
Figure 3.17: Influence of YopD and CsrA on transcript stability of the yscW-lcrF operon. (A) RNA stability assay of 
wild-type (YPIII), yopD mutant (YP91), csrA (YP53) and yopD/∆csrA (YP145) mutant to determine the stability of the lcrF 
transcript. All strains were grown in LB medium for 2 h at 25 °C following a shift to 37 °C for 4 h and transcription was 
stopped by addition of rifampicin to a final concentration of 1 mg/mL. Samples were taken before the addition of rifampicin 
(0) and then 30 s, 1 min, 2 min, 3 min, 4 min and 5 min after the transcription stop. The total RNA was isolated, 10 µg of 
total RNA per lane were separated and the lcrF transcript was detected by northern blot analysis using a lcrF specific DIG-
labeled DNA probe. The 16S and 23S ribosomal RNA was stained with ethidium bromide and served as a loading control. 
(B) Northern blots were documented and quantified using the ImageJ software. Data are presented as the relative lcrF 
intensity (lcrF intensity/RNA intensity) over time on a half-logarithmic scale (Experiment in cooperation with M. Pimenova). 
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3.18 YopD and CsrA influence expression of RNA degradosome 
components 
Previously an involvement of RNA degradosome components in the regulation of Yersinia 
virulence and Ysc-Yop expression was demonstrated. In Y. pestis RNase E and PNPase were 
found to be required for the expression of the Ysc-Yop-T3SS and virulence in mouse 
infection. A pnp deficient strain is severely attenuated in a mouse infection model. 
Furthermore, RNase E is required for optimal function of the T3SS and virulence, as 
evidenced by reduced virulence in macrophage infection in cell culture and Yop secretion 
[Lawal et al., 2011; Rosenzweig & Schesser, 2007; Yang et al., 2008]. Recent results 
demonstrated that PNPase inhibits synthesis of the virulence master regulator LcrF. 
Furthermore, rne and pnp transcript levels are strongly reduced in a yopD mutant strain 
[Steinmann, PhD thesis]. A recent study in E. coli indicated CsrA represses pnp expression by 
decreasing transcript stability and protein synthesis [Park et al., 2015]. As both YopD and 
CsrA are regulators of rne and pnp, their influence on other components of the RNA 
degradosome was investigated by qRT-PCR analysis in the wild-type strain YPIII, the yopD 
mutant, the csrA mutant and the yopD/csrA double mutant strain. All strains were grown 
under T3SS-inducing conditions for 2 h at 25 °C and then shifted to 37 °C for 4 h in the 
presence of Ca
++
 or under Ca
++
-depletion to induce Yop-secretion. The amount of all 
degradosome-associated transcripts decreased under secretion conditions in the wild-type. 
Also, the deletion of yopD led to a strong reduction of all degradosome-associated transcripts, 
irrespective of the secretion status. In the csrA mutant strain, the secretion induced 
downregulation of degradosome transcripts was completely abolished, as no significant 
changes in transcript levels in comparison to the wild-type could be observed. Only a small 
reduction of rne transcript levels could be detected in the yopD/csrA mutant under non-
secretion conditions while other degradosomal transcript levels were unchanged (Fig. 3.18). 
In summary, levels of multiple degradosomal transcripts are repressed under secretion 
conditions (calcium depletion). In absence of yopD, all tested degradosome transcripts 
decreased, whereby secretion had no further effect indicating that YopD stabilizes 
degradosome transcripts. This effect is abolished by secretion of YopD. Additionally, a csrA 
mutant is defective in Yop secretion [Opitz, PhD thesis)] leading to an accumulation of YopD 
in the cell even under secretion conditions, which in turn increases production of 
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degradosome components. In absence of yopD and csrA, degradosomal gene levels were only 
slightly decreased indicating the effect of CsrA abolishes the YopD effect. 
 
  
Figure 3.18: Influence of CsrA and YopD on the expression of degradosome components. The one-step real-time qRT-
PCR analysis was performed with specific primers for degradosomal core components and associated factors. All strains 
were grown in LB medium for 2 h at 25 °C. Then secretion was induced by adding NaOx and MgCl2 (+sec) or not (-sec) after 
a shift to 37 °C for 4 h. The total RNA of the wild-type (YPIII), yopD (YP91), csrA (YP53) and yopD/csrA (YP145) mutant 
strain was isolated and used for qRT-PCR. The analysis was performed in at least 3 biological and 2 technical replicates. 
Transcript levels were normalized to the sopB reference transcript and are shown as relative expression levels to the wild-
type (YPIII) under non-secretion conditions. Data were analyzed by applying a one sample t-test with * (P < 0.05). 
 
3.19 CsrA target identification and analysis 
The RNA-binding protein CsrA is a global regulator in many bacteria. In Yersinia, CsrA has a 
huge regulon of at least 500 open reading frames as demonstrated in csrA microarray and 
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transcriptome analyses [Bücker et al., 2014; Nuss, unpublished data]. As demonstrated in this 
study, CsrA is an important regulator of virulence-associated genes. The global regulatory 
role of CsrA has been studied in different Gram-negative bacteria, like Salmonella 
typhimurium, Pseudomonas aeruginosa and E. coli by differential RNA-Seq analysis 
[Esquerre et al., 2016], interactome studies [Holmqvist et al., 2016; Edwards et al., 2011] and 
an in silico target prediction [Kulkarni et al., 2014]. Recently, the CsrA-dependent regulon in 
Y. pseudotuberculosis at 25 °C and 37 °C has been identified by a comparative RNA-Seq 
approach [Nuss, unpublished data]. 
3.19.1 In silico prediction of CsrA targets in Y. pseudotuberculosis 
Most probably not all CsrA-dependent genes are directly targeted by CsrA. To identify 
directly regulated CsrA target genes, an in silico CsrA target prediction was applied, 
combined with an analysis of the CsrA regulon of Y. pseudotuberculosis. 
The RNA features that are recognized by CsrA are well characterized and parameters 
affecting the binding affinity could be identified. The 5'-UTR of high-affinity targets carry 
multiple high-affinity (ANGGA or AGGA) or low-affinity binding motifs (AGAGA, 
CTGGA, CGGGA, TGGGA) within a maximal distance of 60 nt. Additionally, at least one of 
these high-affinity motifs overlaps with the RBS [Dubey et al., 2005; Lapouge et al., 2013; 
Duss et al., 2014]. 
By using these parameters, high-affinity targets were predicted by analyzing the upstream 
region of all annotated coding genes in Y. pseudotuberculosis YPIII. Based on an algorithm 
published by Kulkarni et al. to predict CsrA target sequences in E. coli, P. aeruginosa and S. 
typhimurium, the upstream target regions of all 4306 annotated ORFs encoded on the 
Y. pseudotuberculosis YPIII chromosome (NC_10465) were extracted and analyzed by a self-
written Python script (CSRA_TARGET_PREDICTER). Since CsrA is known to especially 
target the 5'-UTR of target sequences, thereby influencing RNA stability or translation 
initiation, the region from 150 nt upstream to 60 nt downstream of the translational start site 
(-150 to +60) of coding genes was isolated and analyzed for CsrA binding sites. 
In this algorithm, the most important features for a high-affinity CsrA target RNAs were 
defined as: (1) The analyzed RNA sequence must have at least one primary binding site 
present in the vicinity of the ribosomal binding site (-30 to +5 nt relative to the start codon). 
(2) The RNA sequence harbors at least three CsrA binding sites in total (primary (ps) or 
secondary (ss) binding sites). (3) The target sequence contains at least three primary binding 
sites (ps >= 3) or two if at least two additional secondary binding sites (ps = 2 and ss >= 2) are 
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present in the vicinity of the primary motifs. This is important because low-affinity motifs, 
which are in the vicinity to a primary binding site, support binding of CsrA to a primary motif 
[Kulkarni et al., 2014]. (4) Finally, as CsrA dimers were demonstrated to bridge two motifs 
with a spacing of up to 60 nt, all CsrA binding sites neighboring another binding site in a 
distance of 10 to 60 nt were counted. All genes with at least two of these binding sites were 
defined as putative CsrA targets. 
The analysis led to the identification of 233 putative direct CsrA targets (Fig. 3.19A; table 
S2). Considering that direct CsrA targets are also part of the CsrA regulon, the 233 in silico 
predicted CsrA target genes were compared to the CsrA regulon at stationary phase 25 °C or 
37 °C and a genomic distribution analysis was performed to identify genomic regions with 
CsrA target gene clusters (Fig. 3.19BC). Only differentially regulated genes that were at least 
four times depleted/enriched (-2 >= log2(fc) >= 2) were considered as part of the CsrA 
regulon. 
The analysis revealed 32 in silico predicted direct targets that were also differentially 
regulated at 25 °C and 23 in silico predicted CsrA target genes being differentially regulated 
at 37 °C (Fig. 3.19D). Confirming the approach, csrA was identified which is known for its 
direct autoregulation. Interestingly, the genomic distribution analysis highlighted four genes 
that were highly differentially expressed at 25 °C, in silico predicted and clustered closely 
together on the genome (YPK_0389 - impG/vasA; YPK_0391 - impI/vasC; YPK_0393 - 
impJ/vasE) (Fig. 3.19B). These genes are part of the type six secretion system 1 (T6SS-1) and 
were at least 8 times (log2(fc) > 3) enriched in a csrA negative mutant in comparison to the 
wild-type [Nuss, unpublished data]. 
Noteworthy, the T6SS-4 associated gene rovC, was also identified as a putative direct CsrA 
target by this analysis. rovC was in silico predicted and is highly upregulated at 25 °C in the 
absence of csrA. The rovC gene (YPK_3567) encodes a transcriptional regulator of the T6SS-
4 and is a known direct target of CsrA [Knittel, Master thesis]. Surprisingly, additional T6SS-
4 genes were predicted as direct CsrA targets (YPK_3556, YPK_3552, YPK_3550, 
YPK_3566, YPK_3564) (Table S2), but are not differentially regulated by CsrA at stationary 
phase 25 °C or 37 °C. Furthermore, the prediction revealed two genes belonging to the T6SS-
2 (YPK_1472 (uncharacterized ImpH/VasB protein), YPK_1475 (fimbrial precursor protein)) 
(Table S2). All these T6SS genes are not differentially regulated in absence of csrA because 
they are not expressed by Y. pseudotuberculosis when grown in LB medium to stationary 
phase at 25 °C or 37 °C. Nonetheless, these genes might be regulated and directly targeted by 
CsrA under other conditions. 
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Another differentially regulated mRNA and predicted direct target of CsrA was rovA (Fig. 
3.19B). The rovA gene encodes an important transcriptional regulator of early virulence 
genes. Expression of rovA was previously shown to be regulated by CsrA. However, this 
regulation occurred indirectly via CsrA-mediated control of rovM, a direct repressor of rovA 
transcription [Heroven et al., 2008]. The 5'-UTR of rovA contains six GGA motifs (three 
high-affinity motifs). This might indicate, that CsrA can also directly regulate rovA 
expression. Another virulence-associated gene that was in silico predicted and found to be 
CsrA-dependent regulated at 37 °C was yadC that encodes a putative adhesin (Fig 3.19C). 
In summary, by comparing the list of predicted direct CsrA targets with the set of 
differentially regulated genes, new possible direct CsrA target genes could be identified. 
Interestingly, among them are genes of three different T6SSs (T6SS-1, T6SS-2 and T6SS-4). 
Furthermore, the transcriptional regulator of early virulence rovA might be directly targeted 
by CsrA. Taken together, besides CsrA's role as a regulator of metabolism, these results 
emphasize the role of CsrA as a direct regulator of virulence systems, especially T6SSs, in 
Y. pseudotuberculosis. 
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Figure 3.19: CsrA is a direct regulator of multiple T6SS. (A) Flowchart of the CsrA target prediction algorithm CSRA-
TARGET_PREDICTER of Y. pseudotuberculosis YPIII [adopted from Kulkarni et al., 2014]. 4033 upstream regions of 
YPIII chromosomally encoded ORFs were analyzed for CsrA primary sites (ps; A(N)GGA) and secondary sites (ss; 
AGAGA, CTGGA, CGGGA, TGGGA). The number of analyzed and processed sequences are depicted next to flow line 
arrows. (B+C) Genomic distribution of predicted high-affinity CsrA targets, which are differentially regulated by csrA in 
stationary phase at 25 °C (B) or 37 °C (C). CsrA-dependent regulated, predicted genes are depicted with their log2(fc) versus 
their localization [Mbp] on the plus (upper panel) or minus strand (lower panel). Upregulated genes in a csrA (YP53) mutant 
are marked with a blue up-pointing triangle and down-regulated genes are marked with a red down-pointing triangle. (D) 
Venn diagram showing the comparison of in silico predicted genes and csrA-dependent differentially regulated genes at 
stationary phase 25 °C or 37 ° (regulon: -2 >= log2(fc) >= 2). 
 
3.19.2 CsrA RIP-Seq 
The combined analysis of in silico predicted, direct CsrA targets and the CsrA regulon already 
gave the first insight into CsrA's role at 25 °C. CsrA is an important regulator of virulence at 
body host temperature (37 °C) and influences the expression of the injectisome. To identify 
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direct targets that are crucial for Yersinia virulence under T3SS-inducing conditions (37 °C) 
an RNA-binding protein immunoprecipitation sequencing (RIP-Seq) analysis was performed. 
A Y. pseudotuberculosis YPIII wild-type strain expressing a plasmid-encoding csrA-3xFLAG 
gene under control of the csrA promoter (PcsrA::csrA-3xFLAG; pJH35; IP sample) or 
containing a plasmid control (pHSG576; background control sample) were grown under 
T3SS-inducing conditions. Cells were lysed and CsrA-bound RNAs were extracted by hot 
phenol RNA extraction after CsrA immunoprecipitation (IP) with anti-FLAG IgG-coupled 
magnetic beads. Purified RNAs were then analyzed by high throughput RNA-Sequencing. 
The IP resulted in a very pure CsrA elution fraction (Fig. 3.20A). Only the immunoglobulin 
IgG heavy and light chain were copurified in the control setup, while an additional CsrA-
3xFLAG band appeared in the IP sample (Fig. 3.20A). Furthermore, in western blot analysis, 
only wild-type CsrA and an unspecific band could be detected in the control sample, that 
disappeared in the wash fractions. In the IP sample, CsrA-3xFLAG was detectable in the 
lysate and eluate fraction. Additionally, a fraction of untagged CsrA was co-
immunoprecipitated most probably as part of a CsrA-CsrA-3xFLAG heterodimer (Fig. 
3.20A). RNA sequencing of cDNA libraries of at least four samples per condition resulted in 
18 - 25 million reads per sample (Table S3). The global gene expression patterns of control 
and IP samples were distinct and the related samples clustered together (Fig. 3.20B). The 
mapping analyses also revealed a specific enrichment of RNAs by the IP. 35% of total reads 
could be uniquely mapped in the IP samples, in comparison to only 4% in the control samples 
(Fig. 3.20C). Other reads (not uniquely mapped) originate from multiple copy genes like 
ribosomal RNAs, tRNAs and primer dimers. Additionally, reads in the control samples 
equally mapped to the plus and minus strand, while the IP lead to an enrichment of reads to 
the minus strand (Fig. 3.20D). This shift corresponded to an enrichment of the small non-
coding RNAs csrB and csrC by CsrA. Both small RNAs represented the most enriched RNAs 
in all IP samples. Especially, csrC, which is encoded on the minus strand and the most 
abundant ncRNA of the Csr system under T3SS-inducing conditions, was four times more 
enriched than csrB, which is encoded on the plus strand, explaining the shift to the minus 
strand. 
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Figure 3.20: Immunoprecipitation of CsrA-enriched RNAs. (A) Coomassie blue-stained SDS-PAGE and western blot 
analysis of CsrA immunoprecipitation by Anti-FLAG affinity chromatography. The Y. pseudotuberculosis YPIII wild-type 
was either transformed with a csrA+ expressing vector (background; pKB60) or csrA-FLAG+ expressing vector (pJH35). 
Strains were grown in LB medium for 2 h at 25 °C and subsequently shifted to 37 °C for 4 h. Following this, cells were 
harvested, lysed and the resulting lysates were used for CsrA immunoprecipitation using Anti-FLAG dynabeads. Supernatant 
(S); wash fraction (W1-5); eluate fraction (E1-6). An OD600 equivalent of 0.5 was used for SDS-PAGE following a 
Coomassie blue stain or western blot analysis using a polyclonal α-CsrA rabbit serum. (B) Principal component analysis 
(PCA) plot of IP (red) and the control (blue; background) samples after RNA-Seq. (C) Read mapping analysis. Depicted is 
the mean percentage of uniquely mapped (blue) or other reads (red) relative to all mapped reads. (D) Analysis of the mean 
relative strand distribution of uniquely mapped reads of control or IP samples to the + (blue) or - (red) strand. 
 
3.19.3 Identification of direct CsrA targets in Y. pseudotuberculosis 
The RIP-Seq analysis revealed a total of 1743 enriched target RNAs with an enrichment of at 
least 8 fold (log2(fc) > 3) after pull-down of CsrA (Fig. 3.21A; Table S4). From these RNAs, 
1248 corresponded to coding mRNAs, 29 trans-, 16 antisense encoded RNAs and 19 tRNAs. 
Under the 20 most enriched target RNAs, both non-coding RNAs csrB (log2(fc) = 6.6) and 
csrC (log2(fc) = 5.8) were identified. This result was expected as these ncRNAs harbor many 
exposed CsrA binding motifs and function as a molecular sponge to sequester CsrA proteins 
[Romeo et al., 2012]. Additionally, the csrA mRNA could be found under the 20 mostly 
enriched RNAs (log2(fc) = 6.3). Since CsrA directly interacts with its transcript with a high 
binding affinity, this indicates a specific enrichment (Fig. 3.6) [Yakhnin et al., 2011]. To 
analyze the genomic distribution of the enriched transcripts, the mean of normalized reads 
(rpk (reads per kbp gene length)) of the IP or the background (control) samples were plotted 
corresponding to their genomic location (Fig. 3.21B). Although, the 5S, the 6S and the 16S 
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rRNA were depleted, apparently, almost every RNA was enriched by the CsrA IP. Due to the 
high sensitivity of the RNA-Seq method, this could point to an overrepresentation of 
unspecifically bound transcripts in the control sample (Fig. 3.21B). Furthermore, the CsrA 
RIP-Seq enriched three times more potential CsrA target candidates (~1700 targets) than 
present in the CsrA regulon (~500 targets), corresponding to previously published csrA 
microarray and transcriptome data [Bücker et al., 2014; Nuss, unpublished data]. This also 
indicates enrichment of RNAs that are unspecifically bound by CsrA, probably due to 
overexpression of CsrA or insufficient washing. 
To get an idea of specific CsrA-bound RNAs, enriched transcripts of the interactome analysis 
(see chapter 3.19.2) were compared to the CsrA-transcriptome dataset [Nuss, unpublished 
data]. For the CsrA regulon data set, only RNAs which were at least four times enriched or 
depleted (-2 >= log2(fc) >=2 ) were considered. At 25 °C and 37 °C 548 and 476 genes were 
differentially regulated, respectively (Fig. 3.21C). Of these genes, 292 CsrA-dependently 
regulated genes overlapped with the interactome (Fig. 3.21C; Table S4). This overlap 
corresponds to 16% of the interactome. These candidates might reflect direct targets of CsrA. 
As part of the mostly IP-enriched transcripts of the CsrA interactome/regulon overlap, the 
known direct CsrA target transcripts csrA, csrB and csrC could be identified. Additionally, a 
high number of tRNAs and the M1 RNA of RNase P were also highly enriched. RNase P is an 
endoribonuclease that is involved in the maturation process of precursor tRNAs to mature 
tRNAs [Altman, 1975; Evans et al., 2006]. These results highlight the role of CsrA as a 
modulator of the cellular tRNA landscape. 
Finally, the interactome data set was compared with the list of in silico predicted, and 
differentially regulated genes to more specify direct high-affinity targets. This analysis 
revealed 47 differentially regulated, predicted coding genes (25 °C: 32 genes; 37 °C: 23 
genes) and 97 predicted genes that were identified by the RIP-Seq analysis (Fig. 3.21D; 
Table S4). Only 6 genes could be identified as being predicted, differentially regulated at 
both temperatures and enriched in the RIP-Seq analysis. These genes, besides csrA itself, all 
encoded metabolism-associated regulators enzymes or transporters, like ulaB (ascorbate-
specific phosphotransferase enzyme subunit IIB component), ggt (Gamma-
glutamyltranspeptidase) and miaB which encodes a tRNA-modifying enzyme. Remarkably, 
overlapping with the 25 °C regulon, the predicted CsrA target and T6SS-1 gene YPK_0393 
and the early virulence regulator gene rovA were also enriched in the RIP-Seq, besides treB 
(trehalose-specific PTS enzyme) and the putative chemotaxis protein yoaH (methyl-accepting 
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chemotaxis protein). Although unaffected by CsrA at 37 °C, rovA was enriched in the RIP-
Seq, this might indicate expression of rovA is influenced by CsrA even at 37 °C. 
These results are in compliance with CsrA's role as a global regulator of metabolism and 
virulence. Since CsrA regulates and possibly directly targets tRNA and tRNA-associated 
genes at 37 °C, it might remodel the tRNA landscape to prepare the bacterial cell for the 
expression of the Ysc-Yop T3SS and the conditions inside the warm-blooded host. The 
comparative analysis of CsrA RIP-Seq data with comparative RNA-Seq and in silico CsrA 
target prediction data revealed only a small overlap suggesting that the list of direct CsrA 
targets in Y. pseudotuberculosis still needs to be completed. The in silico prediction analysis 
gave the first overview of putative direct CsrA targets and can support but not replace the 
experimental validation. For that reason, the in silico prediction algorithm still needs to be 
optimized. 
 
 
Figure 3.21: Enrichment of putative CsrA interacting RNAs. (A) Scatter plot of the log10 mean rpk values of genes from 
control or IP samples. Genes with a log2(fc)> 3 are represented as blue dots, other genes are depicted in black. (B) Genomic 
distribution of chromosomally encoded genes of control (blue) or IP (red) samples. Depicted are log2 rpk (reads per gene 
length [kb]) values versus chromosomal position [Mbp] of all chromosomally encoded genes of YPIII. Genes encoded on the 
plus strand are shown on the upper panel, while minus strand encoded genes are shown on the lower. (C) Venn diagram 
showing the comparison of genes enriched in CsrA RIP-Seq (interactome: log2(fc) > 3) and the csrA-dependent differentially 
regulated genes at stationary phase 25 °C or 37 ° (regulon: -2 >= log2(fc) >= 2). (D) Venn diagram showing the comparison 
of in silico predicted genes enriched in CsrA RIP-Seq (interactome: log2(fc) > 3) and the csrA-dependent differentially 
regulated genes at stationary phase 25 °C or 37 ° (regulon: -2 >= log2(fc) >= 2). 
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3.19.4 In silico prediction of CsrA targets in Y. pseudotuberculosis and 
 E. coli 
A comparative analysis of the in silico CsrA target prediction data set by Kulkarni et al. of 
E. coli, S. typhimurium and P. aeruginosa [Kulkarni et al., 2014] revealed only a small 
overlap of predicted CsrA target genes. Apparently, a comparison of CsrA regulons and 
interactomes of S. typhimurium, E. coli and Y. pseudotuberculosis confirmed this observation 
(data not shown) [Edwards et al., 2011; Holmqvist et al., 2016; Esquerre et al., 2016; Nuss, 
unpublished data]. These differences probably originate from the phylogenetic distance of 
these organisms. Still, CsrA regulates similar cellular processes in all these bacteria (e.g. 
metabolism, motility, stress responses, information processing) [Heroven et al., 2012; 
Vakulskas et al., 2015]. 
In order to identify the evolutionary mechanism behind the diversification of the CsrA 
regulon, CsrA targets of Y. pseudotuberculosis YPIII and E. coli K-12 MG1655 were in silico 
predicted using the CSRA_TARGET_PREDICTER script. The 5'-UTRs of individually 
predicted targets of Y. pseudotuberculosis and E. coli were aligned to analyze changes in the 
CsrA binding site number and distribution. For this purpose, a target prediction in E. coli was 
carried out using the same script and parameters as for the CsrA target prediction in 
Y. pseudotuberculosis (see chapter 3.19.1). The upstream region (-150 to +60 nt relative to 
the translational start site) of all 4147 chromosomally encoded, annotated ORFs in E. coli 
MG1655 (NC_000913) were extracted and putative high-affinity CsrA targets were predicted 
using the CSRA_TARGET_PREDICTER script. The analysis led to the identification of 275 
putative CsrA targets (Fig. S2; Table S2+6). This approach was chosen to ensure the 
comparability of the E. coli and Y. pseudotuberculosis in silico target prediction data sets (see 
chapter 3.19.1). 
Next, the list of predicted CsrA targets in E. coli and Y. pseudotuberculosis was compared. 
The predicted CsrA target genes of E. coli and Y. pseudotuberculosis were assigned by 
aligning their protein sequences utilizing the blastp command line tool [Camacho et al., 
2009]. 113 Y. pseudotuberculosis ORFs were unassignable to E. coli, mostly encoding T6SS-
associated and hypothetical genes. This is not surprising as Y. pseudotuberculosis YPIII 
encodes four T6SSs, while the non-pathogenic laboratory E. coli strain K12 completely lacks 
T6SSs [Journet & Cascales, 2015]. 
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Remarkably, only 24 common CsrA target genes were predicted including the csrA gene (Fig. 
3.22A). As the remaining 90% of CsrA target genes were predicted either in E. coli or 
Y. pseudotuberculosis, the upstream region of CsrA target genes were further analyzed for 
differences in the number and distribution of primary and secondary binding site by a 
ClustalO sequence alignment [Sievers et al., 2011]. This analysis demonstrated that CsrA 
binding motifs in the upstream region are only lowly conserved between E. coli and 
Y. pseudotuberculosis explaining the low overlap of targets. Interestingly, the comparison of 
in silico predicted CsrA targets revealed a low conservation of individual target genes, but 
still genes belonging to the same pathway were identified (see table 3.1). 
 
Table 3.1: Selection of predicted CsrA targets in E. coli and Y. pseudotuberculosis as predicted by the 
CSRA_TARGET_PREDICTER algorithm 
R
 - CsrA-dependent differential regulation in E. coli MG1665 [Esquerre et al., 2016] 
B
 - Co-purified with CsrA-His6 in E. coli MG1665 [Edwards et al., 2011] 
*
 - CsrA-dependent differential regulation on Y. pseudotuberculosis YPIII [Bücker et al., 2014] 
I
 - Co-purified with CsrA-3xFLAG in RIP-Seq analysis in Y. pseudotuberculosis YPIII 
 
Gene name Gene description Pathway 
Common targets  
glgBR+B 
csrAR+ I 
flgGR+ I 
 
 
Glycogen branching protein 
Carbon storage regulator 
FtsH protease regulator HflK 
Flagellar basal body rod protein FlgG 
 
Glycogen metabolism 
Signal transduction 
Proteolysis 
Motility 
 
E. coli specific targets  
glgCR+B 
aroF I 
ulaD  
fliKR+B 
fliRR 
 
 
Glucose-1-phosphate adenyltransferase 
Phospho-2-dehydro-3-deoxyheptonate aldolase 
L-ascorbate utilization protein D 
Flagellar hook-length control protein FliK 
Flagellar motor switch protein FliN 
 
Glycogen metabolism 
Amino acid metabolism 
Ascorbate metabolism 
Motility 
Motility 
 
Y. pseudotuberculosis specific targets  
glgP-2*+ I 
glgX* 
ulaB*+ I 
aroE I 
aroG*+ I 
flhB* 
flgC*+ I 
flgH I 
motB* 
 
 
Glycogen/starch/alpha-glucan phosphorylase 
Glycogen debranching enzyme  
Ascorbate-specific PTS system, EIIB component  
Shikimate 5-dehydrogenase 
Phospho-2-dehydro-3-deoxyheptonate aldolase 
Flagellar biosynthesis protein FlhB 
Flagellar basal body rod protein FlgC 
Flagellar L-ring protein FlgH 
Flagellar motor protein MotB 
 
Glycogen metabolism 
Glycogen metabolism 
Ascorbate metabolism 
Amino acid metabolism 
Amino acid metabolism 
Motility 
Motility 
Motility 
Motility 
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Thus, different genes accounted to motility, aromatic amino acid, glycogen and ascorbate 
metabolism were predicted in both organisms. In more detail, the aromatic amino acid 
metabolism gene aroF was a predicted CsrA target in E. coli, while aroG was predicted in 
Y. pseudotuberculosis. The aroF gene functions upstream of the Shikimate pathway in which 
aroE is involved in. Furthermore, in Y. pseudotuberculosis, a component of the ascorbate 
phosphotransferase system (ulaB) was predicted, while in E. coli the gene of the ascorbate 
utilization enzyme UlaD was predicted as a CsrA target, which acts downstream in the 
ascorbate metabolism. Another example, that showed obvious differences in the number and 
distribution of CsrA binding sites in both species is the glgC gene and other genes of the glg 
operon (Fig. 3.22BC). The glgC gene encodes the ADP-glucose synthase and is one of the 
first identified and well-described CsrA-bound target RNAs. For the glgC gene are the CsrA 
binding mechanism as well as the CsrA-bound RNA regions and structures well characterized 
[Liu et al., 1995; Baker et al., 2002]. Baker et al. demonstrated, that especially the primary 
binding motif within the ribosomal binding site and the directly upstream located ANGGA 
motif are involved in the CsrA-dependent glgC regulation [Baker et al., 2002]. However, only 
the binding motif within the RBS is present in Y. pseudotuberculosis, which indicates a 
change in the CsrA binding mechanism and might also affect the CsrA binding affinity. 
Similar observations were made for other genes of glg operon (Fig. 3.22C). Changes in the 
CsrA binding site distribution might be the cause for the low comparability of the CsrA 
regulon in Enterobacteriaceae. 
The data of this study propose that the CsrA dependency of individual pathways in 
Enterobacteriaceae is conserved rather than individual CsrA target genes. This mechanism 
might allow a species-specific adaptation. 
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Figure 3.22: Distribution of primary and secondary CsrA binding sites in 5'-UTRs of glg genes. (A) Venn diagram 
showing the comparison of chromosomally encoded genes which were in silico predicted in Y. pseudotuberculosis YPIII and 
E. coli K12. (B) Schematic presentation of the glg operon of E. coli showing the different promoters (broken arrows). (C) 
Sequence alignment of the upstream region of individual glg genes from E. coli K12 and Y. pseudotuberculosis YPIII 
(ClustalO [Goujon et al., 2010]). High-affinity CsrA binding motifs are marked in violet (ANGGA) or red (AGGA). Low-
affinity binding sites are marked in green. 
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4 Discussion 
Y. pseudotuberculosis encodes a vast arsenal of virulence factors, whose expression needs to 
be timed and coordinated depending on its environment and infection phase. Expression of 
these virulence factors is resource and energy consuming. Because of this, a complex 
decision-making system is needed that allows or restricts expression of individual adaptation 
and virulence systems [Han et al., 2016; Somerville & Proctor, 2009; Erhardt & Dersch, 
2015]. One of the major virulence factors of Y. pseudotuberculosis is the Ysc-Yop T3SS, 
which is required for colonization of lymphatic tissues and to overcome the host innate 
immune response. Assembly and maintenance of this nanomolecular machinery are strictly 
regulated [Portaliou et al., 2016]. Thereby, the expression of structural components, as well 
as, the transcriptional master regulator of the Ysc-Yop T3SS is controlled by the RNA-
binding regulators YopD and CsrA in a negative feedback loop. The aim of this study was to 
analyze the interplay of CsrA and YopD in the regulation of Ysc-Yop T3SS expression. 
 
4.1 Regulation of csrA expression in Y. pseudotuberculosis 
The RNA-binding protein CsrA is the main player in the regulation of a plethora of cellular 
processes. CsrA is involved in the regulation of metabolism, motility and virulence, such as 
biofilm formation and the injectisome [Diepold & Armitage, 2015]. 
In this study, the regulation of csrA of Y. pseudotuberculosis was examined. Although 
expression of csrA is well-studied in E. coli, there is only limited knowledge about csrA 
expression in Y. pseudotuberculosis. In E. coli, csrA is transcribed from five σ70 (RpoD)- or σ
S
 
(RpoS)-dependent promoters [Yakhnin et al., 2011]. In this study, the position of the csrA 
promoters was predicted by a comparative sequence alignment of Y. pseudotuberculosis and 
E. coli csrA. Furthermore, csrA promoter activity was studied by reporter gene analysis of 
csrA'-'lacZ fusions encoding the different promoters as predicted by sequence alignment of 
the csrA locus. The analysis revealed only promoters P3, P4 and P5 are active at 37 °C during 
the transition to stationary phase. No activity of the predicted promoters P1 and P2 on the 
basis of E. coli were detectable in Y. pseudotuberculosis. Because the region of promoters P1 
and P2 is only slightly conserved, these promoters might be E. coli-specific and might not be 
present in Y. pseudotuberculosis. Another explanation could be that promoter P1 and P2 of 
Yersinia are not expressed under the tested growth conditions. Indeed, these two promoters 
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are only and weakly expressed when E. coli was grown in minimal medium during stationary 
phase [Yakhnin et al., 2011]. 
A complex autoregulation of csrA and its homolog rsmA is described in E. coli and P. 
aeruginosa, but in Y. pseudotuberculosis and other Gram-negative prokaryotes such an 
autoregulation was unknown until now [Heroven et al., 2012; Syell & Van Melderen, 2013; 
Jean-Pierre et al., 2015]. In this study a direct translational repression of the upstream region 
and an indirect autoactivation of csrA, similar to E. coli, was demonstrated by RNA-EMSA 
binding studies and csrA'-'lacZ reporter gene fusions harboring deletions in the autoregulatory 
regions of csrA. Under non-secretory conditions, these opposing autoregulatory effects are 
nearly compensatory, as a deletion of the csrA gene resulted in only a mild repression of a 
csrA'-'lacZ reporter gene fusion encoding the whole regulatory upstream region (Fig. 3.7). 
In Y. pseudotuberculosis as well as in E. coli, the direct negative autoregulation is mediated 
through two primary CsrA binding motifs (ANGGA motif). The first is located within the 
RBS of csrA and the second in the region of promoters P4 and P5. The 5'-UTR is highly 
conserved between both species and contains two additional secondary binding motifs, which 
are bound by CsrA in E. coli [Yakhnin et al., 2011]. Deletion of the upstream located primary 
binding motif (ANGGA) obstructed CsrA binding and autorepression, reflecting the 
importance of this motif (Fig. 3.6). Interestingly, CsrA binding was abolished although two 
neighboring secondary binding motifs were still present. These secondary motifs are essential 
for CsrA-binding in E. coli [Yakhnin et al., 2011], but not in Y. pseudotuberculosis (Fig. 3.6). 
Binding of CsrA to low-affinity binding motifs, like AGAGA, was found for many of its 
targets. When in the vicinity of a neighboring high-affinity binding motif (ANGGA), these 
secondary motifs increase the general CsrA binding affinity, by increasing the local CsrA 
concentration. Through this mechanism, low-affinity motifs contribute to the cooperative 
binding of target transcripts [Wang et al., 2005; Dubey et al., 2002]. Furthermore, secondary 
motifs need to be in close vicinity to high-affinity binding motifs, either in the primary or the 
secondary structure [Kulkarni et al., 2014; Baker et al., 2002]. The closest distance between a 
secondary binding site and the RBS which contains a primary binding motif had a distance of 
more than 20 nt and is probably too distant to support effective CsrA binding when the 
upstream ANGGA motif is missing. Therefore, removal of the primary binding site in the 
promoter P4/5 region completely abolished binding to the 5'-UTR of csrA. 
Consistent with data from E. coli, the direct autorepression probably functions by inhibition of 
the translational initiation, because CsrA binds to its ribosomal binding site, [Yakhnin et al., 
2011]. 
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The direct negative autoregulation of csrA in Y. pseudotuberculosis and E. coli is conserved 
as well for rsmA in P. aeruginosa. However, the location of the binding sites differs in 
P. aeruginosa. While Yersinia CsrA interacts with binding sites in the 5'-UTR and the RBS, 
P. aeruginosa RsmA binds to two neighboring binding motifs in the RBS and another one 
located in the coding sequence [Jean-Pierre et al., 2015]. The conservation of the direct 
autorepression demonstrates its importance for csrA expression even though the changed 
binding site distribution might lead to changes in the csrA expression strength. 
 
The autoinduction of csrA is conferred by a region upstream of the Yersinia of promoters P4/5 
(Fig. 3.7) As no additional CsrA binding sites are present in the autoinducing region, a direct 
autoactivation of csrA transcription can be excluded (Fig. S1). Moreover, no DNA-binding 
capabilities of CsrA have been described to date [Koharudin et al., 2013]. Taken together, this 
indicates an indirect transcriptional autoactivation, as proposed for E. coli [Yakhnin et al., 
2011]. The nature of the transcriptional regulator mediating csrA autoactivation is elusive. 
Apart from the sigma subunits RpoD and RpoS, no direct transcriptional regulators of csrA 
are known in E. coli [Yakhnin et al., 2011; Vakulska et al., 2015]. Recently, in P. aeruginosa 
a transcriptional activation of promoter P3 by sigma subunit AlgU (RpoE) was shown [Stacey 
& Pritchett, 2016]. AlgU/RpoE is involved in the extracytoplasmic stress, heat shock and 
oxidative stress response [Potvin et al., 2008]. An RpoE-dependent regulation of Yersinia 
csrA has not yet been demonstrated. In Legionella pneumophila, csrA transcription is directly 
activated by the PmrA/B two-component system, by binding upstream of the -10 promoter 
region. In silico predictions using a motif model of the PmrA binding site found the PmrA/B 
two-component system is also a predicted regulator of csrA in Salmonella spp. and Yersinia 
pestis CO92 [Marchal et al., 2004]. As the csrA upstream region of Y. pestis CO92 and 
Y. pseudotuberculosis YPIII is 100% conserved, a PmrA-dependent regulation of csrA can be 
also expected in YPIII. Although PmrA might be a direct transcriptional activator of csrA in 
Yersinia, its involvement in the indirect transcriptional autoactivation of csrA is questionable, 
as a CsrA-dependent regulation of pmrAB has not yet been described. 
 
Expression of csrA is very sensitive to changes in CsrA protein levels, because of the 
underlying autoregulatory feedforward loop. Both excessive and very low CsrA protein levels 
strongly trigger csrA autorepression or autoinduction, respectively. Autoregulatory 
feedforward loops are very robust network motifs, allowing fast adaptation to changing 
conditions. Moreover, autoregulatory feedforward loops allow precise fine-tuning of protein 
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levels and protect the system from random noises [Alon, 2007]. Through such an 
autoregulatory principle, it is possible to strongly induce gene expression through 
transcriptional autoactivation. Upon reaching a certain threshold, the direct autorepression 
ensures a rapid shut-down of gene expression and thereby counterbalances the autoactivation 
and prevents an overshoot of gene expression [Adamson & Lim, 2013; Alon, 2007]. The 
multileveled autoregulation of csrA conferred by the CsrA protein and the ncRNAs CsrB/C 
allows complex signal integration and very rapid shifts in csrA gene expression [Romeo, 
1998; Seyel & Van Melderen, 2013; Heroven et al., 2012]. 
 
4.2 YopD-mediated control of csrA 
In a recent study, it was shown that the Y. pseudotuberculosis translocator protein YopD is an 
activator of csrA expression at host body temperature, as csrA expression is repressed in a 
yopD mutant strain and when YopD is secreted [Steinmann, PhD thesis]. YopD is a 
bifunctional protein that is part of the Ysc-Yop T3SS. Secreted YopD assembles into a pore in 
the cell membrane of target host cells and functions as a translocator of effector proteins 
[Montagner et al., 2011]. Cytosolic YopD together with its chaperone LcrH was described as 
a posttranscriptional repressor of many ysc-yop genes [Chen & Anderson, 2011]. By limiting 
the synthesis of injectisome components and associated factors it acts as a feedback regulator 
for the Ysc-Yop T3SS [Ramamurthi & Schneewind, 2002; Steinmann, PhD thesis]  
In this study, binding of YopD/LcrH complexes to the csrA leader transcript could be 
demonstrated. Thereby, a region in close proximity to csrA promoters P4 and P5 was 
identified as being crucial for YopD binding. A shorter transcript with a partial deletion of the 
YopD binding site bound only weakly at higher protein concentrations. Similarly, the well-
studied YopD target yopQ is also regulated independently of its promoter region by direct 
binding of the YopD/LcrH complex to the yopQ leader transcript [Anderson et al., 2002]. 
Most 5'-UTRs of characterized YopD target genes, such as yopK, yscN or yopE, contain an 
AT-rich sequence. This motif is crucial for YopD-dependent regulation, although dispensable 
for YopD-binding [Chen & Anderson, 2011]. Such an AT-rich stretch is also located directly 
upstream of the RBS of csrA. However, deletion of this region did not affect the binding 
affinity of YopD/LcrH (Fig. 3.3). Furthermore, a csrA'-'lacZ reporter fusion missing this 
element was still YopD-dependent (data not shown). Strikingly, only YopD-repressed yop 
genes contain such a sequence feature [Chen & Anderson, 2011]. This strongly indicates that 
another sequence feature might be required for YopD-mediated gene activation. Besides this, 
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the YopD consensus motif, identified in yop genes, contains a higher adenine content in 
comparison to the AT-rich stretch in the 5'-UTR of csrA. This suggests that the putative YopD 
binding site upstream of the RBS of csrA might not represent a YopD consensus motif. In 
contrast to the described AT-rich motif (GC content 0%), the YopD binding region in the 
csrA 5'-UTR has a GC content of ~50% which matches the GC content of the YPIII 
chromosome (47.5%). 
 
Cytosolic YopD is protected by its chaperone LcrH, which remains in the cytosol even after 
secretion of YopD. As csrA expression is repressed in a yopD mutant strain and under 
calcium depletion when YopD is exported from the cytosol, csrA is regulated dependent on 
the secretion status of the injectisome and the loading status of LcrH. In B. subtilis and 
Campylobacter jejuni, csrA is also regulated depending on the secretion status of its flagellar 
T3SS. During flagellum assembly, the flagellin protein Hag gets secreted and its alternative 
chaperone FliW remains unbound in the cytosol to regulate csrA [Mukherjee et al., 2011; 
Dugar et al., 2015]. The FliW-dependent csrA regulation in B. subtilis is the only known 
example in which a T3SS-associated factor acts as a feedback regulator of CsrA. As 
demonstrated in this study, the T3SS chaperone LcrH is not directly involved in csrA 
regulation. In accordance with results by other groups, LcrH alone does not confer RNA-
binding activity (Fig. 3.4) [Chen & Anderson, 2011]. Moreover, the chaperone function of 
LcrH is needed for YopD-dependent binding [Anderson et al., 2002]. The presence of LcrH 
promotes YopD synthesis as well as functionality by stabilizing YopD. Like other 
chaperones, LcrH keeps the YopD protein in its native and functional fold and confers 
protection from aggregation and degradation [Hartl et al., 2011; Anderson et al., 2002]. For 
this reason, deletion of lcrH leads to a down-regulation of CsrA levels comparable to a yopD 
deficient mutant. 
 
YopD synthesis is induced at 37 °C (Fig. 3.10). Strikingly, while CsrA synthesis is also 
induced at 37 °C, csrA mRNA levels are not altered by the induction of YopD synthesis, 
hinting to a posttranscriptional regulation mechanism. Moreover, both, deletion of the yopD 
gene and secretion of the YopD protein decrease csrA transcript levels at 37 °C, although the 
transcript stability remains unchanged (Fig. 3.9; Fig. 4.1). This observation can be explained 
by a YopD-dependent transcriptional regulation of csrA at 37 °C, in addition to the 
posttranscriptional YopD-dependent thermo-induction. The repression of csrA transcription at 
37 °C may be mediated by an unknown transcriptional repressor of csrA, as DNA-binding of 
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YopD has not been shown and YopD does not contain any known DNA-binding motifs 
[Olsson et al., 2004; Chen & Anderson, 2011]. The nature of this transcriptional repressor is 
still elusive. Interestingly, heterologous expression of YopD and LcrH in E. coli did not 
influence CsrA protein level or its growth, even though the YopD binding region in the csrA 
upstream region is highly conserved. This indicates that the unknown transcriptional repressor 
is Yersinia-specific. 
Furthermore, the presence of an alternative csrA transcript in the yopD mutant strain might 
indicate a YopD-dependent differential transcription of csrA, possibly conferred by a 
transcriptional regulator like RpoS or RpoE (AlgU) (Fig. 3.9) [Stacey & Pitchett, 2016]. 
4.3 YopD- and CsrA-dependent regulation of csrA expression 
Deletion of the putative YopD binding region close to promoters P4 and P5 only incompletely 
derepressed csrA expression in the yopD mutant strain (Fig. 3.5). This region also contains a 
high-affinity binding motif of CsrA crucial for autoregulation as demonstrated by RNA-
EMSAs and csrA'-'lacZ reporter gene assays, hinting towards a YopD-dependent modulation 
of csrA autoregulation (Fig. 3.6+7). This study demonstrated that YopD is a 
posttranscriptional activator of csrA expression. By binding to the csrA transcript, YopD most 
presumably induces csrA translation and by interfering with CsrA-mediated autorepression, as 
demonstrated by a csrA'-'lacZ reporter gene assay of the csrA upstream region containing the 
YopD and CsrA binding regions under the control of a constitutive promoter (Fig. 3.8). 
 
Taken together, this study demonstrated a complex regulation of csrA expression by the T3SS 
translocator YopD and the CsrA protein itself. At environmental temperature (25 °C), CsrA 
steady-state levels are mainly controlled by its dual autoregulation. CsrA activates its 
transcription from promoter P3, while at the same time limiting CsrA synthesis by directly 
binding to its own mRNA when a certain threshold is reached (Fig. 4.1). When 
Y. pseudotuberculosis enters its warm-blooded host, expression of the Ysc-Yop-T3SS and 
thereby of YopD and LcrH is induced, preparing the pathogen for an encounter with the 
innate immune system. YopD and LcrH start to accumulate in the cytosol and YopD, 
protected by its chaperone LcrH, binds the csrA transcript, thereby occupying the 
autorepressive CsrA binding site (Fig. 4.1). Hence, CsrA synthesis is directly as well as 
indirectly induced by a YopD-dependent activation and by interfering with CsrA 
autorepression on the post-transcriptional level. Nevertheless, csrA transcript levels are 
comparable at 37 °C and 25 °C in the absence of secretion. This might be due to the 
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additional autoregulatory mechanism of the Csr system, conferred by the small non-coding 
RNAs CsrB/C. A thermo-induction of CsrB/C might reduce CsrA activity by sequestration, 
thereby preventing the transcriptional autoactivation of csrA at 37 °C. Recent results of an 
RNA-Seq analysis of the Y. pseudotuberculosis wild-type at 25 °C and 37 °C hint to a 
thermo-regulation of CsrB/C expression, although a thermo-induction still needs to be 
analyzed [Nuss, unpublished data]. 
Upon host cell contact, YopD is secreted. Now, CsrA autorepression is reactivated, as the 
CsrA binding site is free. Furthermore, transcription of csrA is reduced through an yet 
unidentified repressor that either is no longer repressed by YopD or by another secretion-
dependent factor (Fig. 4.1). 
 
 
Figure 4.1: Model of the YopD- and CsrA-dependent regulation of csrA expression. At 25 °C, the expression of csrA is 
regulated through complex autoregulation, involving an indirect transcriptional activation and a direct translational repression 
when CsrA dimers (green) bind to its transcript. At 37 °C, YopD (red) and its chaperone LcrH (brown) are synthesized 
binding to the csrA transcript and thereby blocking CsrA autorepression. Through this mechanism, CsrA synthesis is induced. 
Additionally, expression of an unidentified transcriptional repressor (gray) is blocked by the YopD/LcrH complex. When 
secretion is triggered, YopD dissociates from LcrH and is exported, while LcrH remains in the cytosol. As a consequence a 
transcriptional repressor accumulates and represses csrA transcription, reducing csrA transcript and protein levels. 
 
4.4 Thermoregulation of yopD 
The yopD gene is part of the ysc-yop regulon and is regulated in response to temperature and 
by the transcriptional regulator LcrF. At moderate temperatures (25 °C), the expression of 
LcrF is repressed and consequently LcrF target genes are not expressed [Schwiesow et al., 
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2015]. Therefore, it was surprising to find basal YopD protein levels at 25 °C (Fig. 3.10). 
YopD is encoded as the last gene of the polycistronic lcrGVH-yopBD operon that is expressed 
from a LcrF-dependent and temperature-regulated promoter (PlcrG). Being the major promoter 
of this operon, promoter PlcrG ensures expression at 37 °C. As demonstrated by Li et al., yopD 
is additionally transcribed from an upstream promoter located in the yopB gene [Li et al., 
2014]. This study showed that at 25 °C, yopD is mainly expressed from its own promoter 
(PyopD), while promoter PlcrG is almost silent. At 37 °C, this effect is reversed. Through this 
mechanism, a shift between the shorter yopD to the full-length lcrGVH-yopBD transcript 
takes place (Fig. 3.12). The role of promoter PyopD is still unclear. In large polycistronic 
operons, internal promoters amplify transcription of 3'-located genes [Platt, 1986; de Smit et 
al., 2008]. This ensures expression of terminal genes, as with increasing transcript length the 
probability of premature elongation interruption increases. Due to intracistronic 
transcriptional polarity, terminal genes would then be transcribed in low amounts [Richardson 
& Roberts, 1993; Lodish et al., 2000; Montero et al., 2011]. Besides this, alternative 
promoters increase the robustness of a regulatory system by enabling a higher number of 
signal integration possibilities. In this case, the internal promoter enables a LcrF-independent 
basal expression of yopD. As a consequence, the expression of yopD is decoupled from the 
expression of its upstream located chaperone lcrH. As demonstrated in this study, LcrH is 
strictly needed for YopD functionality and stability (see Fig. 3.4 and Fig. 3.13). Thus, it is not 
surprising that YopD is degraded at 25 °C when PlcrG is repressed. This destabilization seems 
to be the result of insufficient chaperone levels, as ectopic expression of LcrH can increase 
YopD protein levels at 25 °C and 37 °C (Fig. 3.13). Constant degradation of YopD holds it in 
standby mode. Interruption of its constant proteolysis allows rapid adaptation to 
environmental changes, as it results in a fast accumulation of the regulator protein. A similar 
mechanism is utilized by E. coli to ensure a fast activation of its heat shock response. At 
37 °C (no heat stress), heat shock sigma factor RpoH (σ32) is constantly synthesized and 
sequestrated from the RNA polymerase holoenzyme through the action of the small heat 
shock chaperone DnaK. DnaK-bound RpoH is targeted for the regulated proteolysis by FtsH. 
Upon heat shock, unfolded cytosolic proteins accumulate and sequester DnaK, thereby freeing 
and stabilizing RpoH which now rapidly accumulates. Free RpoH associates with the RNA 
polymerase core enzyme and activates transcription of heat shock genes [Blaszczak et al., 
1995; Narberhaus et al., 2009; Obrist et al., 2007]. YopD and LcrH could be involved in a 
similar mechanism to activate cell-contact induction of the T3SS at moderate temperatures. At 
25 °C, the expression of lcrF, the master activator of the ysc-yop regulon, is repressed. Upon 
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cell contact, synthesis of the Ysc-Yop T3SS is triggered even at low temperature [Opitz, PhD 
thesis; Pimenova, Master thesis]. 
ATP-dependent proteases of the Hsp100/Clp- or AAA+ families are often involved in 
controlling regulatory processes by ensuring a rapid protein turnover [Kirstein et al., 2009]. 
To identify the protease, involved in YopD degradation at 25 °C, mutant strains of the 
proteolytic subunit of ATP-dependent proteases were analyzed for YopD expression. A 
deletion of the protease involved in YopD degradation would cause a stabilization of YopD 
and increase its steady-state protein level. Apparently, the ClpP-associated proteolytic 
machinery is not involved in degradation of YopD. Contrary to expectation, inactivation of 
the individual AAA+ proteases Lon, HslV (ClpQ) or FtsH completely abolished expression of 
YopD and LcrH (Fig. 3.13). As both, LcrH and YopD, are encoded by the same 
transcriptional unit and are affected by a deletion of all three proteases, it is possible that 
another protease is upregulated in their absence which degrades YopD and LcrH. 
Alternatively, a regulatory factor of the lcrVGH-yopBD operon could be affected. 
The involvement of the Lon protease in the regulation of the Ysc-Yop T3SS master regulator 
LcrF was already described previously. Lon is required for the thermo-regulated degradation 
of the LcrF repressor YmoA [Jackson et al., 2004]. At moderate temperature, YmoA is stable 
and represses expression of lcrF. At 37 °C, YmoA is degraded by the Lon protease and 
transcription of the yscW-lcrF operon can occur (Fig. 1.3) [Jackson et al., 2004; Boehme et 
al., 2012]. Thus it is also possible that the decrease of YopD and LcrH protein levels in the 
corresponding protease mutants are triggered by a reduction of LcrF levels. 
4.5 Complex YopD- and CsrA-dependent regulation of yscW-lcrF 
The yscW-lcrF operon encodes the master regulator of the Ysc-Yop T3SS, LcrF. The amount 
of synthesized LcrF protein is tightly controlled by a negative feedforward loop, which shuts 
down lcrF expression when YopD accumulates in the cytosol. This control is released when 
secretion is triggered by cell contact and YopD gets exported [Steinmann, PhD thesis; 
Williams & Straley, 1998; Schiano & Lathem, 2012]. A secretion-dependent feedback control 
of T3SSs is a reoccurring motif in the regulation of T3SSs. A post-transcriptional control, as 
present in Yersinia, seems to be a unique feature. Most known secretion-dependent feedback 
loops are conferred by sequestration of transcriptional activators through an anti-sigma factor 
control system. Such a regulatory system is present in the regulation of the flagellar T3SS of 
Gram-negative bacteria. The assembly of the flagellum is controlled by the FlgM-FliA sigma-
anti-sigma factor system [Katsukake &Iino, 1994; Chilcott & Hughes, 2000]. In P. 
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aeruginosa, the expression of T3SS components and effector gene transcription is regulated 
by a more complex regulator sequestration mechanism (anti-anti-activator system). This 
system involves the AraC-like transcriptional activator ExsA and three additional anti-
activator proteins (ExsD/C/E). Secretion of the anti-anti-activator ExsE, leads to a partner-
switching which frees activator ExsA and allows T3SS gene expression [Dasgupta et al., 
2004; Diaz et al., 2011]. All these systems assure a control step that stops T3SS gene 
expression until the secretion through the T3SS is activated. 
A CsrA-dependent regulation of T3SS master regulators is a common motif in many 
pathogens. In E. coli, CsrA is a post-transcriptional activator of the flagellar T3SS master 
regulator FlhDC. CsrA binds the 5'-UTR of the flhDC gene thereby protects the transcript 
from RNase E-dependent degradation [Yakhnin et al., 2013]. In Salmonella, CsrA post-
transcriptionally represses expression of the AraC-like transcription factor HilD, which in turn 
leads to a down regulation of the SPI-1 and SPI-2 T3SSs [Martinez et al., 2011]. In P. 
aeruginosa, the CsrA-homolog RsmA induces expression of the AraC-like regulator and 
LcrF-homolog exsA on a post-transcriptional level [Intile et al., 2014; Zhu et al., 2016]. 
In Yersinia, expression of the transcriptional activator lcrF is precisely controlled through the 
action of the RNA-binding proteins YopD and CsrA. The global regulator CsrA is a dual 
regulator of lcrF. On the one hand, it indirectly represses transcription of the yscW-lcrF 
operon and on the other hand, it is involved in the posttranscriptional regulation of yscW and 
lcrF [Opitz, PhD thesis; Pimenova, Master thesis]. Translocator YopD is a long known 
repressor of lcrF expression. In this study, it could be demonstrated that CsrA and YopD 
directly influence the LcrF synthesis. 
 
4.5.1 YopD is a direct regulator of the yscW-lcrF operon 
In this study, a direct interaction of YopD/LcrH with the 5'-UTR of yscW and lcrF could be 
shown. Both leader transcripts harbor 'AUAAA' motifs, which are involved in feedback 
regulation by YopD/LcrH [Cambronne & Schneewind, 2002; Chen & Anderson, 2011]. 
These motifs only play a minor role in YopD-dependent lcrF repression, as deletion of the 
'AUAAA' motif-containing region in the 5'-UTR of lcrF changed the YopD/LcrH binding 
pattern, but did not abolish binding (Fig. 3.14) or YopD-dependent regulation [Steinmann, 
PhD thesis]. Until now no alternative binding sequences involved in YopD binding could be 
identified. This suggests that RNA structural elements (e.g. hairpin structures) could be 
involved in YopD/LcrH binding. 
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Interestingly, the 'AUAAA' motif is needed for YopD/LcrH-dependent regulation of yopH, 
but is dispensable for binding [Chen & Anderson, 2011]. Strikingly, the proposed AU-rich 
sequence motif is also involved in LcrQ-dependent regulation. YopD, LcrH and LcrQ 
(YscM1/2 in Y. enterocolitica) often act synergistically and are involved in the same 
posttranscriptional repression mechanisms [Cambronne & Schneewind, 2002]. Therefore, the 
described AU-rich motif is probably not needed for YopD binding but could be important for 
LcrQ-dependent repression, as deletion of yopD, lcrH or lcrQ derepresses lcrF and yopQ 
[Steinmann, PhD thesis; Anderson et al., 2002; Cambronne & Schneewind, 2002]. The 
complex interplay of these proteins is still unknown and needs to be further assessed. Other 
studies indicate that YopD-dependent gene repression involves additional factors. SycH, the 
chaperone of YopH, seems to be involved in the same regulatory mechanism. The N-terminus 
of LcrQ is homologous to parts of YopH and can interact with SycH. An excess of SycH, 
therefore, mimics a lcrQ mutant after secretion of YopD and LcrQ [Wulf-Strobel et al., 
2002]. Notably, the interaction of SycH and LcrQ seems to be involved in the cell contact-
mediated yop gene derepression. Repressor LcrQ is in contrast to YopD not secreted by the 
T3SS [Cambronne et al., 2000]. After secretion of the effector protein YopH, its chaperone 
SycH remains in the cytosol and might bind to LcrQ (YscM1/YscM2) and deactivate its 
regulatory function [Cambronne et al., 2004]. 
 
4.5.2 CsrA is a direct regulator of yscW and lcrF 
In this study, binding of CsrA to the 5'-UTR of yscW and lcrF was demonstrated. The 
distribution and the type of CsrA binding sites in the tested 5'-UTRs differed significantly, 
which was reflected in different binding affinities. For efficient CsrA binding, target RNAs 
need at least two primary binding sites exposed on hairpin structures [Vakulskas et al., 2015]. 
Moreover, in this study the importance of a secondary, low-affinity binding motif (AGAGA) 
for CsrA binding of 5'-lcrF became apparent. The 5'-UTR of lcrF is needed for the CsrA-
dependent post-transcriptional activation of lcrF [Pimenova, unpublished results] and is 
directly bound by CsrA although it only contains one GGA motif within the RBS. A 
secondary binding motif was located within the first codons of its coding sequence (Fig. 
3.15D). Elongation of the 5'-lcrF RNA fragment encompassing this low-affinity motif 
dramatically increased the CsrA binding affinity (Fig. 3.15F). This is exceptional, other 
described CsrA targets usually contain at least two high-affinity binding motifs [Kulkarni et 
al., 2014]. The lowest number of binding motifs of a direct CsrA target are found in the 5'-
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UTR of hfq [Baker et al., 2007]. Notably, AGA motifs are often accompanied by multiple 
primary binding sites and played only a minor role in direct CsrA binding. In toeprint 
analyses of E. coli, the importance of these AGA motifs was shown for multiple CsrA targets, 
for example, the pgaA, glgC, lcrF or nhaR transcripts (Fig. 3.15) [Baker et al., 2002; Wang et 
al., 2005; Yakhnin et al., 2011; Pannuri et al., 2012]. AGA motifs support and enhance 
binding of CsrA to a neighboring primary binding motif, by increasing the local concentration 
of CsrA molecules [Kulkarni et al., 2014]. However, a recent CsrA interactome study in S. 
enterica serovar Typhimurium identified only [A/C]UGGA motifs as the consensus motif in 
vivo. In addition, CsrA-bound sequences contain at least one minimal GGA and one primary 
ANGGA motif. Low-affinity (AG)AGA motifs were only enriched in a minor fraction of 
CLIP peaks whereby most of these motifs were located in close vicinity to a GGA motif 
[Holmqvist et al., 2016]. 
 
The intergenic region of the yscW-lcrF operon harbors a 'four U' motif, which base pairs with 
the GGA motif of the lcrF ribosomal binding site at low temperature, functioning as an RNA 
thermometer. This 'four U' motif is crucial for the thermoregulation of lcrF and ensures that 
synthesis of LcrF and thereby expression of the Ysc-Yop T3SS only occurs inside the warm-
blooded host. Mutations in the RNA thermometer caused a deregulation of LcrF synthesis and 
decreased Yersinia virulence [Boehme et al., 2012; Steinmann, PhD thesis]. Notably, lcrF 
translation is induced in the presence of CsrA by its binding of the GGA motif located within 
the RBS (Fig. 3.15) [Pimenova, Master thesis]. This study demonstrated CsrA binding of the 
lcrF leader transcripts depends on the open state of its RNA thermometer, as demonstrated by 
RNA-EMSAs of the lcrF 5'-UTR containing mutations in the 'four U' motif. These mutations 
prevent ('open') or promote ('closed' thermometer) base pairing of the 'four U' motif with the 
RBS, as indicated by RNA fold predictions (Fig. 3.16) [Steinmann, PhD thesis]. CsrA binding 
probably modulates the opening of the thermo loop. In vivo, CsrA might bind to the RBS and 
thereby obstructs closing of the thermo loop. As shown in this study, CsrA has a weak 
binding affinity to this region and might get easily replaced by ribosomes. A lcrF'-'lacZ 
reporter fusion encoding the intergenic region of yscW-lcrF and parts of the lcrF CDS is 
activated in the presence of CsrA. Additionally, the presence of CsrA is needed at moderate 
temperatures (25 °C) for a cell contact-dependent activation of lcrF expression [Pimenova, 
Master thesis]. At 25 °C, the RBS is inaccessible due to the closed thermometer and lcrF 
translation is restricted. Possibly, CsrA binding to the thermo loop may be needed to open the 
RNA thermometer and trigger cell contact-dependent lcrF induction. Until now, a modulation 
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of 'four U' RNA thermometer by RNA-binding proteins has not been described. Interestingly, 
in Salmonella the melting temperature of such a thermoresponsive element is modulated by 
binding of magnesium ions and plays a crucial role in the regulation of heat shock gene agsA 
[Rinnenthal et al., 2011]. Since 'four U' RNA-thermometers are often involved in translational 
regulation through a base pairing mechanism to the 'AGGA' motif of the ribosomal binding 
site [Waldminghaus et al., 2007], CsrA might be a general modulator of this type of RNA 
thermometers. 
 
4.5.3 CsrA and YopD influence lcrF transcript stability and counter-
regulate the degradosome 
In this study, an antagonistic effect of CsrA and YopD on the stability of the yscW-lcrF 
transcript was observed. At 37 °C under non-secretory conditions, YopD accumulates in the 
bacterial cytosol and destabilizes the lcrF mRNA. High protein levels of CsrA antagonize the 
YopD effect by stabilizing the lcrF transcript. For this reason, in presence of both regulators, 
the lcrF transcript exhibits an intermediate stability. In the csrA deficient mutant, the 
stabilizing effect of CsrA is missing and YopD destabilizes the lcrF transcript and a rapid 
mRNA turnover occurs. In the double mutant, the effect of both regulators is diminished and 
in comparison to the wild-type, the lcrF transcript is stabilized to some extent (Fig. 3.18), 
pointing to a dominant effect of YopD over CsrA on the mRNA stability to a certain degree. 
Previous data demonstrated that YopD activates the expression of rne encoding the RNase E 
and pnp encoding the PNPase. Both proteins are core components of the RNA degradosome. 
The involvement of CsrA and YopD in the regulation of degradosomal components was 
examined by qRT analysis. Transcripts of all integral (RNase E, PNPase) and associated 
(helicase RhlB/E and enolase) degradosome components were induced in the presence of 
YopD. Accordingly, all of these genes were downregulated in a yopD mutant background and 
under secretion conditions, where YopD is exported from the cytosol. These results confirm 
previous microarray data comparing a csrA mutant and a csrA/yopD double mutant 
[Steinmann, PhD thesis]. In the csrA/yopD double mutant, downregulation, as seen in the 
absence of yopD alone, was almost completely diminished, indicating a counter-regulation of 
the degradosome by both RNA-binding proteins. This is surprising as in absence of csrA no 
significant effects on the transcript levels of degradosomal genes were detectable (Fig. 3.18). 
A recent RNA-seq analysis comparing the Y. pseudotuberculosis wild-type and the csrA 
mutant indicated a mild CsrA-dependent repression of all degradosomal genes [Nuss, 
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unpublished data]. In E. coli, CsrA is a known strong repressor of pnp translation. CsrA-
dependent regulation of pnp is complex and involves RNase III and PNPase which 
nucleolyticly process the pnp 5'-UTR. The action of both RNases frees a CsrA binding site 
(AGGA) which was priorly sequestered in a secondary RNA structure. The now accessible 
binding site, as well as the RBS, is bound by CsrA and a translational repression of pnp takes 
place [Park et al., 2015]. In Yersinia, the CsrA-dependent effect on pnp transcript levels is 
minor in contrast to the strong repression described in E. coli. This may be explained by the 
fact that the pnp 5'-UTR of Yersinia misses the AGGA binding motif located upstream of its 
RBS which is crucial for CsrA binding in E. coli. This might indicate that the CsrA-dependent 
pnp regulation in Yersinia differs from E. coli. 
Notably, deletion of yopD and csrA, affect multiple components of the degradosome. Whether 
this regulation is direct and occurs by targeting every degradosomal gene individually or 
indirectly by triggering the autoregulation of the whole degradosome is still unclear. Until 
now, such an intrinsic regulation of the RNA degradosome has not been shown yet but is 
likely as RNase E is involved in the autoregulation of pnp [Carzaniga et al., 2009, Park et al., 
2015]. 
In summary, YopD and CsrA are opposed regulators of the RNA degradosome: YopD 
induces the degradosome and enhances the global RNA decay, whereas CsrA antagonizes the 
YopD effect and probably accelerates down-regulation of the degradosome components after 
secretion of YopD. Additionally, binding of the yscW-lcrF transcript by YopD might tag the 
transcript for a rapid degradation, while CsrA binding might prevent degradation of the lcrF 
transcript. The YopD-dependent increase of the global RNA decay also explains the large 
number of genes that are members of the YopD regulon and why YopD is mostly described as 
a repressor of target genes [Steinmann, PhD thesis]. 
 
4.6 Cross-talk between CsrA- and YopD-dependent feedback loops 
regulating lcrF expression - a complex model 
The control of the Ysc-Yop T3SS expression in the enteropathogenic bacterium 
Y. pseudotuberculosis is regulated by intertwined CsrA- and YopD-dependent feedback loops. 
Expression of both RNA-binding proteins is mutually dependent and couples the secretion 
status of the injectisome (YopD) to the CsrA-mediated control of metabolism, stress 
adaptation and other virulence systems. Both, CsrA and YopD, interact with the yscW-lcrF 
mRNA and regulate its expression on multiple levels (Fig. 4.2). 
 Discussion 
107 
CsrA indirectly represses transcription from the PyscW promoter and thereby strongly reduces 
yscW-lcrF transcript levels. Additionally, CsrA directly binds the 5'-UTR of yscW and lcrF 
and controls protein synthesis. Binding of CsrA to the lcrF 5'-UTR induces translation at 
37 °C, while CsrA-promoted translational activation of yscW occurs only under secretion 
conditions [Pimenova, Master thesis; Opitz, PhD thesis]. CsrA seems to supports lcrF-
induction at moderate temperatures by modulating the open state of the RNA thermometer in 
the 5'-UTR of lcrF. Furthermore, in the absence of YopD, CsrA stabilizes the whole yscW-
lcrF transcript, most likely by repressing the expression of RNA degradosome components. 
Under non-secretory conditions, when YopD accumulates in the cytosol, it antagonizes the 
action of CsrA. YopD binds the yscW-lcrF transcript at multiple sites and competes with 
CsrA binding of the lcrF 5'-UTR. On a global level, YopD induces expression of the whole 
RNA degradosome, thus enhancing yscW-lcrF mRNA decay. 
Cell contact induces the secretion of effector molecules and the regulators YopD and LcrQ by 
the Ysc-Yop T3SS. This, in turn, derepresses the production of Yop proteins and LcrF. 
Expression of the degradosome is down-regulated, probably supported by the action of CsrA. 
As a result, lcrF transcript stability increases. Since the absence of YopD decreases CsrA 
synthesis (see Fig. 4.1), lcrF transcription is further induced. Thereby, lcrF expression is 
triggered by an increase in the transcription synthesis rate and a stabilization of the lcrF 
transcript. These complex rearrangements in the global regulatory systems ensure a fast and 
perfect adaptation to changing conditions during the infection process. 
 
 
Figure 4.2: Working model of YopD- and CsrA-dependent feedforward regulation of the late virulence gene 
regulation. The regulatory network controlling the expression of late virulence master regulator lcrF. Expression of lcrF is 
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regulated on the transcriptional and post-transcriptional level by YopD, CsrA and the RNA degradosome. Direct and indirect 
(dashed line) regulatory effects of the involved factors are shown. Arrows symbolize gene activation, while bar-headed lines 
symbolize gene repression. 
 
4.7 CsrA targets in Yersinia 
In order to identify direct CsrA targets, a RIP-Seq, and a differential RNA-Seq approach were 
combined with an in silico prediction. The analysis of in silico predicted, differentially 
regulated genes revealed a high number of type six secretion system (T6SS) associated genes. 
Especially, structural genes of the T6SS-1, the T6SS-2 and the T6SS-4 were predicted. T6SSs 
form complex macromolecular syringes which function in the interbacterial defense, enhance 
virulence and pathogenicity [Sana et al., 2016; Hachani et al., 2016]. Notably, the 5'-UTRs of 
impG/vasA, impI and impJ/vasE (YPK_0389, YPK_0391; YPK_0393) harbor a high number 
of CsrA binding motifs (data not shown) and are strongly repressed by CsrA in 
Y .pseudotuberculosis YPIII [Nuss, unpublished data]. Besides the putative T6SS-4 regulator 
rovC (YPK_3567), which is repressed by CsrA at 25 °C [Knittel, Master thesis] other T6SS-4 
genes were predicted, but are not differentially regulated by CsrA at 25 °C or 37 °C (Fig. 
3.21) [Nuss, unpublished data]. 
RovC is a Yersinia-specific uncharacterized DNA-binding protein with an unknown fold. The 
rovC mRNA is a specifically targeted by CsrA, as demonstrated by RNA-EMSA and reporter 
gene studies [Knittel, Master thesis; Seekircher, PhD thesis]. Some of the T6SS genes 
predicted by the algorithm were already positively tested for CsrA-dependency in β-
galactosidase reporter gene assays [Kukarcev, Bachelor thesis]. These T6SS-4 genes all 
harbor a high number of CsrA binding motifs in their upstream regions (data not shown) but 
are not expressed under the employed conditions of the differential RNA-Seq [Nuss, 
unpublished data]. In 2009, a direct regulation by the CsrA-homolog RsmA was shown for 
the structural T6SS genes PA0081 (YPK_0391; T6SS-1) and PA0082 (YPK_3566; T6SS-4) 
in P. aeruginosa [Brencic & Lory, 2009]. When comparing the 5'-UTRs of these genes in 
Pseudomonas and Yersinia, a comparably high number of primary binding sites was 
observed, suggesting a direct CsrA regulation as well in Y. pseudotuberculosis YPIII (Fig. 
S12+13). These results extend the list of CsrA targets and highlight the role of CsrA as a 
central regulator and coordinator of virulence-associated secretion systems in Yersinia. 
Also, the rovA gene encoding the transcriptional regulator of the initial infection phase and an 
activator of invasin was identified as a possible direct CsrA target. A CsrA-dependent 
regulation of rovA has long been known, although so far it was assumed its influence occurs 
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solely indirectly via the RovA regulator RovM [Heroven et al., 2008]. Results of this study 
point to a more complex CsrA-dependent regulation of rovA. The leader transcript of rovA 
harbors three primary binding sites in the vicinity and overlapping with the RBS. This 
suggests a CsrA-dependent feedforward regulation of rovA, as CsrA is a possible direct as 
well as an indirect regulator of rovA. The complex regulation might be important to precisely 
adjust rovA expression. Precise RovA levels are needed for a successful infection, since 
changes in the rovA expression pattern are disadvantageous for the colonization of the MLNs 
in the mouse model [Nuss et al., 2016; Schuster PhD thesis]. 
Additionally, the analysis of predicted target genes, which are CsrA dependent and are part of 
the CsrA interactome, revealed mostly metabolic genes. These results are in agreement with 
CsrA's role as a regulator of metabolism and virulence [Barnard et al., 2004; Heroven et al., 
2012]. Additionally, tRNAs, the tRNA-modifying enzyme miaA and the M1 RNA of RNase P 
were identified as putative direct CsrA targets at 37 °C. These transcripts were enriched in the 
RIP-Seq analysis and are part of the CsrA regulon. Interestingly, most of these tRNAs contain 
only a single or no CsrA binding motif at all. For this reason, these tRNAs seem to be 
unlikely CsrA targets. Interestingly, mature tRNAs are processed from longer precursor tRNA 
involving multiple maturation events [Phizicky & Hopper, 2010]. These pre-tRNAs are 
probably targeted by CsrA. The differential RNA-seq analysis of the YPIII wild-type and the 
csrA mutant gave evidence for a temperature-dependent regulation of tRNA genes. CsrA 
seems to be involved in this temperature-dependent reorganization of the cellular tRNAs and 
therefore the cellular codon composition [Nuss, unpublished data]. Genes that need to be 
expressed at similar levels tend to use the same codons. A remodeling of the cellular tRNA 
codon availability supports the reorganization of the cellular proteome [Plotkin & Kudla, 
2011; Novoa et al., 2012]. At body host temperature, mostly proteins of the Ysc-Yop T3SS 
are synthesized. Hence, the availability of certain tRNAs might lead to a preferential synthesis 
of Ysc-Yop T3SS genes. 
 
Interactome analysis, differential RNA-Seq and in silico target prediction are valuable tools 
for the identification of direct CsrA targets, however, all these approaches have some 
drawbacks. A differential RNA-Seq analysis cannot identify target genes those RNA levels 
are unaffected by CsrA, for example when only translation initiation is changed by CsrA 
binding, as seen in the CsrA-dependent regulation of hfq [Baker et al., 2007]. Additionally, 
not all differentially regulated RNAs are directly targeted by CsrA. A weakness of the RIP-
Seq approach can be seen by an absence of the fixation of in vivo RNA-protein interactions. 
 Discussion 
110 
Because of this, interactions can still take place during the in vitro IP leading to results that do 
not necessarily correspond to interactions occurring inside the cell. This can cause an 
overrepresentation of false-positive RNAs [Mili & Steitz, 2004; Riley & Steitz, 2013]. To 
overcome some of the disadvantages of RIP-Seq, other IP approaches can be used. For 
example, UV cross-linking immunoprecipitation coupled with RNA-Seq (CLIP-Seq). The 
fixation of RNA-RBP interactions allows RNase treatment to isolate binding sites in target 
RNAs. The applied fixation can cause an overrepresentation of high abundant RNAs that are 
only bound by CsrA with a low affinity [Holmqvist et al., 2016; Zhang et al., 2015; Waters et 
al., 2016]. The CsrA core binding motif GGA is also part of the ribosomal binding site and 
can be found in the leader transcript of a majority of coding genes. These RNAs might only 
temporarily associate with CsrA due to their low binding affinity. Enriched RNAs are always 
the sum of binding affinity and abundance of the corresponding transcript, which interferes 
with the identification of high-affinity targets [Head et al., 2014; Riley & Steitz, 2013]. For 
this reason, CLIP-Seq cannot be used to identify high-affinity targets. To obtain a better 
understanding of in vivo binding dynamics, covalent RNA-tagging can be applied. Here, the 
RNA-binding protein of choice is fused to a poly(U)-polymerase that adds a growing 
polyuridine tag dependent on interaction duration and frequency [Lapointe et al., 2015]. 
Interactome approaches are a valuable tool to identify direct RBP target RNAs. Noteworthy, 
these approaches only reflect RNAs that are expressed under specific conditions and might 
contain high abundant RNAs with a low-affinity binding affinity. Moreover, in silico 
prediction algorithms can help to identify high-affinity targets and circumvent the drawbacks 
of in vivo approaches that only consider certain growth conditions. A weakness of the 
employed prediction algorithm of this study is that it only considers the binding motif 
distribution in the primary RNA sequence and not the secondary structure of putative target 
RNAs. However, binding motifs need to be exposed on hairpin structures [Vakulskas et al., 
2015]. To take this into account, in silico RNA folding algorithm can be employed, such as 
mfold or similar tools [Zuker, 2003, Rybarczyck et al., 2015]. Such an approach was also 
tested during this study. Considering only folds with a minimal free energy +/-10% deviation, 
most 5'-UTRs contained at least one CsrA binding motif exposed on a hairpin (data not 
shown). Moreover, the fold of a given in vivo transcript is not only dependent on the 
calculated minimal free energy of the fold, but also on additional factors, like the cellular ion 
concentration, RNA processing, RNA-binding proteins or other molecules. Additionally, 
crowding in the cytosol causes a deviation between in silico and in vivo folds [Gao et al., 
2016; Righetti et al., 2016]. Recently, the in vitro RNA structurome of Y. pseudotuberculosis 
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was published, which could be combined with in silico fold predictions [Righetti et al., 2016]. 
Both methods can be applied to improve results of the target prediction algorithm used in this 
study. 
 
A comparison of identified CsrA targets in Y. pseudotuberculosis by RIP-Seq and in silico 
prediction data of other bacteria revealed only a minor overlap indicating a low phylogenetic 
conservation of CsrA target genes (data not shown). This observation was also made in a 
comparison of in silico predicted CsrA targets in Y. pseudotuberculosis and E. coli (see 
chapter 3.19.4) and in prediction dataset of S. typhimurium and P. aeruginosa by Kulkarni et 
al. [Kulkarni et al., 2014]. The number of in silico predicted targets in these species was 
comparable. However, only a fraction of these target genes overlapped between the analyzed 
species (see chapter 3.19.4) [Kulkarni et al., 2014]. A ClustalO alignment of the upstream 
region of target genes in E. coli and Y. pseudotuberculosis revealed that, due to mutations, the 
distribution and number of CsrA binding motifs were drastically changed (see Fig. S8-11). 
According to these results, species-specific differences in the CsrA target gene set can be 
explained by the phylogenetic distance. 
Remarkably, when comparing the list of the CsrA targets of the CLIP-Seq interactome in 
S. typhimurium [Holmqvist et al., 2016] to predicted genes in Y. pseudotuberculosis, CsrA 
target genes changed within the same functional enzymatic cascade (data not shown). Such a 
pattern was also recognizable when comparing the data of predicted CsrA targets between E. 
coli, S. typhimurium and P. aeruginosa by Kulkarni and colleagues (data not shown) 
[Kulkarni et al., 2014] and predicted targets of Y. pseudotuberculosis and E. coli (table 3.1). 
These changes were shown for the extensively studied glycogen (glg) operon (see chapter 
3.19.4). In E. coli, the glgC gene is regulated and bound by CsrA, due to a high number of 
binding sites. In Y. pseudotuberculosis a CsrA-dependent regulation of this gene was detected 
neither at 25 °C nor at 37 °C [Nuss, unpublished data] and crucial binding sites are not 
present. Furthermore, the 5'-UTRs of other glg operon genes were analyzed and compared by 
a ClustalO alignment and analyzed for CsrA binding motifs. The analysis revealed a change 
in the binding motif composition within the 5'-UTR of individual glg genes resulting in an 
extensive reorganization of the CsrA target gene set within the glg operon. Indeed, glgX and 
glgB have a low number of binding sites (Fig. 3.22) and display no CsrA dependency in E. 
coli [Yang et al., 1996]. In contrast, Y. pseudotuberculosis glgB and glgX have several 
binding motifs (Fig. 3.19.4) and are repressed by CsrA to some extent [Nuss, unpublished 
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data]. Similar observations were made for motility-specific genes and the tRNA-modifying 
genes miaA/B (see chapter 3.19.4). 
Taken together, this points to a change in the CsrA dependency of individual glg genes and 
other metabolic genes in E. coli and Y. pseudotuberculosis and a phylogenetic conservation of 
CsrA-dependent functional modules. Although the glycogen metabolism operon keeps its 
overall CsrA dependency, individual CsrA targets change or their affinity is weakened. 
Similar observation was also made for the small non-coding RNAs csrB/C. These RNAs 
contain a high number of GGA motifs and control the activity of CsrA through a sequestration 
mechanism. Homologs of csrB/C were identified in many Gram-negative bacteria but differ in 
the number of CsrA binding sites [Babitzke & Romeo, 2007]. These differences might have a 
major influence on the available amount of CsrA and therefore change the species-specific 
CsrA regulon. 
In conclusion, CsrA target gene sets are only partially conserved between bacteria, but the 
CsrA dependency of regulated pathways remains (chapter 3.19.4). A reason for frequent 
changes of CsrA binding sites might be the low complexity of the CsrA core binding motif 
(GGA). Point mutations within this short motif decrease the binding affinity or destroy the 
binding motif. Additionally, UTRs display only a low degree of evolutionary conservation in 
comparison to the well-conserved coding sequence. Because of this, CsrA binding motifs in 
the upstream region of target genes can be easily lost or gained by mutations. While it seems 
to be crucial for survival to maintain the CsrA-dependent regulation of certain pathways, the 
CsrA-dependencies can easily switch between genes. This would result in an evolutionary 
selection of CsrA-dependent pathways rather than of individual CsrA targets. This might also 
be the reason why CsrA targets dramatically differ with increasing phylogenetic distance and 
predicted and determined binding sites only lowly overlap between species. 
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5 Outlook 
This study demonstrated the complex regulation of the Ysc-Yop T3SS by the RNA-binding 
proteins YopD and CsrA. Expression of both regulators is linked in mutually dependent 
feedback loops. To further investigate the YopD-dependent regulation of csrA, the YopD-
controlled transcriptional regulator of csrA needs to be identified. As this regulator is YopD-
dependently regulated and seems to be solely active at 37 °C, a comparative analysis of the 
YopD regulon at 37 °C under non-secretory and secretion conditions with the YopD 
interactome might aid to identify the transcriptional regulator of csrA. 
The RNA-binding domains of YopD as well as the involved RNA binding motifs and folds 
are still uncharacterized. This study proposed the involvement of different RNA features in 
the YopD-dependent gene activation and repression. Therefore, YopD/LcrH should be 
crystallized together with a transcript which is YopD-dependently induced (e.g. csrA) and a 
repressed one (e.g. yopQ or lcrF). This might help to gain a better understanding of the 
unknown domain that confers YopD's RNA binding capacity. Additionally, other studies 
demonstrated that different regions of YopD are needed for pore formation, the translocation, 
yop regulation, secretion and LcrH binding, the crystal structure might help to understand the 
nature of the dual function of YopD as a translocator and regulator. By CLIP-Seq analysis, 
direct YopD target genes and RNA binding sites should be isolated on a global scale. 
Additionally, YopD-dependent repression appears to depend on multiple factors, such as 
SycH and LcrQ. For this reason, their influence on YopD-dependent RNA binding should be 
analyzed in RNA-EMSA analysis. 
Another important task will be to further characterize CsrA binding parameters, as in silico 
target predictions are still challenging, due to the low complexity of the short CsrA binding 
motif. CsrA preferentially binds to ANGGA motifs exposed on hairpin loops. To address this 
parameter, in silico fold algorithms should be taken into account. In this study, in silico fold 
prediction could not be utilized as, for a given probability space of RNA folds, most ANGGA 
motifs will be exposed on hairpin loops in certain folds. As fold algorithms do not consider 
parameters, such as RNA-binding proteins, ion concentration or cytosolic crowding, an RNA 
structurome data set can be used instead. 
On a larger scale, a combined analysis of RNA-Seq, CLIP-Seq and the RNA structurome 
datasets can be further used to gain new insights into CsrA binding of high- and low-affinity 
target RNAs. To classify RNA targets identified by CLIP-Seq into low- and high-affinity 
RNA targets, the abundance of a given transcript needs to be taken into account and can be 
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analyzed by differential RNA-Seq. The RNA structurome dataset addresses in vitro RNA 
folds, which help to localize binding sites identified by CLIP-Seq within the secondary 
structure of a target gene. Moreover, CsrA targets which were identified in this study should 
be validated for in vitro binding by RNA-EMSA. 
.
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6 Summary 
Expression of Ysc-Yop type III secretion system requires a tight regulation, which is 
conferred by two RNA-binding proteins YopD and CsrA. The underlying study demonstrated 
that expression of the transcriptional master regulator lcrF of the Ysc-Yop T3SS is controlled 
in intertwined feedback loops by these RNA-binding proteins. 
CsrA is a global acting post-transcriptional regulator that coordinates metabolic and virulence 
gene expression. This study demonstrated that expression of csrA is precisely controlled in an 
autoregulatory feedback loop, indirectly on the transcriptional and directly on the post-
transcriptional level. CsrA was found to directly bind to two sites in the 5'-UTR of its 
transcript, from which one site is located within the ribosomal binding site. By this 
mechanism, CsrA was shown to block translational initiation and restrict CsrA synthesis when 
a certain CsrA amount is reached. Under non-secretion conditions, the RNA-binding protein 
YopD was shown to bind to the csrA transcript thereby masking a CsrA binding site and 
preventing the direct autoinhibition of csrA. 
Analysis of the mutual role of CsrA and YopD in the regulation of lcrF expression 
demonstrated a direct interaction of both RNA-binding proteins in multiple regions of the 
yscW-lcrF transcript. The 5'-UTR of lcrF contains an RNA-thermometer structure, which 
prevents ribosomal access through a base-pairing mechanism. Furthermore, this study 
demonstrated, CsrA interacts with the ribosomal binding site of lcrF and modulates the 
opening state of the RNA thermometer. 
Interestingly, this work uncovered that both regulators modulate the stability of the lcrF 
transcript. CsrA has a stabilizing and YopD a destabilizing effect on the lcrF mRNA. This is 
caused by the antagonistic YopD- and CsrA-dependent control of the RNA degradosome. 
Additionally, this study analyzed the temperature-dependent regulation of yopD expression. 
The yopD gene is transcribed from two promoters. This study demonstrated, at 25 °C yopD is 
mainly transcribed from its own promoter PyopD. As a consequence, yopD expression is 
uncoupled from its chaperone lcrH. Due to the imbalance of YopD and LcrH protein, YopD is 
constantly degraded and remains in a stand-by mode as it cannot confer its regulatory role. At 
37 °C, yopD is mainly transcribed from the PlcrG promoter allowing the translation of YopD, 
as well as LcrH. Now sufficient amounts of chaperone LcrH are present and the YopD protein 
is stabilized to confer its regulatory control. 
Furthermore, new putative CsrA targets could be identified by an interactome analysis with 
FLAG-tagged CsrA protein. At body host temperature, CsrA specifically interacts with 
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tRNAs and transcripts of tRNA processing proteins. Moreover, a comparison of predicted 
direct CsrA targets in Escherichia coli and Yersinia pseudotuberculosis demonstrated a low 
conservation of CsrA target genes between both species and a low conservation of CsrA 
binding site in the 5'-UTR of these target genes. 
In summary, this study revealed the complex interplay of YopD and CsrA in controlling the 
expression of the T3SS master regulator lcrF. Both regulators are in involved in the post-
transcriptional control of lcrF expression under non-secretion conditions and confer an 
antagonistic regulation. 
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8 Appendix 
E.coli       GCCGAAAATGTTGCGTACCATGGTTGACGATTTAAAAAATCAGCTGGGGTCGACAATTAT 
Y.pstb.      ------------GCGGACAATGGTCGATGACCTTAAAAATCAACTGGGTTCTGCCATTAT 
                         *** **.***** ** **  *:********.***** ** .*.***** 
 
E.coli       CGTGCTGGCAACGGTAGTCGAAGGTAAGGTTTCTCTGATTGCAGGCGTATCTAAGGACGT 
Y.pstb.      TGTATTGGCCACCACAGCTGATGATAAGGTAAGTTTGATTGTTGGGGTGACCAAGGACCT 
              **. ****.** . **  **:*.******:: * ****** :** **.:* ****** * 
 
E.coli       CACAGATCGTGTGAAAGCAGGGGAACTGATTGGTATGGTCGCTCAGCAGGTGGGCGGCAA 
Y.pstb.      GACAGGTAAAGTAAAAGCGGGTGAATTAATCGCGGACATTGCTCAGCAGGTGGGCGGTAA 
              ****.*..:**.*****.** *** *.** *  .: .* ***************** ** 
 
E.coli       GGGTGGTGGACGTCCTGACATGGCGCAAGCCGGTGGTACGGATGCTGCGGCCTTACCTGC 
Y.pstb.      AGGCGGTGGTCGTCCTGATATGGCTCAGGCGGGGGGTACTGATGTGCAGGCTTTGCCAGC 
             .** *****:******** ***** **.** ** ***** ****    *** **.**:** 
             P1 P2 
E.coli       AGCGTTAGCCAGTGTGAAAGGCTGGGTCAGCGCGAAATTGCAATAAtataagcgtcaggc 
Y.pstb.      GGCATTAGCCAGCGTAGAAGCATGGGTAGCATCCCGGATGTAAgtaatcatctattaaat 
             .**.******** **..*** .*****.. . * ...:** **      *    * *    
 
E.coli       aatgccgtggac--tcgcttcacggcat------tcgcattaacgctatcg-----acaa 
Y.pstb.      caacacgccatatctcggtactaggtatggcgttttttaattttcctgtcatagttcaat 
              *   **       *** * *  ** **      *   * *    ** **        *  
              P3 
E.coli       cgataaagtcaggttgaagttgtgtatatcggctaaacttaggtttaacagaatgtaatg 
Y.pstb.      cacaaagttaaacgcaaagttgtttgcttcagctaaactt-gtattagttagggactc-g 
             *   **  * *     ******* *   ** ********* * :***  : *  *    * 
 
E.coli       ccatgactgcttagatgtaatgtgtttgtcattgcttactttttggcgttatatgatgga 
Y.pstb.      accaagctacttacattttatatgaatgtaatggcttacgttttcacggtgtatgatgga 
              *    ** **** ** * ** **  *** ** ****** ****  ** * ********* 
      P4       P5 
E.coli       taatgccgggata-cagagagacccgactcttttaatctttcaaggagcaaagaATGCTG 
Y.pstb.      taatggcggggaaacagagagacccgactcttttaatttttcaaggagcaaagaATGCTT 
             ***** *****:* *********************** *********************  
 
E.coli       ATTCTGACTCGTCGAGTTGGTGAGACCCTCATGATTGGGGATGAGGTCACCGTGACAGTT 
Y.pstb.      ATTCTGACTCGTCGAGTTGGTGAAACACTCATGATTGGCGATGAGGTTACGGTTACTGTA 
             ***********************.**.*********** ******** ** ** **:**: 
 
E.coli       TTAGGGGTAAAGGGCAACCAGGTACGTATTGGCGTAAATGCCCCGAAGGAAGTTTCTGTT 
Y.pstb.      TTAGGGGTTAAAGGCAACCAGGTTCGAATTGGTGTAAATGCTCCGAAAGAGGTTTCTGTT 
             ********:**.***********:**:***** ******** *****.**.********* 
 
E.coli       CACCGTGAAGAGATCTACCAGCGTATCCAGGCTGAAAAATCCCAGCAGTCCAGTTACTAA 
Y.pstb.      CACCGTGAAGAAATCTACCAGCGCATCCAAGCAGAAAAGTCTCAACCGACGACTTACTGA 
             ***********.*********** *****.**:*****.** **.*.*:* * *****.* 
 
Figure S1: DNA sequence alignment of the csrA locus of Y. pseudotuberculosis YPIII and E. coli K12. ClustalO was 
used for the alignment of the csrA locus (-520 to +186 relative to the translational start site) with default parameters. 
Nucleotides which were identical in both species are marked with a star below the sequence. The position of the -35 (blue) 
and -10 boxes (cyan), transcriptional start sites (gray) the ribosomal binding site (red) and the coding sequence (yellow) are 
indicated. The position of the -35 and -10 boxes, as well as, the transcriptional start site were identified in E. coli [Yakhnin et 
al., 2011]. The position of the transcriptional start site of Y. pseudotuberculosis are shown as identified by RNA-Seq [Nuss et 
al., 2015]. 
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Table S2: CsrA targets in Y. pseudotuberculosis YPIII as predicted by the CSRA_TARGET_PREDICTER script. 
CsrA dependently up or down regulated genes are highlighted with an up or down pointing arrow. CsrA dependently up or 
down regulated genes are highlighted with an up or down pointing arrow. Highlighted are only genes which were at least 4 
times enriched or depleted (-2 >= log2(fc) >= 2) in stationary phase at 25 °C (diff. S25) or 37 °C (diff. S37) in absence of 
csrA [Nuss, unpublished data]. 
Locus Gene name Gene description diff. S25 diff. S37 
YPK_0008 ilvA, tdcB pyridoxal-phosphate dependent enzyme family protein 
  YPK_0013 yidE Mediator of hyperadherence YidE 
  YPK_0043 selB Selenocysteine-specific translation elongation factor 
  YPK_0046   hypothetical protein 
  YPK_0063   hypothetical protein 
  
YPK_0075 cysK-1 
Pyridoxal-5'-phosphate-dependent enzyme beta superfamily 
(fold type II) 
  
YPK_0088 dppA 
Dipeptide-binding ABC transporter, periplasmic substrate-
binding component 
  YPK_0108   hypothetical protein 
  YPK_0121 uspB Universal stress protein B 
  YPK_0126 rbsC-1 ABC transport system, permease protein Z5690 
  YPK_0147 glgB 1,4-alpha-glucan (glycogen) branching enzyme 
  YPK_0148 glgX Glycogen debranching enzyme 
  YPK_0161 glgP-2 Maltodextrin phosphorylase 
  YPK_0162 malQ 4-alpha-glucanotransferase (amylomaltase) 
  YPK_0174 pckA Phosphoenolpyruvate carboxykinase [ATP] 
  YPK_0201   hypothetical protein 
  YPK_0202   COG4382: Mu-like prophage protein gp16 
  YPK_0220 hofM Type IV pilus biogenesis protein PilM 
  YPK_0259 tauB-1 Taurine transport ATP-binding protein TauB 
  YPK_0271   YheO-like PAS domain 
  YPK_0279 tnp-4 Mobile element protein 
  YPK_0284 rplD LSU ribosomal protein L4p (L1e) 
  YPK_0321 aroE-1 Shikimate 5-dehydrogenase I alpha 
  YPK_0366 aceK Isocitrate dehydrogenase phosphatase 
 
↑ 
YPK_0389 impG-1, vasA-1 Protein ImpG/VasA 
  YPK_0391 impI, vasC Uncharacterized protein ImpI/VasC 
  YPK_0393 impJ-1, vasE-1 Uncharacterized protein ImpJ/VasE ↑ 
 YPK_0402   hypothetical protein 
  YPK_0427   Mobile element protein 
  YPK_0449   Putative metabolite transport protein 
  YPK_0487   Ribonuclease (Barnase), secreted 
  YPK_0489 yjgA FIG138315: Putative alpha helix protein 
  YPK_0495 treB PTS system, trehalose-specific IIB component ↑ 
 
YPK_0512 mlaF Phospholipid ABC transporter ATP-binding protein MlaF 
  YPK_0534 elbB Sigma cross-reacting protein 27A 
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YPK_0538 yraN 
Predicted endonuclease distantly related to archaeal Holliday 
junction resolvase 
  YPK_0580   Rhs-family protein 
  YPK_0588 lacI-2, galR-2 LacI-family regulatory protein 
  YPK_0600   putative membrane protein 
  YPK_0670 yghB DedA family inner membrane protein YghB 
  YPK_0732   hypothetical protein 
  
YPK_0752   
Siderophore biosynthesis non-ribosomal peptide synthetase 
modules 
  YPK_0755   Thioesterase in siderophore biosynthesis gene cluster 
  YPK_0759   Putative exported protein precursor 
 
↓ 
YPK_0765   hypothetical protein 
  YPK_0769   hypothetical protein 
  YPK_0777   putative membrane protein 
  YPK_0781   Galactose permease 
  YPK_0783 iucD L-lysine 6-monooxygenase [NADPH] 
  YPK_0796   Phage protein 
  YPK_0819 yggX FIG001341: Probable Fe(2+)-trafficking protein YggX 
  YPK_0838 gshB Glutathione synthetase 
  YPK_0846 
 
Mobile element protein 
  YPK_0848 tnp-4 Mobile element protein 
  
YPK_0854 mscS Protein involved in stability of MscS mechanosensitive channel 
  YPK_0889   FIG01221547: hypothetical protein 
  YPK_0919   hypothetical protein 
 
↓ 
YPK_0933   hypothetical protein 
  YPK_0950   hypothetical protein 
  YPK_0978 exuT-2 Putative MFS superfamily hexuronate transporter 
  YPK_0984 ydeN, yidJ N-acetylgalactosamine 6-sulfate sulfatase (GALNS) 
  YPK_1006 gspF General secretion pathway protein F 
 
↓ 
YPK_1008 gspH General secretion pathway protein H 
  YPK_1009 gspI General secretion pathway protein I 
  YPK_1045 argA N-acetylglutamate synthase 
  YPK_1056 ygdH Decarboxylase family protein 
  YPK_1111 hpxB Uricase (urate oxidase) 
  YPK_1123   hypothetical protein 
  YPK_1134 ureE Urease accessory protein UreE 
  
YPK_1148 chbG N,N'-diacetylchitobiose utilization operon protein YdjC 
  YPK_1162   FIG143828: Hypothetical protein YbgA 
  YPK_1179 srmB ATP-dependent RNA helicase SrmB 
  YPK_1186   putative membrane protein ↑ 
 YPK_1198   Phage DNA binding protein Roi 
  YPK_1299   Uncharacterized protein YfgJ 
  YPK_1339   FIG01222552: hypothetical protein 
  YPK_1344 ppk Polyphosphate kinase 
  
 Appendix 
IX 
YPK_1357 perM Putative permease PerM 
  YPK_1362 dapA 4-hydroxy-tetrahydrodipicolinate synthase 
  YPK_1391 maeB NADP-dependent malic enzyme 
  YPK_1426 crr PTS system, glucose-specific IIA component 
  YPK_1451   putative lipoprotein 
  YPK_1459 yhhZ-3 hypothetical protein 
  YPK_1472 impH-2, vasB-2 Uncharacterized protein ImpH/VasB 
  YPK_1475 fimA-2 Fimbrial protein precursor 
  YPK_1532 folC Dihydrofolate synthase 
  YPK_1542 yfcH Cell division inhibitor Slr1223 
  YPK_1547 ulaB, sgaB Putative sugar phosphotransferase component II B ↓ ↓ 
YPK_1576 idnO 5-keto-D-gluconate 5-reductase 
  YPK_1617   putative membrane protein 
  YPK_1629   Putative large exoprotein involved in heme utilization 
  YPK_1644 cas-1 CRISPR-associated protein Cas1 
  YPK_1659   hypothetical protein 
 
↑ 
YPK_1679 
 
Mobile element protein 
  YPK_1703   hypothetical protein 
 
↓ 
YPK_1718 purB Adenylosuccinate lyase 
  
YPK_1719 hflD 
 Protein of unknown function perhaps involved in purine 
metabolism 
  YPK_1725   hypothetical protein 
  YPK_1748 motB-2 Flagellar motor rotation protein MotB 
  YPK_1752   putative lipoprotein 
  YPK_1773   Sigma-fimbriae tip adhesin 
  
YPK_1782 proQ ProQ: influences osmotic activation of compatible solute ProP 
  YPK_1807   Mobile element protein 
  
YPK_1852 sufE-2 Sulfur acceptor protein SufE for iron-sulfur cluster assembly 
  YPK_1876 rovA, slyA Transcriptional regulator SlyA ↓ 
 YPK_1885   Inner membrane protein YohC 
  YPK_1901   putative phosphatase/kinase 
  YPK_1932   hypothetical protein 
  
YPK_1961 rbsA-4 
Predicted erythritol ABC transporter 2, ATP-binding 
component 
 
↓ 
YPK_1964   hypothetical protein 
  YPK_2022 osmB Osmotically inducible lipoprotein B precursor 
  
YPK_2064   
FIG002901: hypothetical protein co-occurring with Cardiolipin 
synthetase 
  YPK_2114   hypothetical protein 
  YPK_2131 mdtJ Spermidine export protein MdtJ 
  YPK_2154 yecM Protein YecM 
  YPK_2195   Putative exported protein precursor 
  YPK_2234 tnp-4 Mobile element protein 
  YPK_2254 glsA-2 Glutaminase 
 
↓ 
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YPK_2258 nqrE-1 Na(+)-translocating NADH-quinone reductase subunit E 
  YPK_2267 ripB, ich-Y Transcriptional regulator 
  YPK_2292   Mobile element protein 
  YPK_2304   Phage-related tail protein 
  YPK_2338   hypothetical protein ↓ ↓ 
YPK_2351   Phage-related tail protein 
  YPK_2373   hypothetical protein 
  
YPK_2374 yecC 
L-cystine ABC transporter (wide substrate range), ATP-binding 
protein 
  YPK_2406   hypothetical protein 
  YPK_2409 yphE-2; ytfR-2 ABC-type sugar transport system, ATP-binding protein 
  YPK_2419 flgH Flagellar L-ring protein FlgH 
  YPK_2420 flgG Flagellar basal-body rod protein FlgG 
  YPK_2424 flgC-2 Flagellar basal-body rod protein FlgC 
  YPK_2432 flhB-2 Flagellar biosynthesis protein FlhB 
  YPK_2433   putative membrane protein 
  YPK_2448 yoaH hypothetical protein ↓ 
 YPK_2465 manY PTS system, mannose-specific IIC component 
  YPK_2509   2,4-diketo-3-deoxy-L-fuconate hydrolase 
  YPK_2533 
 
Mobile element protein 
  
YPK_2538   
Siderophore [Alcaligin-like] biosynthesis complex, medium 
chain 
  
YPK_2545 ysuH, alcB Siderophore [Alcaligin-like] biosynthesis complex, short chain 
  YPK_2567 yeiB Uncharacterized protein YeiB 
  YPK_2571 frmA, adhC S-(hydroxymethyl)glutathione dehydrogenase 
  YPK_2593   hypothetical protein 
  YPK_2601   hypothetical protein 
  YPK_2628 tfoX DNA transformation protein TfoX ↑ 
 YPK_2631 tnp-4 Mobile element protein 
  YPK_2662 cspB-2 Cold shock protein CspI ↑ 
 YPK_2672 yadC Putative exported protein precursor 
  YPK_2674 ansB L-asparaginase 
  YPK_2678   hypothetical protein 
  YPK_2704   hypothetical protein 
  YPK_2746   Phosphoserine phosphatase ↑ 
 YPK_2766 yphD-7, ytfT-7 Xylose ABC transporter, permease protein XylH ↑ 
 YPK_2801   hypothetical protein 
  YPK_2817   hypothetical protein 
  YPK_2822   Putative bacteriophage protein 
  YPK_2889 
 
Mobile element protein 
  YPK_2905   Transcriptional regulator 
  
YPK_2908 zraS, hydH 
Sensor protein of zinc sigma-54-dependent two-component 
system 
  YPK_2927   Probable ATP-binding ABC transporter protein 
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YPK_2949 aroG 
2-keto-3-deoxy-D-arabino-heptulosonate-7-phosphate 
synthase I alpha 
  YPK_2951 zitB Cobalt-zinc-cadmium resistance protein CzcD 
  YPK_2981   Phage integrase 
  YPK_2995 
 
Mobile element protein 
  YPK_3005 miaB tRNA-i(6)A37 methylthiotransferase ↑ ↑ 
YPK_3038   hypothetical protein 
  YPK_3053 yfhM putative membrane protein 
  YPK_3055 ner-1, nlp-1 Putative regulatory protein 
 
↑ 
YPK_3078   putative membrane protein 
  YPK_3143   hypothetical protein 
  YPK_3146   hypothetical protein 
  YPK_3151 ybcJ FIG002958: hypothetical protein 
  YPK_3165 copA Copper-translocating P-type ATPase 
  YPK_3168   hypothetical protein 
  YPK_3173 
 
Mobile element protein 
  YPK_3209 tnp-4 Mobile element protein 
  YPK_3242 cyoB Cytochrome O ubiquinol oxidase subunit I 
  YPK_3260   hypothetical protein 
  YPK_3269 ggt Gamma-glutamyltranspeptidase ↑ ↑ 
YPK_3270   Putative short-chain dehydrogenase 
  
YPK_3301 nqrE Na(+)-translocating NADH-quinone reductase subunit E 
  YPK_3310   hypothetical protein 
  YPK_3367 yfjD Putative membrane protein YfjD 
  YPK_3372 csrA Carbon storage regulator ↓ ↓ 
YPK_3412 pheC Prephenate dehydratase 
  YPK_3414   hypothetical protein 
  YPK_3428 surE 5-nucleotidase SurE 
  YPK_3435 cysN Sulfate adenylyltransferase subunit 1 ↑ 
 YPK_3439   hypothetical protein 
  YPK_3473 panC Pantoate--beta-alanine ligase 
  YPK_3488 
 
Mobile element protein 
  YPK_3506 
 
Mobile element protein 
  
YPK_3521 mraY Phospho-N-acetylmuramoyl-pentapeptide-transferase 
  YPK_3526 mraW, rsmH 16S rRNA (cytosine(1402)-N(4))-methyltransferase 
  YPK_3530 ilvH Acetolactate synthase small subunit 
  
YPK_3542 thiB, tbpA Thiamin ABC transporter, substrate-binding component 
  YPK_3548   hypothetical protein 
  YPK_3550 impL-4, vasK-4 Putative membrane protein precursor 
  YPK_3552 impJ-4, vasE-4 Uncharacterized protein ImpJ/VasE 
  YPK_3556   hypothetical protein 
  YPK_3564 impC-4 Uncharacterized protein ImpC 
  YPK_3566 impA-2 Uncharacterized protein ImpA 
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YPK_3567 rovC hypothetical protein 
  YPK_3593 dnaJ Chaperone protein DnaJ 
  YPK_3645   hypothetical protein 
  YPK_3679 pepA Cytosol aminopeptidase PepA 
  
YPK_3694 phnG 
Alpha-D-ribose 1-methylphosphonate 5-triphosphate synthase 
subunit PhnG 
  
YPK_3699 phnL 
Alpha-D-ribose 1-methylphosphonate 5-triphosphate synthase 
subunit PhnL  
  YPK_3721   Putative membrane protein ↓ ↓ 
YPK_3725 nlpI Lipoprotein NlpI 
  YPK_3759   hypothetical protein 
  YPK_3767 ppa Inorganic pyrophosphatase 
  YPK_3770 ytfM Outer membrane component of TAM transport system 
  YPK_3791 rnr 3'-to-5' exoribonuclease RNase R 
  YPK_3796 hflK HflK protein 
  YPK_3808 orn 3'-to-5' oligoribonuclease (orn) 
  YPK_3820   hypothetical protein 
  YPK_3873 terD Tellurium resistance protein TerD 
  
YPK_3878   Carbamoylphosphate synthase large subunit (split gene in MJ) 
  YPK_3915   FIG027385: Putative type III secretion apparatus 
  YPK_3943 ubiB Ubiquinone biosynthesis monooxygenase UbiB 
  YPK_3969   hypothetical protein 
  YPK_4005   hypothetical protein 
  YPK_4028 rffH, rfbA Glucose-1-phosphate thymidylyltransferase 
  YPK_4047   Colicin immunity protein 
  
YPK_4062 comM, yifB MG(2+) CHELATASE FAMILY PROTEIN/ComM-related protein 
  
YPK_4068 yphF-6, ytfQ-6 
Putative sugar ABC transport system, periplasmic binding 
protein YtfQ precursor 
  YPK_4085 hasA Hemophore HasA 
  
YPK_4143 yibQ 
Putative periplasmic protein YibQ, distant homology with 
nucleoside diphosphatase and polysaccharide deacetylase 
  YPK_4171   hypothetical protein 
  YPK_4173   hypothetical protein 
  YPK_4190 glnL, ntrB Nitrogen regulation protein NtrB 
  YPK_4201 
 
Mobile element protein 
  
YPK_4237   
ABC-type amino acid transport/signal transduction systems, 
periplasmic component/domain ↑ 
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Table S3: Mapping statistic of RIP-Seq analysis with CsrA-3xFLAG. 
# 
sample 
name 
sample 
group 
read 
length total reads total mapped 
total uniquely 
mapped 
total unique 
plus strand 
total unique 
minus strand 
total mapped to 
genes 
mapped to no 
features 
1 wt_2_ctr wt_ctr 51 18,191,601 15,445,875 399,514 181,019 218,495 336,462 40,898 
2 wt_2_IP wt_IP 51 20,830,793 18,213,767 6,735,667 2,099,822 4,635,845 6,041,256 418,259 
3 wt_3_ctr wt_ctr 51 20,166,439 16,093,235 419,586 197,477 222,109 347,579 45,152 
4 wt_3_IP wt_IP 51 16,094,846 13,536,810 6,307,911 1,704,938 4,602,973 5,682,617 362,563 
5 wt_4_ctr wt_ctr 51 14,492,392 14,277,487 822,344 389,285 433,059 689,889 103,107 
6 wt_4_IP wt_IP 51 19,984,315 19,721,130 4,689,053 1,848,003 2,841,050 4,111,468 422,499 
7 wt_5_ctr wt_ctr 51 16,838,458 16,659,654 548,752 280,028 268,724 468,459 59,738 
8 wt_5_IP wt_IP 51 25,326,874 25,039,089 8,004,987 3,138,102 4,866,885 7,071,951 704,272 
10 wt_6_IP wt_IP 51 24,016,000 23,716,102 8,268,722 2,811,980 5,456,742 7,369,373 692,316 
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Table S4: Transcripts enriched by CsrA-3xFLAG in RIP-Seq analysis. Shown are transcripts which were at least 8 times (log2(fc) > 3) enriched in IP samples compared to control samples. 
RNAs which were predicted by the CSRA_TARGET_PREDICTER script are marked with an X mark. CsrA-dependently up or down regulated genes are highlighted with an up or down pointing 
arrow. Only genes which were at least 4 times enriched or depleted (-2 >= log2(fc) >= 2) in a comparative CsrA RNA-Seq of bacteria grown to stationary phase at 25 °C (diff. S25) or 37 °C (diff. 
S37) are shown [Nuss, unpublished data] For the complete dataset see dataset S4. 
Locus Gene name Gene description Class 
mean_ctr 
(rpk) 
mean_IP 
(rpk) log2(fc) 
pre- 
dicted diff. S25 diff. S37 
YPK_3372 csrA carbon storage regulator CDS 336.02 26,261.29 6.29 X ↓ ↓ 
YPK_3721   hypothetical protein CDS 3.44 92.78 4.75 X ↓ ↓ 
YPK_2338   hypothetical protein CDS 5.41 129.00 4.58 X ↓ ↓ 
YPK_1547 ulaB, sgaB 
PTS system lactose/cellobiose-specific 
transporter subunit IIB CDS 60.76 1,202.08 4.31 X ↓ ↓ 
YPK_3005 miaB 
(dimethylallyl)adenosine tRNA 
methylthiotransferase CDS 206.70 2,394.25 3.53 X ↑ ↑ 
YPK_3269 ggt gamma-glutamyltransferase CDS 21.26 180.05 3.08 X ↑ ↑ 
Ysr179 csrB CsrB transRNA 18,082.02 1,747,479.50 6.59 
 
↓ ↓ 
Ysr200 
  
transRNA 23.58 1,784.91 6.24 
 
↓ ↓ 
Ysr186 csrC CsrC transRNA 160,013.47 8,631,616.84 5.75 
 
↓ ↓ 
Ysr192 
  
transRNA 58.08 2,913.13 5.65 
 
↓ ↓ 
YPK_3035   hypothetical protein CDS 661.54 25,749.74 5.28 
 
↓ ↓ 
YPK_1765   hypothetical protein CDS 14.10 524.10 5.22 
 
↓ ↓ 
YPK_3101   hypothetical protein CDS 1.21 33.82 4.81 
 
↑ ↑ 
sR009/ryhB RyhB RyhB transRNA 7.14 200.00 4.81 
 
↓ ↓ 
YPK_2207   
Sel1 domain protein repeat-containing 
protein CDS 22.31 621.08 4.80 
 
↑ ↓ 
YPK_R0022 tRNA-Ser tRNA Ser tRNA 5.56 133.33 4.58 
 
↓ ↑ 
YPK_1440   hypothetical protein CDS 45.89 1,020.77 4.48 
 
↑ ↑ 
YPK_4108   hypothetical protein CDS 412.50 8,756.67 4.41 
 
↑ ↑ 
Ysr199 
  
transRNA 93.37 1,871.08 4.32 
 
↓ ↓ 
Ysr280   conserved hypothetical protein asRNA 2.45 49.02 4.32 
 
↓ ↓ 
YPK_R0068 tRNA-Ser tRNA Ser tRNA 90.91 1,581.82 4.12 
 
↑ ↑ 
YPK_0445 pcp-1 17 kDa surface antigen CDS 104.70 1,760.68 4.07 
 
↓ ↓ 
YPK_2405   hypothetical protein CDS 32.74 534.52 4.03 
 
↓ ↓ 
YPK_3421 ydjJ alcohol dehydrogenase CDS 16.58 269.00 4.02 
 
↑ ↓ 
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YPK_0962   hypothetical protein CDS 62.65 1,004.20 4.00 
 
↓ ↓ 
YPK_1766   hypothetical protein CDS 2.08 33.33 4.00 
 
↓ ↓ 
YPK_2471   hypothetical protein CDS 66.31 979.21 3.88 
 
↓ ↓ 
YPK_1607   
cation diffusion facilitator family 
transporter CDS 6.66 95.63 3.84 
 
↓ ↓ 
YPK_2224 ompC-1 porin CDS 14.08 191.51 3.77 
 
↓ ↓ 
Ysr252 yecS 
polar amino acid ABC transporter, inner 
membrane subunit asRNA 3.38 45.95 3.77 
 
↓ ↓ 
Ysr110/sR065 
  
transRNA 140.43 1,903.09 3.76 
 
↓ ↓ 
YPK_3418 dhaL dihydroxyacetone kinase subunit DhaL CDS 52.96 713.19 3.75 
 
↑ ↓ 
YPK_2655 mukB cell division protein MukB CDS 40.26 534.63 3.73 
 
↑ ↑ 
YPK_3020 rlmH, ybeA rRNA large subunit methyltransferase CDS 43.52 548.62 3.66 
 
↑ ↑ 
YPK_3748   hypothetical protein CDS 4.66 57.81 3.63 
 
↓ ↓ 
YPK_3158 ybbA-3 
putative ABC transporter ATP-binding 
protein YbbA CDS 5.82 71.91 3.63 
 
↑ ↑ 
YPK_3388 katG catalase/peroxidase HPI CDS 86.38 959.62 3.47 
 
↓ ↓ 
YPK_R0044 tRNA-Leu tRNA Leu tRNA 45.98 501.15 3.45 
 
↓ ↓ 
YPK_3028 tatE twin arginine translocase protein A CDS 464.15 5,046.51 3.44 
 
↑ ↑ 
YPK_0283 rplC 50S ribosomal protein L3 CDS 86.11 926.35 3.43 
 
↑ ↑ 
Ysr256   FAD linked oxidase domain protein asRNA 28.09 296.63 3.40 
 
↓ ↓ 
YPK_3389 cybC-2 cytochrome b562 CDS 59.24 616.15 3.38 
 
↓ ↓ 
YPK_2696 macA-2 macrolide transporter subunit MacA CDS 39.98 403.41 3.33 
 
↑ ↑ 
YPK_3656   hypothetical protein CDS 99.59 983.33 3.30 
 
↑ ↑ 
YPK_3760 ner-2, nlp-2, sfsB-2 putative transcriptional regulator Nlp CDS 781.70 7,659.42 3.29 
 
↓ ↓ 
YPK_2971 sdhD 
succinate dehydrogenase cytochrome 
b556 small membrane subunit CDS 191.09 1,805.75 3.24 
 
↑ ↑ 
YPK_2880   hypothetical protein CDS 56.16 526.99 3.23 
 
↑ ↑ 
YPK_2641 rlmL 
23S rRNA m(2)G2445 
methyltransferase CDS 37.95 350.12 3.21 
 
↑ ↑ 
YPK_2360 ailC 
virulence-related outer membrane 
protein CDS 2.72 25.00 3.20 
 
↓ ↓ 
Ysr275 yjgQ permease YjgP/YjgQ family protein asRNA 9.09 83.64 3.20 
 
↓ ↓ 
YPK_2763 fruK 1-phosphofructokinase CDS 8.79 77.74 3.15 
 
↑ ↑ 
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YPK_2611 fabZ-2 
beta-hydroxyacyl-(acyl-carrier-protein) 
dehydratase FabA/FabZ CDS 0.95 8.38 3.14 
 
↓ ↓ 
YPK_3015 leuS leucyl-tRNA synthetase CDS 85.75 747.66 3.12 
 
↑ ↑ 
YPK_0947   hypothetical protein CDS 3.27 27.45 3.07 
 
↑ ↑ 
YPK_3671 
 
hypothetical protein CDS 4.87 40.15 3.04 
 
↓ ↓ 
YPK_1703   hypothetical protein CDS 15.60 946.38 5.92 X 
 
↓ 
YPK_3055 ner-1, nlp-1 putative transcriptional regulator Nlp CDS 28.46 756.91 4.73 X 
 
↑ 
YPK_0759   hypothetical protein CDS 42.81 809.59 4.24 X 
 
↓ 
YPK_1006 gspF type II secretion system protein CDS 1.66 29.59 4.15 X 
 
↓ 
YPK_0919   hypothetical protein CDS 8.84 135.35 3.94 X 
 
↓ 
YPK_1961 rbsA-4 ABC transporter related CDS 5.52 82.39 3.90 X 
 
↓ 
YPK_2254 glsA-2 glutaminase CDS 27.53 382.94 3.80 X 
 
↓ 
YPK_1659   hypothetical protein CDS 1.02 13.82 3.77 X 
 
↑ 
YPK_0366 aceK 
bifunctional isocitrate dehydrogenase 
kinase/phosphatase protein CDS 8.70 71.89 3.05 X 
 
↑ 
YPK_0762 gntP gluconate transporter CDS 11.64 385.29 5.05 
  
↓ 
Ysr151/sR007 RNase P RNase P (M1 RNA) transRNA 11,411.61 370,964.64 5.02 
  
↑ 
YPK_R0027 tRNA-Pro tRNA Pro tRNA 16.23 516.88 4.99 
  
↓ 
YPK_3631   hypothetical protein CDS 23.15 671.60 4.86 
  
↑ 
YPK_2130 mdtI multidrug efflux system protein MdtI CDS 25.00 683.03 4.77 
  
↑ 
Ysr259   hypothetical protein asRNA 7.14 190.00 4.73 
  
↓ 
YPK_0949   hypothetical protein CDS 0.76 18.87 4.63 
  
↓ 
YPK_R0051 tRNA-Leu tRNA Leu tRNA 270.11 6,036.78 4.48 
  
↓ 
YPK_3628 nupC-2 nucleoside transporter CDS 22.60 478.30 4.40 
  
↑ 
YPK_0533 arcB 
aerobic respiration control sensor 
protein ArcB CDS 343.50 6,392.55 4.22 
  
↓ 
YPK_3733 secG preprotein translocase subunit SecG CDS 347.47 6,387.50 4.20 
  
↑ 
YPK_2135 hexR 
DNA-binding transcriptional regulator 
HexR CDS 91.61 1,640.18 4.16 
  
↓ 
Ysr194 
  
transRNA 203.39 3,440.68 4.08 
  
↑ 
Ysr201 
  
transRNA 7.14 120.00 4.07 
  
↓ 
YPK_3817 sugE small multidrug resistance protein CDS 3.79 63.64 4.07 
  
↑ 
YPK_R0049 tRNA-Gly tRNA Gly tRNA 36.18 597.37 4.05 
  
↑ 
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YPK_0968 cycB, ganO 
sugar(maltose) ABC transporter 
substrate-binding protein CDS 56.43 929.77 4.04 
  
↓ 
YPK_1573   hypothetical protein CDS 3.47 56.67 4.03 
  
↓ 
YPK_3422 rpiB-1 ribose-5-phosphate isomerase B CDS 43.86 692.54 3.98 
  
↓ 
YPK_R0042 tRNA-Arg tRNA Arg tRNA 386.36 5,997.40 3.96 
  
↓ 
YPK_0953   hypothetical protein CDS 151.52 2,313.13 3.93 
  
↑ 
YPK_2660 kdsB 
3-deoxy-manno-octulosonate 
cytidylyltransferase CDS 21.58 329.35 3.93 
  
↑ 
YPK_2413   short chain dehydrogenase CDS 2.18 33.09 3.93 
  
↓ 
YPK_1419   hypothetical protein CDS 3.79 56.57 3.90 
  
↓ 
YPK_3106   hypothetical protein CDS 127.64 1,891.98 3.89 
  
↑ 
YPK_1452   
4Fe-4S ferredoxin iron-sulfur binding 
domain protein CDS 35.96 532.98 3.89 
  
↓ 
YPK_2796 ndpA, yejK nucleoid-associated protein NdpA CDS 76.37 1,127.56 3.88 
  
↑ 
YPK_1978   hypothetical protein CDS 67.07 982.93 3.87 
  
↑ 
YPK_2496 dctP 
TRAP dicarboxylate transporter subunit 
DctP CDS 38.02 529.51 3.80 
  
↓ 
YPK_1197   hypothetical protein CDS 0.54 7.47 3.79 
  
↓ 
YPK_3419 dhaK glycerone kinase CDS 32.37 442.61 3.77 
  
↓ 
YPK_3345 yfiM hypothetical protein CDS 27.05 367.25 3.76 
  
↓ 
YPK_3362 trmD 
tRNA (guanine-N(1)-)-
methyltransferase CDS 336.71 4,564.91 3.76 
  
↑ 
YPK_3420   short chain dehydrogenase CDS 14.59 197.41 3.76 
  
↓ 
YPK_3029   hypothetical protein CDS 116.01 1,541.18 3.73 
  
↑ 
Ysr243 cvrA, nhaP2 sodium/hydrogen exchanger asRNA 83.33 1,106.25 3.73 
  
↓ 
YPK_0517   BolA family protein CDS 62.50 828.79 3.73 
  
↑ 
YPK_2168   ABC transporter-like protein CDS 6.09 77.72 3.67 
  
↓ 
YPK_2962 ybgT cyd operon protein YbgT CDS 62.96 802.96 3.67 
  
↑ 
YPK_4154 rpmB 50S ribosomal protein L28 CDS 1,314.35 16,322.36 3.63 
  
↑ 
YPK_2920 moaD molybdopterin synthase small subunit CDS 12.20 150.41 3.62 
  
↑ 
YPK_1175 yplA phospholipase A(1) CDS 8.31 99.27 3.58 
  
↓ 
YPK_3773 ytfK hypothetical protein CDS 4,419.01 52,341.78 3.57 
  
↑ 
YPK_4029 rffG, rfbB dTDP-glucose 4,6-dehydratase CDS 52.20 602.43 3.53 
  
↑ 
YPK_0465 mreB rod shape-determining protein MreB CDS 119.73 1,368.01 3.51 
  
↑ 
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YPK_1544 yfcE phosphodiesterase CDS 111.87 1,277.90 3.51 
  
↑ 
YPK_2775 ykgJ, yeiW hypothetical protein CDS 0.98 10.98 3.49 
  
↑ 
YPK_R0016 tRNA-Val tRNA Val tRNA 52.63 584.21 3.47 
  
↑ 
YPK_1558 aat, alaA, ybfQ aminotransferase class I and II CDS 28.60 315.88 3.47 
  
↑ 
YPK_3157 ybbP-3 hypothetical protein CDS 4.53 49.96 3.46 
  
↑ 
YPK_1355 arsC, yfgD arsenate reductase CDS 177.87 1,956.86 3.46 
  
↑ 
YPK_0153   hypothetical protein CDS 5.33 58.13 3.45 
  
↓ 
Ysr203 
  
transRNA 46.15 502.31 3.44 
  
↓ 
YPK_0210   hypothetical protein CDS 1.79 19.46 3.44 
  
↓ 
YPK_3723   hypothetical protein CDS 54.20 582.66 3.43 
  
↓ 
YPK_1457   hypothetical protein CDS 5.30 56.07 3.40 
  
↑ 
YPK_0306 rpsK 30S ribosomal protein S11 CDS 696.15 7,337.44 3.40 
  
↑ 
YPK_R0041 tRNA-Trp tRNA Trp tRNA 9.87 102.63 3.38 
  
↓ 
YPK_2915 betI transcriptional regulator BetI CDS 3.68 38.31 3.38 
  
↑ 
YPK_0993 agaS AgaS family sugar isomerase CDS 36.85 377.55 3.36 
  
↓ 
YPK_4214 asnA asparagine synthetase AsnA CDS 90.13 906.75 3.33 
  
↓ 
YPK_2759 psaA pH 6 antigen CDS 70.23 700.63 3.32 
  
↑ 
YPK_1767   hypothetical protein CDS 363.45 3,517.27 3.27 
  
↓ 
YPK_3069 rluF 23S rRNA pseudouridine synthase F CDS 55.27 529.21 3.26 
  
↑ 
YPK_0044   hypothetical protein CDS 59.31 562.16 3.24 
  
↓ 
YPK_0766   YD repeat protein CDS 1.87 17.41 3.21 
  
↑ 
YPK_0750 fhuA-1, yncD-1 
TonB-dependent O,M, iron siderophore 
receptor/transporter CDS 2.05 18.81 3.20 
  
↓ 
YPK_0832 yggS 
alanine racemase domain-containing 
protein CDS 27.18 244.06 3.17 
  
↑ 
YPK_2703 poxB pyruvate dehydrogenase CDS 119.48 1,072.82 3.17 
  
↑ 
YPK_3040 iolE 
xylose isomerase domain-containing 
protein CDS 11.29 101.17 3.16 
  
↑ 
YPK_2243 tehB tellurite resistance protein TehB CDS 31.53 280.63 3.15 
  
↓ 
YPK_0448 pcaC-1 carboxymuconolactone decarboxylase CDS 22.73 200.51 3.14 
  
↓ 
YPK_0011 ibpA heat shock protein IbpA CDS 358.70 3,127.05 3.12 
  
↓ 
YPK_0003 recF recombination protein F CDS 36.60 317.86 3.12 
  
↑ 
YPK_3654 lsrF aldolase CDS 119.58 1,002.74 3.07 
  
↑ 
YPK_1733 lrp-1 AsnC family transcriptional regulator CDS 116.11 966.67 3.06 
  
↓ 
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YPK_2699 ybjD hypothetical protein CDS 15.44 128.18 3.05 
  
↑ 
YPK_3021 pbpA, mrdA penicillin-binding protein 2 CDS 22.28 182.07 3.03 
  
↑ 
YPK_0797   hypothetical protein CDS 16.03 130.77 3.03 
  
↑ 
YPK_2862 yehW-1, yehY-1, opuBD-1 
binding-protein-dependent transport 
systems inner membrane component CDS 7.47 60.45 3.02 
  
↑ 
YPK_3677 lptG, yjgQ 
lipopolysaccharide export system 
permease protein CDS 42.71 341.88 3.00 
  
↑ 
YPK_2746   HAD family hydrolase CDS 33.56 594.87 4.15 X ↑ 
 YPK_2628 tfoX competence-specific genes regulator CDS 47.96 830.50 4.11 X ↑ 
 YPK_1186   hypothetical protein CDS 2.63 31.81 3.60 X ↑ 
 YPK_4237   extracellular solute-binding protein CDS 13.74 156.49 3.51 X ↑ 
 YPK_2766 yphD-7, ytfT-7, yjfF-7 monosaccharide-transporting ATPase CDS 1.00 11.21 3.49 X ↑ 
 YPK_1876 rovA, slyA MarR family transcriptional regulator CDS 361.69 3,572.22 3.30 X ↓ 
 
YPK_0495 treB 
PTS system trehalose(maltose)-specific 
transporter subunit IIBC CDS 618.47 5,944.49 3.26 X ↑ 
 YPK_2448 yoaH hypothetical protein CDS 48.45 462.79 3.26 X ↓ 
 YPK_3435 cysN sulfate adenylyltransferase subunit 1 CDS 6.42 61.00 3.25 X ↑ 
 
YPK_0393 impJ-1, vasE-1 
type VI secretion protein, VC_A0114 
family CDS 2.60 23.76 3.19 X ↑ 
 
YPK_2662 cspB-2 
cold-shock DNA-binding domain-
containing protein CDS 534.52 4,355.24 3.03 X ↑ 
 YPK_2522   hypothetical protein CDS 638.02 53,193.75 6.38 
 
↓ 
 YPK_R0048 tRNA-Gly tRNA Gly tRNA 72.37 3,968.42 5.78 
 
↓ 
 YPK_4187 yihX phosphatase CDS 195.01 7,981.05 5.35 
 
↑ 
 YPK_1911   hypothetical protein CDS 3.97 142.86 5.17 
 
↓ 
 YPK_1496 ccmA heme exporter protein CcmA CDS 37.29 1,203.35 5.01 
 
↓ 
 YPK_0900   small terminase subunit CDS 1.43 44.64 4.96 
 
↑ 
 Ysr16 
  
transRNA 27.60 857.14 4.96 
 
↓ 
 YPK_3061   hypothetical protein CDS 4.96 146.83 4.89 
 
↑ 
 YPK_1754 
 
pseudogene CDS 4.46 127.22 4.83 
 
↓ 
 YPK_3109   DinI family protein CDS 448.17 12,688.62 4.82 
 
↑ 
 YPK_2206   hypothetical protein CDS 26.73 745.91 4.80 
 
↓ 
 YPK_2023 yciH translation initiation factor SUI1 CDS 948.01 25,051.99 4.72 
 
↓ 
 YPK_0384   hypothetical protein CDS 1.14 30.14 4.72 
 
↑ 
 
 Appendix 
XX 
Ysr223 
  
transRNA 377.91 9,960.47 4.72 
 
↓ 
 YPK_2744   2OG-Fe(II) oxygenase CDS 0.47 11.80 4.66 
 
↑ 
 YPK_2299   hypothetical protein CDS 13.44 337.63 4.65 
 
↑ 
 
YPK_2458 hpaD 
3,4-dihydroxyphenylacetate 2,3-
dioxygenase CDS 2.62 62.94 4.58 
 
↑ 
 
YPK_1388 napB 
citrate reductase cytochrome c-type 
subunit CDS 5.34 126.50 4.57 
 
↑ 
 YPK_R0083 tRNA-Phe tRNA Phe tRNA 9.87 226.32 4.52 
 
↓ 
 
YPK_3684 argI 
ornithine carbamoyltransferase subunit 
I CDS 4.96 112.70 4.51 
 
↑ 
 
YPK_3297   
glycerophosphoryl diester 
phosphodiesterase CDS 22.94 480.17 4.39 
 
↑ 
 YPK_3031 cspE cold shock protein CspE CDS 1,838.10 35,702.86 4.28 
 
↓ 
 YPK_4107   hypothetical protein CDS 10.68 203.76 4.25 
 
↑ 
 YPK_3271 malZ-2 maltodextrin glucosidase CDS 19.54 371.15 4.25 
 
↑ 
 
YPK_0092 dppF 
oligopeptide/dipeptide ABC 
transporter, ATPase subunit CDS 36.21 684.49 4.24 
 
↓ 
 YPK_1623   hypothetical protein CDS 11.90 221.59 4.22 
 
↓ 
 Ysr211/ryeB RyeB RyeB transRNA 13.51 250.00 4.21 
 
↓ 
 YPK_1130   hypothetical protein CDS 21.83 396.83 4.18 
 
↓ 
 
YPK_3192 ddhD, rfbI, ascD 
CDP-6-deoxy-delta-3,4-glucoseen 
reductase CDS 27.78 484.44 4.12 
 
↓ 
 YPK_2895 
 
hypothetical protein CDS 2.98 51.19 4.10 
 
↑ 
 
Ysr287 ypkA 
putative targeted effector protein 
kinase asRNA 13.33 229.33 4.10 
 
↓ 
 YPK_2814   Mu P family protein CDS 2.13 36.55 4.10 
 
↑ 
 YPK_2434   hypothetical protein CDS 26.76 455.05 4.09 
 
↓ 
 YPK_3894 metC-2 cystathionine beta-lyase CDS 30.25 508.29 4.07 
 
↑ 
 YPK_0793   abortive infection protein CDS 0.38 6.45 4.07 
 
↓ 
 YPK_0583 yapF outer membrane autotransporter CDS 11.59 194.40 4.07 
 
↓ 
 YPK_2425 flgB-2 flagellar basal body rod protein FlgB CDS 4.83 80.19 4.05 
 
↓ 
 YPK_3071   hypothetical protein CDS 20.24 335.22 4.05 
 
↑ 
 YPK_0392 vasD-1, lip-1 putative lipoprotein CDS 10.07 164.84 4.03 
 
↑ 
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Ysr279   
lysine 2,3-aminomutase, YodO family 
protein asRNA 28.48 463.29 4.02 
 
↓ 
 YPK_2421 flgF flagellar basal body rod protein FlgF CDS 1.98 32.01 4.01 
 
↓ 
 Ysr215 
  
transRNA 10.42 166.67 4.00 
 
↓ 
 YPK_2640 uup ABC transporter ATPase CDS 50.16 783.39 3.97 
 
↑ 
 YPK_2382 fliD flagellar capping protein CDS 2.86 44.11 3.95 
 
↓ 
 YPK_3123   hypothetical protein CDS 4.35 66.09 3.93 
 
↑ 
 Ysr205 
  
transRNA 14.39 212.95 3.89 
 
↓ 
 YPK_3122   Mu tail sheath family protein CDS 5.23 76.85 3.88 
 
↑ 
 YPK_1761 yadE YadA domain-containing protein CDS 15.11 219.61 3.86 
 
↑ 
 YPK_2635   hypothetical protein CDS 31.75 452.91 3.83 
 
↑ 
 
YPK_2205   
Sel1 domain protein repeat-containing 
protein CDS 67.95 964.20 3.83 
 
↑ 
 YPK_2767 yphE-4, ytfR-4 ABC transporter-like protein CDS 5.56 78.73 3.82 
 
↑ 
 Ysr282 murI glutamate racemase asRNA 27.40 383.56 3.81 
 
↓ 
 YPK_3167 ybaK hypothetical protein CDS 40.10 559.58 3.80 
 
↑ 
 YPK_2441   hypothetical protein CDS 690.79 9,621.05 3.80 
 
↓ 
 YPK_3326 glnQ-2 ABC transporter-like protein CDS 110.78 1,516.47 3.77 
 
↓ 
 YPK_2816   hypothetical protein CDS 6.69 91.57 3.77 
 
↑ 
 YPK_1646 csy-1 CRISPR-associated Csy1 family protein CDS 18.93 258.50 3.77 
 
↑ 
 
YPK_4238   
polar amino acid ABC transporter inner 
membrane subunit CDS 4.07 55.28 3.77 
 
↑ 
 YPK_1616 dmlA, ttuC, yeaU tartrate dehydrogenase CDS 4.14 55.99 3.76 
 
↓ 
 YPK_1375 afuA, fbpA extracellular solute-binding protein CDS 5.51 73.09 3.73 
 
↑ 
 YPK_0494 treC trehalose-6-phosphate hydrolase CDS 470.37 6,192.66 3.72 
 
↑ 
 YPK_1747 motA-2 flagellar motor protein MotA CDS 50.39 653.38 3.70 
 
↓ 
 YPK_2953 nadA quinolinate synthetase CDS 72.50 932.96 3.69 
 
↑ 
 YPK_1647 csy-2 CRISPR-associated Csy2 family protein CDS 7.36 94.64 3.68 
 
↑ 
 YPK_2483   hypothetical protein CDS 2,019.74 25,943.86 3.68 
 
↓ 
 YPK_2854 yfaZ hypothetical protein CDS 105.43 1,349.17 3.68 
 
↑ 
 pYV0091   transposase CDS 21.87 278.01 3.67 
 
↑ 
 YPK_1577   hypothetical protein CDS 9.93 126.01 3.67 
 
↑ 
 Ysr1 
  
transRNA 110.89 1,401.61 3.66 
 
↓ 
 YPK_2569 yjiJ hypothetical protein CDS 7.81 98.61 3.66 
 
↓ 
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YPK_1645 cas-3 
CRISPR-associated helicase Cas3 family 
protein CDS 10.64 134.06 3.65 
 
↑ 
 YPK_0631   hypothetical protein CDS 6,893.20 86,746.28 3.65 
 
↓ 
 YPK_4088 argB acetylglutamate kinase CDS 31.85 399.74 3.65 
 
↑ 
 YPK_3840 rhaT rhamnose-proton symporter CDS 14.49 179.90 3.63 
 
↓ 
 YPK_2863 yehX, opuA ABC transporter-like protein CDS 25.56 316.93 3.63 
 
↑ 
 
YPK_2670 aroA 
3-phosphoshikimate 1-
carboxyvinyltransferase CDS 222.61 2,714.84 3.61 
 
↑ 
 YPK_1121   hypothetical protein CDS 4.46 54.17 3.60 
 
↑ 
 YPK_0665 sufI, ftsP repressor protein for FtsI CDS 34.91 416.56 3.58 
 
↑ 
 YPK_2671 serC phosphoserine aminotransferase CDS 334.71 3,962.80 3.57 
 
↑ 
 YPK_2430 flhE flagellar FlhE family protein CDS 1.77 20.80 3.55 
 
↓ 
 YPK_4109 raxA, cvaA secretion protein HlyD family protein CDS 1.35 15.78 3.54 
 
↑ 
 YPK_1762   hypothetical protein CDS 4.98 57.65 3.53 
 
↑ 
 Ysr262   hypothetical protein YPK_3103 asRNA 173.33 2,000.00 3.53 
 
↑ 
 YPK_0117 rsmJ putative methyltransferase CDS 3.24 37.09 3.52 
 
↑ 
 YPK_3549   hypothetical protein CDS 90.40 1,027.12 3.51 
 
↑ 
 YPK_1007 gspG general secretion pathway protein G CDS 4.00 45.21 3.50 
 
↓ 
 YPK_3371 yqaB fructose-1-phosphatase CDS 91.71 1,029.28 3.49 
 
↑ 
 
YPK_0513 mlaE 
putative phospholipid ABC transporter 
permease protein MlaE CDS 54.92 608.68 3.47 
 
↑ 
 YPK_0397   hypothetical protein CDS 3.28 36.10 3.46 
 
↑ 
 YPK_3788 aidB isovaleryl CoA dehydrogenase CDS 270.99 2,982.36 3.46 
 
↓ 
 YPK_1951   hypothetical protein CDS 8.18 89.81 3.46 
 
↑ 
 YPK_1729   hypothetical protein CDS 169.35 1,821.51 3.43 
 
↓ 
 YPK_1087   hypothetical protein CDS 1,334.58 14,298.51 3.42 
 
↓ 
 YPK_R0078 tRNA-Ala tRNA Ala tRNA 23.03 242.11 3.39 
 
↓ 
 YPK_2815   DNA circulation family protein CDS 2.13 22.17 3.38 
 
↑ 
 
YPK_3079   
beta-lactamase fold Zn-dependent 
hydrolase CDS 4.98 51.74 3.38 
 
↑ 
 YPK_1001 cynT, can carbonic anhydrase CDS 1,022.49 10,620.90 3.38 
 
↓ 
 
YPK_0516 mlaB 
putative phospholipid ABC transporter-
binding protein MlaB CDS 162.54 1,685.15 3.37 
 
↑ 
 YPK_2669 cmk cytidylate kinase CDS 209.96 2,147.19 3.35 
 
↑ 
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YPK_0390 impH-1, vasB-1 
type VI secretion protein, VC_A0111 
family CDS 2.80 28.38 3.34 
 
↑ 
 YPK_1763   hypothetical protein CDS 7.18 71.26 3.31 
 
↑ 
 YPK_3072 bglB glycoside hydrolase family 3 CDS 21.31 207.56 3.28 
 
↑ 
 YPK_2505 argG argininosuccinate synthase CDS 15.90 153.95 3.28 
 
↑ 
 
YPK_2764 fruB 
bifunctional PTS system fructose-
specific transporter subunit IIA/HPr 
protein CDS 6.17 59.61 3.27 
 
↑ 
 
YPK_1753 cheD, tsr 
methyl-accepting chemotaxis sensory 
transducer CDS 3.14 30.11 3.26 
 
↓ 
 YPK_1741 dsrB hypothetical protein CDS 145.83 1,398.96 3.26 
 
↓ 
 YPK_2752 lysP lysine transporter CDS 15.87 152.25 3.26 
 
↑ 
 
YPK_0867 gcvT 
glycine cleavage system 
aminomethyltransferase T CDS 358.83 3,423.50 3.25 
 
↑ 
 YPK_1712 pepT-2 peptidase T CDS 338.19 3,223.46 3.25 
 
↓ 
 YPK_2811   baseplate J family protein CDS 1.10 10.38 3.24 
 
↑ 
 Ysr114 trxB thioredoxin reductase asRNA 18.82 176.10 3.23 
 
↑ 
 YPK_2381 fliC flagellin CDS 2.03 18.92 3.22 
 
↓ 
 YPK_3142   hypothetical protein CDS 77.59 721.84 3.22 
 
↑ 
 
YPK_0387 impC-1 
type VI secretion protein, 
EvpB/VC_A0108 family CDS 10.29 95.55 3.21 
 
↑ 
 
YPK_0695 papC 
fimbrial biogenesis outer membrane 
usher protein CDS 50.28 463.93 3.21 
 
↓ 
 YPK_0986   glycosyl hydrolase family protein CDS 15.58 143.72 3.21 
 
↑ 
 YPK_2812   GP46 family protein CDS 5.48 50.44 3.20 
 
↑ 
 YPK_3865   outer membrane autotransporter CDS 1.44 13.28 3.20 
 
↓ 
 YPK_3551 
 
hypothetical protein CDS 8.22 75.48 3.20 
 
↑ 
 
YPK_3144 ybjD 
SMC (structural maintenance of 
chromosomes) family protein CDS 32.33 293.02 3.18 
 
↑ 
 YPK_3437 cysG-2 uroporphyrin-III C-methyltransferase CDS 6.17 55.53 3.17 
 
↑ 
 
YPK_0388   
type VI secretion system lysozyme-
related protein CDS 2.83 25.40 3.16 
 
↑ 
 YPK_0395 vasG-1, clpV-1 type VI secretion ATPase, ClpV1 family CDS 2.98 26.65 3.16 
 
↑ 
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YPK_0515 mlaC 
putative phospholipid-binding protein 
MlaC CDS 217.55 1,943.27 3.16 
 
↑ 
 
YPK_2768 yphF-4, ytfQ-4 
sugar ABC transporter substrate-
binding protein CDS 9.64 85.03 3.14 
 
↑ 
 YPK_2638 pqiB paraquat-inducible protein B CDS 37.36 325.95 3.13 
 
↑ 
 YPK_3882   hypothetical protein CDS 23.44 201.67 3.11 
 
↑ 
 YPK_4210 rbsD D-ribose pyranase CDS 259.52 2,228.57 3.10 
 
↓ 
 Ysr229 
  
transRNA 16.90 143.77 3.09 
 
↓ 
 
YPK_0398 vasJ-1 
type VI secretion-associated protein, 
VC_A0119 family CDS 1.80 15.12 3.07 
 
↑ 
 YPK_0281 bfr bacterioferritin CDS 168.25 1,404.64 3.06 
 
↓ 
 YPK_2197   hypothetical protein CDS 125.55 1,030.46 3.04 
 
↑ 
 
YPK_2470 atoS1 
PAS/PAC sensor-containing diguanylate 
cyclase CDS 6.96 56.77 3.03 
 
↑ 
 YPK_0697   fimbrial protein CDS 95.56 775.72 3.02 
 
↓ 
 YPK_0166   hypothetical protein CDS 176.85 1,420.00 3.01 
 
↓ 
 
YPK_2932 bioA 
adenosylmethionine-8-amino-7-
oxononanoate aminotransferase CDS 1.95 15.61 3.00 
 
↓ 
 
YPK_0220 hofM 
DNA catabolic putative pilus assembly 
protein CDS 0.28 14.05 5.66 X 
  YPK_3260   hypothetical protein CDS 1.13 53.60 5.57 X 
  YPK_2419 flgH flagellar basal body L-ring protein CDS 1.45 47.25 5.03 X 
  YPK_1629   hypothetical protein CDS 14.88 462.38 4.96 X 
  YPK_1111 hpxB urate catabolism protein CDS 25.24 772.03 4.94 X 
  
YPK_3759   
MuA-transposase/repressor protein CI 
DNA-binding CDS 58.91 1,696.55 4.85 X 
  YPK_0933   hypothetical protein CDS 0.76 19.39 4.68 X 
  YPK_1451   hypothetical protein CDS 7.61 182.65 4.58 X 
  YPK_1344 ppk polyphosphate kinase CDS 68.56 1,604.55 4.55 X 
  YPK_0202   hypothetical protein CDS 22.39 515.92 4.53 X 
  YPK_0984 ydeN, yidJ sulfatase CDS 10.11 219.03 4.44 X 
  YPK_2131 mdtJ small multidrug resistance protein CDS 35.47 749.55 4.40 X 
  YPK_0538 yraN putative endonuclease CDS 117.23 2,222.03 4.24 X 
  YPK_2433   hypothetical protein CDS 16.67 298.06 4.16 X 
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YPK_1901   hypothetical protein CDS 79.98 1,409.84 4.14 X 
  YPK_2409 yphE-2; ytfR-2 ABC transporter-like protein CDS 6.02 105.58 4.13 X 
  YPK_0854 mscS mechanosensitive ion channel MscS CDS 52.59 920.46 4.13 X 
  YPK_1752   putative lipoprotein CDS 39.17 655.56 4.06 X 
  YPK_3143   hypothetical protein CDS 24.43 395.18 4.02 X 
  YPK_3151 ybcJ hypothetical protein CDS 602.11 9,683.57 4.01 X 
  
YPK_0534 elbB 
isoprenoid biosynthesis protein with 
amidotransferase-like domain CDS 718.27 11,504.89 4.00 X 
  YPK_4171   hypothetical protein CDS 148.52 2,293.55 3.95 X 
  YPK_1123   hypothetical protein CDS 46.46 697.94 3.91 X 
  
YPK_1532 folC 
bifunctional folylpolyglutamate 
synthase/dihydrofolate synthase CDS 49.81 714.94 3.84 X 
  
YPK_4068 yphF-6, ytfQ-6 
periplasmic binding protein/LacI 
transcriptional regulator CDS 32.13 447.44 3.80 X 
  YPK_1725   hypothetical protein CDS 38.31 532.57 3.80 X 
  YPK_1045 argA N-acetylglutamate synthase CDS 30.17 417.35 3.79 X 
  YPK_3168   hypothetical protein CDS 43.60 596.90 3.77 X 
  YPK_1339   hypothetical protein CDS 1.77 24.11 3.77 X 
  
YPK_0752   
putative siderophore biosysnthesis 
protein CDS 9.66 126.84 3.71 X 
  
YPK_2949 aroG 
phospho-2-dehydro-3-deoxyheptonate 
aldolase CDS 256.65 3,249.19 3.66 X 
  
YPK_0259 tauB-1 
taurine transporter ATP-binding 
subunit CDS 2.60 32.55 3.64 X 
  YPK_3428 surE stationary phase survival protein SurE CDS 78.76 971.76 3.63 X 
  YPK_2420 flgG flagellar basal body rod protein FlgG CDS 3.19 38.83 3.60 X 
  YPK_2593   hypothetical protein CDS 1.28 15.07 3.56 X 
  YPK_0201   hypothetical protein CDS 162.10 1,909.13 3.56 X 
  YPK_1362 dapA dihydrodipicolinate synthase CDS 147.50 1,718.00 3.54 X 
  YPK_1426 crr PTS system glucose-specific transporter CDS 883.33 10,286.67 3.54 X 
  YPK_0174 pckA phosphoenolpyruvate carboxykinase CDS 4,312.19 49,625.06 3.52 X 
  YPK_1056 ygdH hypothetical protein CDS 176.74 1,990.62 3.49 X 
  YPK_0013 yidE YidE/YbjL duplication CDS 177.37 1,988.79 3.49 X 
  YPK_0008 ilvA, tdcB threonine dehydratase CDS 51.92 579.65 3.48 X 
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YPK_3796 hflK FtsH protease regulator HflK CDS 65.32 713.70 3.45 X 
  
YPK_1773   
spore coat U domain-containing 
protein CDS 0.51 5.45 3.43 X 
  YPK_2195   cupin CDS 6.37 67.09 3.40 X 
  YPK_3146   hypothetical protein CDS 74.24 770.91 3.38 X 
  
YPK_2374 yecC 
putative amino-acid ABC transporter 
ATP-binding protein YecC CDS 64.30 666.40 3.37 X 
  
YPK_3564 impC-4 
type VI secretion protein, 
EvpB/VC_A0108 family CDS 15.54 159.26 3.36 X 
  
YPK_1472 impH-2, vasB-2 
type VI secretion protein, VC_A0111 
family CDS 0.73 7.41 3.34 X 
  YPK_2905   LysR family transcriptional regulator CDS 7.68 77.19 3.33 X 
  YPK_0046   hypothetical protein CDS 4.03 39.78 3.30 X 
  
YPK_0487   
guanine-specific ribonuclease N1 and 
T1 CDS 260.55 2,567.93 3.30 X 
  YPK_0108   hypothetical protein CDS 1.44 14.02 3.29 X 
  YPK_3310   hypothetical protein CDS 16.40 159.84 3.28 X 
  YPK_1299   hypothetical protein CDS 25.56 248.89 3.28 X 
  YPK_3808 orn oligoribonuclease CDS 81.04 788.64 3.28 X 
  YPK_3078   hypothetical protein CDS 14.71 142.48 3.28 X 
  
YPK_0043 selB 
selenocysteinyl-tRNA-specific 
translation factor CDS 51.67 500.41 3.28 X 
  YPK_3770 ytfM surface antigen (D15) CDS 56.42 545.88 3.27 X 
  
YPK_0512 mlaF 
putative phospholipid import ATP-
binding protein MlaF CDS 105.62 1,020.02 3.27 X 
  
YPK_0161 glgP-2 
glycogen/starch/alpha-glucan 
phosphorylase CDS 17.87 169.58 3.25 X 
  YPK_0321 aroE-1 shikimate 5-dehydrogenase CDS 334.55 3,071.29 3.20 X 
  
YPK_3301 nqrE 
Na(+)-translocating NADH-quinone 
reductase subunit E CDS 52.35 458.29 3.13 X 
  YPK_2154 yecM hypothetical protein CDS 14.76 122.92 3.06 X 
  YPK_3270   short chain dehydrogenase CDS 171.07 1,404.70 3.04 X 
  
YPK_2545 ysuH, alcB 
putative siderophore biosynthetic 
enzyme CDS 2.16 17.62 3.03 X 
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YPK_1782 proQ 
putative solute/DNA competence 
effector CDS 293.07 2,390.48 3.03 X 
  YPK_2674 ansB L-asparaginase II CDS 416.67 3,392.68 3.03 X 
  YPK_2064   dsDNA-mimic protein CDS 167.37 1,362.15 3.02 X 
  YPK_4062 comM, yifB Mg chelatase subunit ChlI CDS 8.69 70.73 3.02 X 
  YPK_2704   hypothetical protein CDS 2.31 18.52 3.00 X 
  YPK_2678   glycosyl transferase family protein CDS 56.67 452.15 3.00 X 
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Figure S5: Flowchart of the CsrA target prediction algorithm CSRA-TARGET_PREDICTER of E. coli K12. 4147 
upstream regions of chromosomally encoded ORFs were analyzed for CsrA primary sites (ps; A(N)GGA) and secondary 
sites (ss; AGAGA, CTGGA, CGGGA, TGGGA). The number of analyzed and processed sequences are depicted next to flow 
line arrows. 
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Table S6: CsrA targets in E. coli MG1655 as predicted by the CSRA_TARGET_PREDICTER script. Shown are genes 
which were predicted by the CSRA_TARGET_PREDICTER script. In silico predicted CsrA by Kulkarni et al., 2014 are 
highlighted with an X mark. 
Locus Gene name Gene description 
predicted 
in Kulkarni 
et al. 2014 
b0024 yaaY hypothetical protein X 
b0037 caiC Crotonobetaine - CoA ligase 
 b0058 rluA Ribosomal large subunit pseudouridine synthase A X 
b0069 sgrR 
SgrR, sugar-phosphate stress, transcriptional activator of SgrS small 
RNA 
 b0076 leuO LysR family transcriptional activator LeuO X 
b0082 mraW 16S rRNA (cytosine(1402)-N(4))-methyltransferase X 
b0084 ftsI Cell division protein FtsI [Peptidoglycan synthetase] 
 b0129 yadI Putative PTS system IIA component yadI 
 
b0176 rseP 
Intramembrane protease RasP/YluC, implicated in cell division based on 
FtsL cleavage 
 b0186 ldcC Lysine decarboxylase 2, constitutive X 
b0187 yaeR Hypothetical protein YaeR with similarity to glyoxylase family 
 b0220 ivy Inhibitor of vertebrate lysozyme X 
b0225 yafQ mRNA interferase YafQ 
 b0233 yafO Toxin YafO X 
b0276 yagJ Putative uncharacterized protein YagJ X 
b0291 yagX CFA/I fimbrial subunit C usher protein 
 
b0301 ykgB 
Inner membrane protein RclC associated with response to reactive 
chlorine species 
 
b0305 ykgD 
Reactive-chlorine-species-specific transcriptional activator RclR, AraC 
family 
 
b0308 ykgG Predicted L-lactate dehydrogenase, hypothetical protein subunit YkgG X 
b0312 betB Betaine aldehyde dehydrogenase 
 b0325 yahK Cinnamyl alcohol dehydrogenase/reductase 
 b0328 yahN Uncharacterized membrane protein YahN 
 b0375 yaiV Uncharacterized protein YaiV 
 b0378 yaiW Uncharacterized outer membrane protein YaiW 
 b0412 yajI Hypothetical lipoprotein yajI X 
b0414 ribD Diaminohydroxyphosphoribosylaminopyrimidine deaminase 
 b0419 yajO Uncharacterized oxidoreductase, YajO family 
 b0425 panE 2-dehydropantoate 2-reductase X 
b0426 yajQ hypothetical protein YajQ 
 b0431 cyoB Cytochrome O ubiquinol oxidase subunit I X 
b0435 bolA Cell division protein BolA X 
b0485 ybaS Glutaminase 
 b0490 ybbL YbbL ABC transporter ATP-binding protein X 
b0493 ybbO Putative NAD(P)-dependent oxidoreductase EC-YbbO 
 b0498 ybbC Uncharacterized protein YbbC 
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b0505 allA Ureidoglycolate lyase 
 b0509 glxR 2-hydroxy-3-oxopropionate reductase 
 b0530 sfmA Uncharacterized fimbrial-like protein SfmA X 
b0592 fepB Ferric enterobactin-binding periplasmic protein FepB 
 b0598 cstA Carbon starvation protein A X 
b0601 ybdM Co-activator of prophage gene expression IbrB 
 b0607 uspG Universal stress protein G 
 b0645 ybeR Uncharacterized protein YbeR 
 b0648 ybeU Uncharacterized protein YbeU 
 b0662 ubiF 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase 
 b0704 ybfC Uncharacterized protein YbfC 
 b0706 ybfD H repeat-associated protein, YhhI family X 
b0712 ybgK Allophanate hydrolase 2 subunit 2  
 b0717 ybgP Uncharacterized fimbrial chaperone YbgP 
 b0722 sdhD Succinate dehydrogenase hydrophobic membrane anchor protein 
 b0758 galT Galactose-1-phosphate uridylyltransferase X 
b0770 ybhI Inner membrane protein YbhI X 
b0787 ybhM Uncharacterized protein YbhM 
 
b0794 ybhF ABC transporter multidrug efflux pump, fused ATP-binding domains 
 b0796 ybiH Transcriptional regulator YbiH, TetR family 
 b0800 ybiB Anthranilate phosphoribosyltransferase like 
 b0827 moeA Molybdopterin molybdenumtransferase  
 b0886 cydC Transport ATP-binding protein CydC 
 b0890 ftsK DNA translocase FtsK 
 b0891 lolA Outer membrane lipoprotein carrier protein LolA X 
b0900 ycaN LysR family transcriptional regulator YcaN 
 b0917 ycaR  Protein YcaR in KDO2-Lipid A biosynthesis cluster 
 b0949 uup ABC transporter ATP-binding protein uup 
 b0963 mgsA Methylglyoxal synthase X 
b0972 hyaA Uptake hydrogenase small subunit precursor X 
b0976 hyaE Hydrogenase maturation factor HoxO/HyaE X 
b0978 appC Cytochrome d ubiquinol oxidase subunit I 
 b0989 cspH Cold shock protein CspH 
 b1004 wrbA NAD(P)H dehydrogenase (quinone) 
 b1024 pgaA Biofilm PGA outer membrane secretin PgaA X 
b1078 flgG Flagellar basal-body rod protein FlgG 
 b1108 ycfP YcfP protein: probably an esterase that is part of a salvage cluster 
 b1122 ymfA Inner membrane protein YmfA X 
b1127 pepT Tripeptide aminopeptidase 
 b1136 icd Isocitrate dehydrogenase [NADP] 
 b1178 ycgK Inhibitor of g-type lysozyme X 
b1212 prmC Peptide chain release factor N(5)-glutamine methyltransferase X 
b1247 oppF Oligopeptide transport ATP-binding protein OppF 
 b1283 osmB Osmotically inducible lipoprotein B precursor 
 b1287 yciW Uncharacterized protein YciW X 
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b1299 puuR Putrescine utilization regulator X 
b1319 ompG Outer membrane protein G precursor X 
b1342 ydaN Zinc transport protein ZntB 
 b1394 paaG 1,2-epoxyphenylacetyl-CoA isomerase 
 b1407 ydbD Uncharacterized protein YdbD X 
b1436 yncJ Uncharacterized protein YncJ 
 b1453 ansP L-asparagine permease 
 b1460 ydcC H repeat-associated protein, YhhI family 
 b1477 yddM Antitoxin HigA X 
b1493 gadB Glutamate decarboxylase X 
b1511 lsrK Autoinducer 2 (AI-2) kinase LsrK X 
b1535 ydeH Diguanylate cyclase YdeH X 
b1558 cspF Cold shock protein CspF X 
b1561 rem Uncharacterized protein Rem X 
b1589 ynfG Anaerobic dimethyl sulfoxide reductase chain B X 
b1606 folM FolM Alternative dihydrofolate reductase 1 X 
b1639 mliC Membrane-bound lysozyme inhibitor of c-type lysozyme 
 b1641 slyB Outer membrane lipoprotein pcp precursor X 
b1646 sodC Superoxide dismutase [Cu-Zn] precursor 
 b1680 sufS Cysteine desulfurase 
 b1694 ydiF Acetyl-CoA:acetoacetyl-CoA transferase, alpha subunit  
 b1695 ydiO Acyl-CoA dehydrogenase YdiO 
 b1707 ydiV Putative anti-FlhC(2)FlhD(4) factor YdiV 
 b1736 chbA PTS system, N,N'-diacetylchitobiose-specific IIA component 
 b1744 astE Succinylglutamate desuccinylase X 
b1764 selD Selenide,water dikinase 
 b1797 yeaR Uncharacterized protein YeaR 
 b1800 yeaU D-malate dehydrogenase [decarboxylating] 
 b1809 yoaB RidA/YER057c/UK114 superfamily 
 b1816 yoaE UPF0053 inner membrane protein YoaE 
 b1818 manY PTS system, mannose-specific IIC component 
 b1821 yebN Probable manganese efflux pump MntP 
 b1831 proQ ProQ: influences osmotic activation of compatible solute ProP 
 b1842 holE DNA polymerase III theta subunit 
 b1856 yebA Murein DD-endopeptidase MepM 
 b1872 torZ Trimethylamine-N-oxide reductase 
 b1943 fliK Flagellar hook-length control protein FliK X 
b1946 fliN Flagellar motor switch protein FliN 
 b1981 shiA Shikimate transporter 
 b1993 cobU Adenosylcobinamide kinase 
 b2001 yeeR Inner membrane protein YeeR 
 b2002 yeeS UPF0758 protein YeeS 
 b2026 hisI Phosphoribosyl-AMP cyclohydrolase  
 b2035 rfc O-antigen polymerase 
 b2083 yegZ Gene D protein 
 b2101 yegW Uncharacterized HTH-type transcriptional regulator YegW 
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b2104 thiM Hydroxyethylthiazole kinase X 
b2112 yehE Uncharacterized protein YehE 
 b2118 yehI Uncharacterized protein YehI 
 b2125 yehT Transcriptional regulatory protein YehT X 
b2162 rihB Pyrimidine-specific ribonucleoside hydrolase RihB X 
b2175 spr Murein DD-endopeptidase MepS 
 b2196 ccmF Cytochrome c-type biogenesis protein CcmF X 
b2203 napB Nitrate reductase cytochrome c550-type subunit 
 b2247 yfaW L-rhamnonate dehydratase X 
b2256 arnD 
4-deoxy-4-formamido-L-arabinose-phosphoundecaprenol deformylase 
ArnD  
 b2261 menC O-succinylbenzoate synthase X 
b2265 menF Isochorismate synthase 
 b2270 yfbK Putative von Willebrand factor 
 b2275 yfbP Uncharacterized protein YfbP X 
b2331 yfcN UPF0115 protein YfcN X 
b2360 yfdQ Uncharacterized protein YfdQ 
 b2377 yfdY Uncharacterized protein YfdY X 
b2420 yfeS Molybdate metabolism regulator X 
b2457 eutM Ethanolamine utilization polyhedral-body-like protein EutM 
 b2463 maeB NADP-dependent malic enzyme 
 b2465 tktB Transketolase 
 b2478 dapA 4-hydroxy-tetrahydrodipicolinate synthase 
 b2482 hyfB Hydrogenase-4 component B X 
b2491 hyfR Formate hydrogenlyase transcriptional activator X 
b2510 yfgJ Uncharacterized protein YfgJ X 
b2513 yfgM Mlr7403 protein X 
b2560 yfhB Phosphatidylglycerophosphatase C 
 
b2601 aroF 2-keto-3-deoxy-D-arabino-heptulosonate-7-phosphate synthase I alpha 
 b2606 rplS LSU ribosomal protein L19p 
 b2628 yfjL hypothetical protein 
 b2644 yfjY UPF0758 protein YfjY 
 b2696 csrA Carbon storage regulator X 
b2706 gutM Glucitol operon activator protein X 
b2714 ascG AscBF operon repressor 
 b2717 hycI Hydrogenase 3 maturation protease X 
b2748 ftsB Cell division protein DivIC (FtsB) 
 b2752 cysD Sulfate adenylyltransferase subunit 2 
 b2760 casA CRISPR-associated protein, Cse1 family 
 b2769 ygcQ Putative electron transfer flavoprotein subunit YgcQ 
 b2776 ygcE Uncharacterized sugar kinase YgcE X 
b2781 mazG Nucleoside triphosphate pyrophosphohydrolase MazG 
 b2784 relA Inactive (p)ppGpp 3'-pyrophosphohydrolase domain 
 b2790 yqcA Hypothetical flavoprotein YqcA X 
b2795 ygdH Decarboxylase family protein 
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b2799 fucO Lactaldehyde reductase 
 b2822 recC Exodeoxyribonuclease V gamma chain 
 
b2840 ygeA 
Uncharacterized protein YgeA of aspartate/glutamate/hydantoin 
racemase family X 
b2880 ygfM Uncharacterized protein YgfM X 
b2881 xdhD Possible hypoxanthine oxidase XdhD 
 b2882 xanQ Putative purine permease YgfO 
 b2883 guaD Guanine deaminase X 
b2903 gcvP Glycine dehydrogenase [decarboxylating] X 
b2916 argP Chromosome initiation inhibitor 
 b2917 scpA Methylmalonyl-CoA mutase 
 b2920 scpC Propionyl-CoA:succinyl-CoA transferase X 
b2921 ygfI LysR family transcriptional regulator YgfI X 
b2925 fbaA Fructose-bisphosphate aldolase class II 
 b2957 ansB L-asparaginase X 
b3003 yghA Putative oxidoreductase X 
b3008 metC Cystathionine beta-lyase 
 b3013 yqhG Uncharacterized protein yqhG precursor 
 b3021 ygiT Transcriptional regulator, Cro/CI family 
 b3032 cpdA 3',5'-cyclic-nucleotide phosphodiesterase 
 b3051 yqiK Inner membrane protein YqiK 
 b3052 rfaE ADP-heptose synthase  
 b3074 ygjH tRNA-binding protein YgjH X 
b3095 yqjA DedA family inner membrane protein YqjA 
 b3096 yqjB Uncharacterized protein YqjB X 
b3150 yraP 21 kDa hemolysin precursor 
 b3157 yhbT Putative lipid carrier protein X 
b3167 rbfA Ribosome-binding factor A 
 b3188 sfsB Ner-like regulatory protein X 
b3210 arcB Aerobic respiration control sensor protein ArcB 
 b3220 yhcG Putative uncharacterized protein YhcG X 
b3251 mreB Rod shape-determining protein MreB 
 b3257 yhdT Membrane protein 
 b3284 smg Protein of unknown function Smg X 
b3288 fmt Methionyl-tRNA formyltransferase 
 b3291 mscL Large-conductance mechanosensitive channel 
 b3317 rplB LSU ribosomal protein L2p (L8e) 
 b3336 bfr Bacterioferritin X 
b3350 kefB Glutathione-regulated potassium-efflux system protein KefB X 
b3393 hofO Type IV pilus biogenesis protein PilO X 
b3416 malQ 4-alpha-glucanotransferase (amylomaltase) 
 b3429 glgA Glycogen synthase, ADP-glucose transglucosylase 
 b3430 glgC Glucose-1-phosphate adenylyltransferase X 
b3432 glgB 1,4-alpha-glucan (glycogen) branching enzyme 
 b3442 yhhZ Uncharacterized protein YhhZ 
 b3483 yhhH Uncharacterized protein YhhH 
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b3484 yhhI H repeat-associated protein, YhhI family X 
b3487 yhiI Uncharacterized protein YhiI X 
b3495 uspA Universal stress protein A X 
b3512 gadE Transcriptional activator GadE X 
b3517 gadA Glutamate decarboxylase X 
b3522 yhjD Inner membrane protein YhjD 
 b3524 yhjG Uncharacterized protein YhjG X 
b3549 tag DNA-3-methyladenine glycosylase X 
b3552 yiaD Probable lipoprotein YiaD X 
b3554 yiaF probable exported protein YPO4070 
 b3562 yiaA Inner membrane protein YiaA 
 b3568 xylH Xylose ABC transporter, permease protein XylH X 
b3573 ysaA Putative electron transport protein YsaA 
 b3574 yiaJ Hypothetical transcriptional regulator yiaJ 
 b3595 yibJ Protein RhsB 
 b3631 rfaG UDP-glucose:(heptosyl) LPS alpha1,3-glucosyltransferase WaaG X 
b3638 yicR UPF0758 protein YicR 
 b3680 yidL Hypothetical transcriptional regulator yidL 
 b3686 ibpB 16 kDa heat shock protein B 
 b3693 dgoK 2-dehydro-3-deoxygalactonokinase 
 b3696 yidX Putative replicase X 
b3697 yidA Sugar phosphatase YidA 
 b3708 tnaA Tryptophanase X 
b3719 yieL Putative xylanase 
 b3724 phoU Phosphate transport system regulatory protein PhoU 
 b3803 hemX Homolog of E. coli HemX protein 
 b3810 yigA Protein of unknown function DUF484 
 b3817 yigF hypothetical protein 
 b3821 pldA Phospholipase A1 
 b3834 yigP Protein YigP 
 b3856 mobB Molybdopterin-guanine dinucleotide biosynthesis protein MobB 
 b3878 yihQ Sulpholipid alpha-glucosidase X 
b3892 fdoI Formate dehydrogenase O gamma subunit X 
b3894 fdoG Formate dehydrogenase O alpha subunit 
 b3899 frvB PTS system, fructose-specific IIB component 
 b3912 cpxR Copper-sensing two-component system response regulator CpxR 
 b3923 uspD Universal stress protein D 
 b3934 cytR Transcriptional (co)regulator CytR X 
b3945 gldA Glycerol dehydrogenase 
 b3965 trmA tRNA (uracil(54)-C5)-methyltransferase 
 b3987 rpoB DNA-directed RNA polymerase beta subunit 
 b3989 yjaZ Heat shock protein C 
 b3993 thiE Thiamin-phosphate pyrophosphorylase 
 b4002 zraP Zinc resistance-associated protein 
 
b4004 zraR 
Response regulator of zinc sigma-54-dependent two-component 
system X 
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b4020 yjbB Sodium-dependent phosphate transporter 
 b4040 ubiA 4-hydroxybenzoate polyprenyltransferase 
 b4071 nrfB Cytochrome c-type protein NrfB precursor 
 
b4080 mdtP Outer membrane component of tripartite multidrug resistance system 
 b4083 yjcS Putative alkyl/aryl-sulfatase YjcS 
 b4119 melA Alpha-galactosidase 
 b4126 yjdI Uncharacterized protein YjdI 
 b4132 cadB Lysine/cadaverine antiporter membrane protein CadB 
 b4135 yjdC Transcriptional regulator, AcrR family 
 b4174 hflK HflK protein X 
b4179 rnr 3'-to-5' exoribonuclease RNase R X 
b4185 yjfM hypothetical protein 
 b4196 ulaD 3-keto-L-gulonate-6-phosphate decarboxylase UlaD 
 b4206 ytfB Putative cell envelope opacity-associated protein A X 
b4255 rraB Ribonuclease E inhibitor RraB 
 b4279 yjhB Sialic acid transporter (permease) NanT 
 b4298 yjhH Uncharacterized lyase YjhH 
 b4305 sgcX Putative sgc region protein sgcX 
 b4311 nanC N-acetylneuraminic acid outer membrane channel protein NanC 
 b4312 fimB Type 1 fimbriae regulatory protein FimB X 
b4316 fimC Chaperone protein FimC X 
b4326 iraD YjiD protein 
 b4333 yjiK hypothetical protein X 
b4357 yjjM Regulator of L-galactonate catabolism YjjM X 
b4365 yjjQ Putative regulatory protein X 
b4366 bglJ Transcriptional activator protein bglJ 
 b4384 deoD Purine nucleoside phosphorylase X 
b4396 rob Right origin-binding protein 
 b4482 yigE hypothetical protein X 
b4539 yoeB YoeB toxin protein X 
b4543 ypaA Uncharacterized protein YfaD 
 b4547 ypfN UPF0370 protein YpfN X 
b4600 ydfJ Putative transport protein 
 b4683 yqeL hypothetical protein 
 b4684 yqfG hypothetical protein 
 b4694 yagP LysR family transcriptional regulator YagP 
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E. coli  AACAAATCATCATCCCCGCCACCCTGTCCTGATCGTTTCCTGAACGATAAATTGTGATCT 
Y. pstb  ----CCTGATGAACTGACTCAGTGTCGCCATTTGGGTGAGTGAGCGTCGCGGT------A 
                    * ** * *     **   *  **   * * *   *** **      *        
 
E. coli  TCGCTGCGTTTCGGGAACGTTCCCGTTTTTAA-------ATTTTTCCGCGCAATATATTC 
Y. pstb  ACACCGAGTAAAAAGGGAATTATAGATTTAATTCGCTGCTGACTTCAGGCAGAGATGGCA 
               * * * **     *    **   * *** *            *** *    * **     
 
E. coli  TGCAGCCAACCAAAAATGTCATCTGCCATGGGGCTTTATGATGAGCAAAATAAACCAAAC 
Y. pstb  TCTCATGCGCGCACGTAACCTTTACGGAAAGGACGATAAAATGGGCAAAGTAAAACAGCA 
              *        *  *      * *     *  ** *  **  *** ***** **** **    
 
E. coli  GGATATCGATCGGTTGATTGAACTGGTCGGCGGGCGC--- 
Y. pstb  GGATATCGATCAACTGATCGTTCTGGTGGGAGGCAGAGAA 
              ***********   **** *  ***** ** **  *     
 
Figure S8: DNA sequence alignment of the treB gene of Y. pseudotuberculosis YPIII and E. coli K12. ClustalO was used 
for the alignment of the E. coli treB (b4240) and Y. pseudotuberculosis treB (YPK_0495) upstream region (-50 to +20 
relative to the translational start site) with default parameters. Nucleotides which were identical in both species are marked 
with a star below the sequence. The positions of high-affinity (ANGGA - pink), low-affinity CsrA binding motifs (green) and 
the start codon (underlined) are indicated. 
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E. coli  GTCATGGTCAATCATCCTGTTAGCAATATGCTTTAAGTTTACAGGATTTTTACCCCTAAG 
Y. pstb  ------ATCACTCAACAGAA--------TAACTCAACGGTTCTGCGGTGGTCATCGCAGA 
          *** *** *            *   * **   * * *   *  *   *  *   
 
E. coli  GGCTGATAAC----------------------GCTCATACTGGTCACAACGGCAGCAAA- 
Y. pstb  GGCAAATGACTACAATGCTCCCTAACGACGAAGCCTTTGCGACTCTCTACTACAACGGAG 
   ***  ** **                      **   * *   ** * **  ** *  *  
 
E. coli  ------GCATTACACTATGCGCCCTGCATTCCTGGCTACTATTTCGCAAGAGCAAGTCGA 
Y. pstb  ATTATCTACCACAACGGAGTACCGCACGGAACGAGGTGATTTTGATGATGAATAACCCGA 
                **   *  **   *    *  * *  * **    * **  **  *** 
 
E. coli  TGACCAAAAAACTCCATATTAAAACCTGGGGCTGTCAGATGAACGAGTACGATTCATCG 
Y. pstb  TGACTAAAAAACTGCATATCAAAACCTGGGGTTGCCAGATGAAT--------------- 
   **** ******** ***** *********** ** ********                 
 
Figure S9: DNA sequence alignment of the miaB gene of Y. pseudotuberculosis YPIII and E. coli K12. ClustalO was 
used for the alignment of the E. coli miaB (b0661) and Y. pseudotuberculosis miaB (YPK_3005) upstream region (-50 to +20 
relative to the translational start site) with default parameters. Nucleotides which were identical in both species are marked 
with a star below the sequence. The positions of high-affinity (AGGA - red; ANGGA - pink) and the start codon (underlined) 
are indicated. 
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E. coli  CTTAAGCGGGAGAAATAAAATTCAGCGGCGTCCTGACGC---CAGAGTAAAGTAATCACA 
Y. pstb  -TTC---TTTCGAATGGTCATAAAGAGATGTCTTATGTACATGTTGGCAATGGGCTACAA 
    **        ***     **  ** *  *** *            * ** *   *   * 
 
E. coli  GCGGGAGATAACGTCTTCATCAGTCCTGACTCTACTGGCTATGTGCCGGGTAGCATGAAA 
Y. pstb  GGCTGCATAAATCACTAAGACAGTGGTGGCAGGA----GTTTACCGCAGGCAGGAATAAA 
   *   *    **   **    ****  ** *   *     * *    * ** ** *  *** 
 
E. coli  TAATTAGCGCCAACA-----ATTTAGCAGGAGTTAACAATGTTTGCAGGTTTACCTTCAC 
Y. pstb  CAGGTATACTCAATAAATTATATGTAGGAGATCAATAGATGCTAGCGGGTATGCCTTCAC 
    *  **    *** *       *      **   *   *** * ** *** * ******* 
 
E. coli  TCACCCATGAACAGCAGCAAAAAGCTGTCGAGCGGATC 
Y. pstb  TTTCCCATGAGGAACAGCAAGAAGCGGTTGAACGTATT 
    *  *******  * ****** **** ** ** ** ** 
 
Figure S10: DNA sequence alignment of the yoaH gene of Y. pseudotuberculosis YPIII and E. coli K12. ClustalO was 
used for the alignment of the E. coli yoaH (b1811) and Y. pseudotuberculosis yoaH (YPK_2448) upstream region (-50 to +20 
relative to the translational start site) with default parameters. Nucleotides which were identical in both species are marked 
with a star below the sequence. The positions of high-affinity (AGGA - red), low-affinity CsrA binding motifs (green) and 
the start codon (underlined) are indicated. 
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E. coli  -----CAAGGCTTCTTCTCCATCGGTATCGCCTTTATGGCCGTCATCATTGTAATTGCAC 
Y. pstb  ATATATAAAATCACTCTCCAATAGATTTCAAGATACAGAGCGGCGGCAACTGGATGGCAC 
         **     **   * ** * * **    *   *  ** *  **     ** **** 
 
E. coli  TG----------GCTTATATGTTCTTCGCTGGCCGCGCGCTGCGCGCAGAAGAAGATGCA 
Y. pstb  CCAAGAGCGGACACAAGTCAGTAATTAGGGGGA---ACGAAGGAAGCCAAC--------- 
                *   *  **  ** *  **     **  *   **  *           
 
E. coli  GAAAAACAACTGGCAGAACAGTCTGCTTAATAAGGAGTTTTGAT--TATGACCGTACGTA 
Y. pstb  -----------GCATCTGCAACTTGCAAGATAACGAGTAAAAAAGGAAAGAAAATGAAAA 
              *      **   ***   **** ****    *    * **   *    * 
 
E. coli  TTCTGGCTGTGTGTGGCAACGGACAAGGCAGTTCCATGATCATGAAG------ 
Y. pstb  TTACAGTGGTCTGTGGTAACGGTTTAGGAACCAGTTTGATGATGGAAATCAGC 
   **   *  ** ***** *****   *** *      **** *** *        
 
Figure S11: DNA sequence alignment of the ulaB gene of Y. pseudotuberculosis YPIII and E. coli K12. ClustalO was 
used for the alignment of the E. coli ulaB (b4194) and Y. pseudotuberculosis ulaB (YPK_1547) upstream region (-50 to +20 
relative to the translational start site) with default parameters. Nucleotides which were identical in both species are marked 
with a star below the sequence. The positions of high-affinity (AGGA - red; ANGGA - pink), low-affinity CsrA binding 
motifs (green) and the start codon (underlined) are indicated. 
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P. aeruginosa ------GTCTTTTATAATCCGGTATCACCCGATGTGTCTTCCCGAGGCG-ACGAAACGCC 
Y. pstb  CGTAACGATTGGTGTAATGGAATAACGATCGGT--GTAATGGAATAACGGCCGACGCGAT 
           *  *  * ****    ** *   ** *  **  *       **  ***  ** 
 
P. aeruginosa GGAAAGCCGTCGGGCCAGCCTGGATGCGAACCGAAATCCCTCG-GGCACGGGGGTGAGCG 
Y. pstb  GGAATAACGGTCGG----CATGATGAAATAACGACCCGCGTTGTGAAATAGCGATCAGCG 
   ****   **   **    * **       * ***    * * * *  *  * * * **** 
 
P. aeruginosa CCTGGAAGAGCCGGGCGC-------------TGGCAATGCAAGGAGTAGCAATGCCGCTG 
Y. pstb  TTATGAAATAAGAATCAGTATTCAGGAAGAGACACCATGGATAAAAAACAACCAACGCTG 
       ***        *                  * *** *   *  *  *    ***** 
 
P. aeruginosa CGATTGACCATCACCAGCTACCACAAGCTGACCCCCGGTCAGTGTTCGGAA 
Y. pstb  TCATTGCGGGTCGTCAACAGCGATAAATTAGAGA-------GT-------- 
     ****    **  ** *  * * **  *            **         
 
Figure S12: DNA sequence alignment of the fha gene of Y. pseudotuberculosis YPIII and P. aeruginosa PAO1. ClustalO 
was used for the alignment of P. aeruginosa (P0081) and Y. pseudotuberculosis (YPK_0391) upstream region (-50 to +20 
relative to the translational start site) with default parameters. Nucleotides which were identical in both species are marked 
with a star below the sequence. The positions of high-affinity (ANGGA - pink), low-affinity CsrA binding motifs (green) and 
the start codon (underlined) are indicated. 
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P. aeruginosa TTGACAAGCCTTGCGGCATGCCACAAGAATTTTGCC-----AACCTTTCGAGTCATCCAA 
Y. pstb  --GGTATGTAAATCAGGATGATTATAAAATATACAAACAGGGAGGTTATAAATCATGTAC 
      *  * *     * * ***     * *** *          *  **   * ****  *  
 
P. aeruginosa TATTCATCAATGGCTCCTACAAGATCCGACGGAGTGGATCTTACAAGCGAAGGTGAGGGC 
Y. pstb  TT---------GACTTTTAAATTCCACATAAGGTTAGCCTCAACCAGCGAATAGCAAGGA 
   *          * **  ** *     *    *  * *     ** ******    * **  
 
P. aeruginosa CGCGCAGCGGC--TTCGATGATA-GGGAGATCGTCACCGTGCTGGATGTACCCGTTTTGC 
Y. pstb  ATAGCAAGCTATTTTTGATTTTAAAACGGATGGACAATAATATG--AGTGACATATTTCC 
      ***       ** ***  **     *** * **      **   **  *   *** * 
 
P. aeruginosa TG--------GCTGCCGTATCCCCGGACTCGCCCTGTGGCGACGATC 
Y. pstb  TCAAGCATTATTCGGCGTTGAATATGATCCGGCCTATGGCGAG---- 
   *            * ***       **  ** *** ******      
 
Figure S13: DNA sequence alignment of the impA gene of Y. pseudotuberculosis YPIII and P. aeruginosa PAO1. 
ClustalO was used for the alignment of the P. aeruginosa (P0082) and Y. pseudotuberculosis rovA (YPK_3566) upstream 
region (-50 to +20 relative to the translational start site) with default parameters. Nucleotides which were identical in both 
species are marked with a star below the sequence. The positions of high-affinity (AGGA - red; ANGGA - pink), low-affinity 
CsrA binding motifs (green) and the start codon (underlined) are indicated.
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